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“Even if I knew that tomorrow the world would go to pieces, 
I would still plant my apple tree.” 
Martin Luther 
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Chapter 1 : Towards artificial extracellular matrix 
and controlled cellular fate in 3D 
 
Abstract 
The design parameters required for artificial extracellular matrix (ECM) that successfully 
induce pre-vascularisation will be defined and evaluated. The importance of stiffness in 
controlling cellular fate will be evaluated and redefined to highlight the importance of a 
previously ignored mechanical signalling queue, which is present in natural ECM, namely 
strain stiffening.  
  
The ultimate goal in tissue engineering is to control cellular fates. In order to do this 
one needs to precisely mimic the behaviour of the extracellular matrix (ECM) in vitro so as 
to elicit cellular responses that are identical to those induced naturally. If cells behaved as if 
in native tissue it would be possible to obtain more accurate tissue and wound healing 
models that would make it possible to obtain tissue that more closely resembles native 
tissue [1]. Once generated, newly formed tissue must be sustainably supported meaning it 
must be properly vascularised to facilitate the efficient transfer of oxygen, nutrients and 
waste products [2]. The search for tissue mimetic environments is advancing at a rapid pace 
[3]. Functional biomimetic materials that mimic the ECM are expected to play a pivotal 
role in the field of tissue engineering and regenerative medicine. The level of complexity 
required in such tissue mimetic environments varies from the interplay of chemical triggers 
(cell adhesion ligands), to the material properties (stiffness) and micro architectures [4-5] 
(porosity), all of which affect cellular fates. In nature the decision of a cell to differentiate, 
proliferate, migrate, apoptose or perform other specific functions is as a result of a 
coordinated response to the complex spatio-temporal biochemical and biomechanical cues 
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from the cellular microenvironment [6]. The cellular microenvironment is a self assembled 
network composed of a mixture of insoluble hydrated fibrillar, helical, finite bundled, strain 
stiffening polymers such as fibrinogen and collagen in the ECM, and intermediate 
filaments, actin filaments and microtubules in the intracellular matrix (ICM) (Figure 1). 
Within this self assembled network there are also soluble macromolecules (chemokines) in 
combination with larger molecules imbedded on the surfaces of neighbouring cells 
(proteins and cell adhesion ligands) to provide chemical signals within the intercellular 
environment (Figure 1b).  
 
A) 
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 Figure 1. a) An artistic representation of the cellular microenvironment demonstrating the interconnectivity of the intracellular (intermediate �ibres, actin �ibres lp=15 µm, microtubules lp=6000 µm) and extracellular matrix (collagen, �ibronectin lp=1000 µm) [7] b) Model of self assembled components in the cellular microenvironment: cell-cell (calcium bridges); cell-ECM interactions; matrix metalloproteinase (MMP) cleavable peptides (pink); �ibrous scaffold (green) with cell adhesion ligands (yellow); cell excreted ECM in blue [8] .
The primary design inputs identified by Hubbell and Lutolf required for a synthetic 
ECM-like scaffold include: high water retention capacity, tenacity for holding cells in a 
stretched position, porosity allowing cells to grow/migrate in 3D, the free flow of nutrients 
and oxygen, the presentation of chemical signals like receptor-binding ligands, 
biodegradability or rather the ability to be remodelled by cells to create space for newly 
formed tissue [3].  
B) 
Integrin
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The influence of matrix stiffness on cellular fate is generally accepted to be directly 
related to its stiffness [9-10]. This is beautifully illustrated in Figure 2 by the image 
illustrating breast tumor cellular fate once exposed to different matrix stiffness could be 
reverted into non-malignant phenotype by adjusting the matrix stiffness [11]. 
 
 
Figure 2. All cells, including those in traditionally mechanically static tissues, such as the breast 
or the brain, are exposed to isometric force or tension that is generated locally at the nanoscale 
level by cell–cell or cell–extracellular matrix interactions and that influences cell function. By 
changing the stiffness of the matrix it is possible to tune phenotype [11]. 
In this chapter the state of the art relating to the development of synthetic ECM 
materials for vasculogenesis, the analysis of the gaps in current knowledge and the 
identification of the key hurdles to be overcome in realising completely synthetic ECM 
mimics capable of predetermining cellular fate will be discussed.  
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Why use hydrogels as tissue mimetic materials: Hydrogels are uniquely suited in 
their material properties for tissue scaffolds, because of their innate similarities to the ECM, 
high water content, easy transport of oxygen, nutrients and waste [12] and the potential to 
act as a 3D scaffold for cells. A plethora of hydrogels have been screened for their ability to 
function as tissue mimetic materials amassing a vast pool of knowledge that relates to 
scaffold properties such as cellular attachment, molecular response, structural integrity, 
biodegradability, biocompatibility and solute transport designed to meet the proliferative 
demands of the newly formed tissue [13]. To not overcomplicate the comparison of 
different tissue mimetic materials and purely focus on material properties (design 
parameters of the artificial ECM), the effect of soluble factors in cell culture media was 
ignored. It is however known that the addition of soluble growth factors and various salts 
does affect cellular fate [14]. The various hydrogels used as tissue mimetic materials can be 
classified into three categories: natural, hybrid or purely synthetic.  
Natural hydrogels or materials from a natural sources used as tissue mimetic materials, 
e.g., collagen with stiffness of ca 7.5 kPa and pore sizes of 2-15 µm [15-21], gelatin [22-
26], cellulose [27], hyaluronic acid (HA) [28], HA-collagen [29], alginate [30-31], fibrin 
with stiffness of 200 Pa at a concentration of 2 mg/mL and pore sizes of 2 - 4 µm [[32-38]], 
PureCol [39], MatrigelTM with pore sizes in the nm range [39-45], have all been used as 
tissue mimetic materials. Natural materials (collagen, fibrin, hyaluronic acid) inherently 
contain biological signals (cell adhesion ligands), hydrogels formed from these materials 
tend to be mechanically weak and manipulation of their chemical and physical properties 
requires chemical crosslinking reactions. Matrigel is a hydrogel derived from mouse 
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sarcoma, which has a low stiffness (440 Pa at 8.2 mg/ml) [46], suffers from batch to batch 
variation and is chemically ill-defined, inherently confounding observations made in this 
system as the matrix itself can influence the results. 
Fully synthetic hydrogels based on the following polymers were used as tissue mimetic 
materials: polyethylene (glycol) (PEG) with a stiffness of 192 Pa with pore sizes of 23 nm 
[47-49], polyethylene (glycol) diacrylate (PEGDA) [50], PEG-PEGDA-KQGDV [51],  
fibrous self-assembling peptide amphiphile or PuraMatrix with stiffnesses ranging from 46 
- 15 000 Pa and pore sizes of 50-200 nm [39,52-53], polyalanine-poly(propylene glycol)-
PEG-poly(propylene glycol)-polyalanine [54], poly(N,N-diethylacrylamide)-YIGSR [55], 
poly (2-hydroxyethyl methacrylate)-polyethylene terephthalate [56-57], poly(N-
isopropylacrylamide)-co-PEG-GRGDS [58], PEG-polypeptide [59]. The polymers are well 
defined chemically and mechanically, but without modification biologically inert. To make 
synthetic materials more biologically active the addition of cell regularity cues to guide cell 
function e.g. cell adhesion ligands (GRGDS) and growth factors are needed [1].  
Hybrid hydrogels consisting of synthetic and naturally derived materials, e.g., 
poly(caprolactone)-collagen & HA[60], PEGDA-HA-gelatin or ExtracelTM with stiffnesses 
between 4-100 kPa [28,39], PEG-fibrinogen with stiffness of upto 45 kPa and pore sizes of 
100-150 µm[61-63],  polylactide-chitosan [64], PLA-gelatin spheres [65], PEG-gelatin-MA 
[66], poly(N-isopropylacrylamide) (PNIPAM)-chitosan [67], PLGA-alginate [68], 
cellulose-polyvinyl alcohol (PVA) [69], poly(epsilon-caprolactone): -chitosan [70]; -
collagen [71]; -fibronectin [72]; -fibrin [72]; -gelatin [73]. Hybrid materials encounter the 
same issues as natural materials that although cellular signals are available, the inherent 
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nature of the naturally sourced material could result in batch to batch variation and potential 
contaminations so it is difficult to quantify what parameters control cell behaviour.[74]. 
Another problem is that by varying the ratio of the synthetic to natural components the 
cellular responses will be affected further complicating interpretation of results. If the 
mechanical stiffness would increase by increasing the concentration of the synthetic 
material simultaneously resulting in a decrease in cellular signals from the natural source, a 
change in porosity and consequently the cellular fate could be induced. 
As can be seen in the previous section, hydrogels as artificial ECM may vary in 
stiffness from 200 – 100,000 Pa and pore sizes from 23 – 150,000 nm. These values are for 
tissue mimetic materials used for everything from tissue culture to injectable materials that 
facilitate wound healing. Still it does seriously challenge the theory that matrix stiffness 
alone effects cellular fate. Before any hard conclusions can be drawn however, let us 
narrow the focus to tissue mimetic materials specifically used to induce vasculogenesis. 
 What tissue mimetic materials have specifically been used for vasculogenesis? As 
discussed earlier, it is not enough to simply affect cellular fate in tissue mimetic 
environments, but the environment also needs to direct cells (human umbilical vein 
endothelial cells (HUVEC) and endothelial progenitor cells) in combination with smooth 
muscle cells to undergo vasculogenesis (formation of vasculature). Its role is ultimately to 
form a pre-vascularised construct that will survive to bridge between native tissue and an 
implanted organ, construct or implant. 
A naturally sourced hydrogel that has been used to induce vasculogenesis is a fibrin 
hydrogel that induced myoblast tube formation of human myoblast cells [32]. Another 
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naturally sourced hydrogel Matrigel was used to both inhibit and induce the sprouting of 
HUVEC [75]. The stiffness of both these natural tissue mimetic materials were in the Pa 
range [46], but the pore sizes of fibrin gels are 2-4 µm whereas those of Matrigel are in the 
nm range [37,76] the relevance of pore size will be discussed later in this chapter, but 
briefly in the case of Matrigel the cells were able to remodel the matrix to enable migration 
through the matrix. 
Hybrid hydrogels consisting of dextran-gelatin have also been used as a matrix to co-
culture smooth muscle cells and human umbilical artery endothelial cells, again the cells 
were seen to sprout and deposit their own ECM [77]. In a similar dextran-gelatin hydrogel 
with stiffness of 800-3000 Pa, human umbilical artery smooth muscle cells were seen to 
spread, proliferate and form extensive cellular networks [78]. Hyaluronic acid-collagen 
hydrogels were used to line a microfluidic device, coated with HUVEC, the addition of 
growth factor and RGD resulted in some migration and the onset of tube formation, but 
detachment from the device/hydrogel occurred within five days [29]. An in vivo tissue 
mimetic model was created by co-culturing retinal stem cells and progenitor cells (RSPC) 
with endothelial cells in agarose covalently labelled with GRGDS and a gradient of 
vascular endothelial growth factor (VEGF), it was possible to both induce and inhibit 
sprouting of the RSPC [79]. In a hybrid PEG-fibrin hydrogel migration and sprouting of 
smooth muscle cells was observed [61]. An interpenetrating network of porous (100-150 
µm) PEG and fibrin was implanted subcutaneously into mice to obtain vascularised 
structures over a 3 week period [63]. A poly(Ɛ-caprolactone)-collagen and hyaluronic acid 
tissue mimetic material was used to study the co-cultured of HUVEC and lung fibroblast 
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cells in vitro, exposed to VEGF and platelet derived growth factor over a five weeks 
primitive capillary networks and HUVEC infiltration was observed [60].   
Therefore in hybrid hydrogels various cellular fates were observed from sprouting to 
vasculogenesis, but it is difficult to define which parameter caused this as there are 
covalently immobilized cell adhesion ligands (variable concentrations), broad stiffness 
ranges and in some cases even covalently immobilized growth factors.  
A synthetic hydrogel consisting of PEG and biologically degradable MMP bonds was 
used to co-culture mesenchymal stem cells and smooth muscle cells, resulting in the 
differentiation of stem cells into more natural smooth muscle cell phenotypes than those 
obtained on conventional 2D surfaces and the proliferation of both cell types over 3 weeks 
[48]. This would suggest that the dynamic nature of matrix and decomposition over time 
could be important material properties. A synthetic block copolymer consisting of PEG 
containing proteolytically cleavable peptides (collagenease and elastase) and cell adhesion 
ligands RGD and KQAGDV was used to investigate SMC migration and degradation of the 
synthetic tissue mimetic material [51]. In another system based on PEG containing RGD 
and a transforming growth factor peptide β1 was used to induce sprouting and the up 
regulation of MMP in HUVEC in 2D cell culture environment [49]. Smooth muscle cells 
(SMC) were cultured on top of PEG hydrogels containing gradients of basic fibroblast 
growth factor and over a time span of 48 h, SMC were seen to align and migrate 
preferentially in the direction of the increasing growth factor gradient when compared to 
controls [80].  From this it is safe to conclude that covalently attached growth factors and 
cell adhesion ligands in a artificial ECM are critical to successful vasculogenesis. 
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Angiogenesis of HUVEC and human microvasculature endothelial cells was investigated 
by culturing cells on top of PEG covalently modified with VEGF and RGDS, showing that 
the cells were able to proliferate, migrate and survive apoptosis in the synthetic 
environment [81]. Other synthetic systems of interest are those based on ionic self 
assembling peptide gels or PuraMatrixTM, which are thought to gelate through the formation 
of a network of peptide β-sheets filaments [82]. HUVEC cultured in 3D inside this 
synthetic tissue mimic with stiffness lower than 100 Pa, elongated and formed 
interconnected capillary networks within two days [52].  This is surprising as the current 
accepted theory of matrix stiffness affecting cellular fate would suggest that this result 
should only be possible at matrix stiffness of ca 3000 Pa (Figure 2), perhaps the effect of 
matrix stiffness cannot be so easily defined. This would suggest that equally important 
factors such as the presence of covalently immobilized growth factors, cell adhesion ligands 
and topography must be included in designing artificial ECM for vascularisation.  
Some conclusions based on the current state of the art on tissue mimetic materials 
used for vasculogenesis: Natural and hybrid hydrogels always induce a cellular response, 
whereas synthetic hydrogels require the presence of covalently bound ligands that can 
interact with the cells. The stiffness that resulted in successful sprouting in vitro varied over 
several orders of magnitude between 46 – 3000 Pa. The pore sizes were known to vary 
from nm – µm range.  
Hybrid materials however appear to have more success in eliciting  cellular responses 
when compared to the purely synthetic systems which leaves the author to postulate that not 
all the design parameters required for tuneable cellular fates which are present in naturally 
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derived materials have been clearly identified and built into the synthetic systems. Not one 
individual element is responsible for guiding cellular fate but perhaps a somewhat 
neglected essential element is the mechanical response of cell-matrix bond, which for 
natural systems or hybrid systems would be the strain stiffening behaviour of the scaffold, 
which is not present in most synthetic materials. Therefore it is fair to assume that not only 
microenvironment, architecture, porosity and stiffness play a role in cellular fate but also 
the behaviour under strain either linear or non linear has an effect on cellular fate. 
Synthetic design parameters identified from state of the art: The design parameters 
for a synthetic tissue mimetic material for vasculogenesis are: the presence of cell adhesion 
ligands (RGD); variable bulk stiffness and fibre stiffness that responds to mechanical 
stimuli in a similar fashion as natural material (strain stiffening) in that it requires very little 
force to rapidly stiffen (to be discussed in more detail see Figure 7) soft gel 100 Pa  to 
1000-10000 Pa; porosity, mesh size and permeability in the µm range and if pore size is in 
the nm range the network itself must be sufficiently soft to enable cellular remodelling and 
ultimately the degradation of the scaffold to make room for newly formed tissue over time. 
In this chapter these design parameters and their ability to induce cellular fate (stem 
cells, endothelial cells, smooth muscle cells) will be evaluated starting with mechanical 
aspects, i.e. bulk and fibre stiffness, non linear behaviour fibre and its effect on effective 
stiffness, pore size which affects bulk stiffness, chemical signals/ligands cell-matrix 
interactions and matrix topology. From all this information, an attempt will be made to 
define the design parameters required to mimic the ECM successfully and control cellular 
fate. Firstly we will look in depth at the effect of all the stiffness present in the tissue 
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mimetic material (Figure 2), biological triggers and finally topology to which the cells are 
exposed and how these factors effect cellular fate. 
So what is stiffness and how do you control it? Stiffness is the rigidity of an object 
and the extent to which it resists deformation in response to an applied force [83]. 
 
Figure 3. Illustration of the concept of stiffness, an external force is applied to a cube, the 
distance the cube is deformed (dx) is related to its stiffness, i.e. a larger dx meaning a lower 
stiffness. Where    is the sample thickness. 
 The stiffness (k) of an object can be defined as its resistance to deform (displacement 
dx) under an applied force (F), i.e. the value required to bend or stretch the fibre. 
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In this thesis bulk stiffness is a value determined through rheology. It is a general term 
referring to the dynamic modulus G of a viscoelastic network that consists of many 
individual fibres much like the ropes of a fisherman’s net. The stiffness here refers to a 
value required to deform the network under oscillating shear, but because the material 
behaves as both a liquid (loss modulus G”) and a solid (storage modulus G’) the more solid 
like its behaviour the stiffer it will be.  
Bulk stiffness = dynamic modulus   
      
      
 
But           
Where       
Stress:    
  
  
      
Strain:    
  
  
      
Where    and   are the amplitudes of stress and strain and   is the phase shift between 
them. 
 
In Figure 4 the various stiffness and force elements present in the matrix that affect 
cellular fate are illustrated. The bulk stiffness in most hydrogels is affected by the degree of 
crosslinking. Therefore the bulk stiffness in terms of the cell is how hard the cell has to pull 
on or push, to squeeze through the hydrogel as a whole. Fibre stiffness affects the cells 
more directly as it affects the mechanical response of the fibre to external stimuli, which in 
turn affects the forces experienced at the cellular surface. Therefore the force the cell 
experiences at the cellular membrane via the fibre/ECM is affected by the type of material 
the ECM consists of e.g. elastic linear response or a non-linear strain stiffening response. 
Cell-matrix forces measured in natural systems (non-linear fibrillar matrix) are 
approximately 43 pN [84]. This force affects the degree of focal adhesions and variations of 
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this force (12 -55 pN) results in tuneable cellular fates [84]. In designing the perfect 
synthetic ECM, this effect on cell-matrix forces via bulk stiffness and fibre stiffness should 
not be ignored and may even be used to actually direct cellular fate. 
 Figure 4. Image of the mechanotransduction forces and stiffness involved in cellular fate, the grey balls depict the cellular membrane; the green �ibre depicts the network component; orange balls depict the chemical soluble factors produced by the cell as a result of mechanical forces either with the network or other cells [85-87].  
What is the effect of stiffness in 2D on cell fate? The bulk stiffness of the ECM is 
thought to have an important influence in the function of cells, the seminal study in this 
field by Engler et al. elucidated the profound effect of substrate stiffness on the fate of stem 
Actin fibres
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cells in 2D culture conditions. Mesenchymal stem cells (MSCs) were cultured on 
polyacrylamide hydrogels of varying stiffness, coated with collagen I. At a gel stiffness 
mimicking that of brain tissue (0.1 – 1.0 kPa), differentiation into neuronal cells was 
induced. In gels of intermediate stiffness (8.0 – 17.0 kPa), muscle cells were formed 
(myogenesis). When the gels were even stiffer (25.0 – 40.0 kPa), close to the stiffness of 
the collagenous bone tissue, the MSCs differentiated into bone cells (osteogenesis). Thus, it 
was clear from this study that a substrate having stiffness resembling a particular tissue 
would induce differentiation into that particular cell lineage [88].  
An important point to note in the context of the stiffness of 2D substrates is that, in 2D 
cell culture condition, cells are seeded on the surface of a substrate that has been either 
coated with ECM fibrillar material (e.g., collagen I), or, functionalized with cell-interactive 
ligands, in which case, these ligands are presented on the surface of the substrate for cell-
substrate interaction. In order for the cell to sense the substrate stiffness, there should be a 
mechanical coupling between cell, mediator (ECM or cell interactive ligand) and substrate. 
In this event, when the cells pull the ECM material, the mechanical feedback of the material 
will include the information of material-substrate interaction. In the case of cell-interactive 
ligands the feedback should directly reflect the mechanical properties of the substrate 
however in the case of ECM coated substrates it is necessary to de-convolute the feedback 
of substrate and mediator. Huck and co-workers have recently demonstrated that MSCs 
cultured on collagen coated PDMS substrates of different stiffnesses did not show any 
difference in cell attachment and differentiation as a function of stiffness [89]. This is 
because collagen cannot penetrate into PDMS therefore the coupling and transfer of 
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information between mediator and substrate is highly inefficient. However, when PDMS 
was replaced with polyacrylamide (PAAm) gels, the stiffness of the gels affected 
differentiation of the cells. Unlike PDMS, PAAm gels are porous, and the porosity 
decreases as the stiffness of the hydrogel is increased, resulting in smaller distance between 
the anchoring points of the collagen, and thus eliciting greater mechanical feedback 
required for integrin clustering, affecting the morphology of the cells.  
What is the effect of bulk stiffness in a 3D matrix on cell fate? The question 
therefore has arisen how does this knowledge of the role of matrix stiffness in 2D cell 
culture conditions translate into 3D? This question is important, since in reality cells are 
immersed and interact within a 3D space. To fully understand the role of the mechanical 
properties relating to the ECM cell interaction there must be a translation of the current 
state of the art 2D data into 3D applicability. Not surprisingly dimensionality has a 
fundamental role that can influence cell response in a significant way; let’s say the cell is 
like a scuba diver, our diver would be much happier under water surrounded by water than 
slithering on top of a shallow puddle. Keeping in mind that both the cell shape and degree 
of spreading have an important role in cell signalling and the eventual cell fate, care must 
be exercised in applying the knowledge from the 2D system in the 3D microenvironment. 
Elucidating the exact role of stiffness in regulating cells in natural hydrogels is a difficult 
proposition, as modifying stiffness is non-trivial. While the bulk mechanics of natural 
hydrogel can be made effectively more stiff by increasing concentration [90-91], this results 
in a decrease in mesh size, an increase in cellular confinement, resistance to transport, and a 
change to the local concentration of ligands presented to cells cultured within [92]. In 
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hybrid hydrogels such as PEG-fibrinogen or collagen-agarose [93] it is possible to tune 
stiffness independent from ligand concentration [61-62], however, the mesh size of hybrid 
hydrogels is commonly much smaller than that of natural hydrogels, thus increasing both 
resistance to transport and cellular confinement. 
One clear example of the above problem of translating the effect of bulk stiffness on 
cellular spreading from 2D into 3D was recently observed by Mooney et al. [94]. They 
explored the effect of stiffness on tuning MSC fate in PEG-RGD and alginate-
G4RGDASSK[TAMRA]Y hydrogels. A clear correlation of MSC differentiation with the 
matrix stiffness was observed in these hydrogels, in agreement with the original finding 
from Engler’s [95-96] work on 2D polyacrylamide substrates.  Unlike the stretched and 
elongated cell structures found on 2D; the cells in 3D retained almost spherical morphology 
in hydrogels of varied stiffnesses, and the differentiation showed a biphasic response to the 
stiffness of the matrix. Mooney proposed that cells employed traction forces to dynamically 
remodel the matrix for integrin-RGD clustering and that this is what ultimately decides 
cellular fate and not the stiffness of the matrix it finds itself in [94]. A complicating factor 
to this theory of reorganization for synapse formation is the inherent strain stiffening 
behaviour of natural fibres [97], as even at very low forces the matrix will once passing its 
critical stress, rapidly increase in stiffness hampering cluster formation. We therefore 
propose that remodelling of the ECM to induce cluster formation would be possible only if 
the rate of remodelling is slow enough to ensure cluster formation prior to entering into the 
non-linear stiffness regime. 
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 Figure 5. Schematic demonstrating concept of cell employed traction forces to dynamically remodel the matrix (green �ibres) for integrin-RGD (red and blue Y) clustering [94].  
Thus, from the results of Mooney’s work, it is intuitive to conclude that traction force 
induced deformation of the matrix in concert with the inherent matrix stiffness, is the 
guiding parameter for cell fate in 3D tissue mimetic materials. However, the situation in 3D 
environment is highly complex and perhaps such a simplistic explanation is too trivial. 
Indeed, Burdick and co-workers have demonstrated that, in covalently cross-linked gels 
based on alginate, dextran or hyaluronic acid, adipogenesis was preferred over osteogenesis 
over a wide range of gel stiffness (4-90 kPa) [28]. This result directly contrasted the finding 
from Mooney’s work, where osteogenesis was the preferred differentiation lineage at 20 
kPa gel stiffness. This difference can be attributed to the fact that covalent cross-linking 
prevented structural mobility in Burdick’s gels, unlike the ionically cross-linked hydrogels 
in Mooney’s work, thus resisting the matrix remodelling required for integrin clustering and 
osteogenesis. The bulk stiffness in terms of crosslink bond strength, as the dissociation 
constant of a covalently cross-linked system would be much higher than that of an ionically 
Cell
 traction
Integrin
Integrin cluster
Bulk Matrix
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cross-linked system, affected the cell-matrix forces that the tissue mimetic material could 
withstand before deforming or breaking. 
The argument that integrin clustering and synaps formation guides cellular fate was 
further supported by the work of Kotlarchyk et al. who observed that by generating 
stiffness gradients in natural (fibrin) hydrogels by directly altering the tensile stress state of 
the hydrogel’s fibre network through the application of shear strain the micro-mechanical 
gradients formed directly affected the morphology of aortic smooth muscle cells cultured in 
this tissue mimetic material [38]. 
Some specific examples of bulk stiffness on cell fate in hybrid hydrogel systems: 
Hyaluronic acid (HA) hydrogels have been used extensively to study the effect of varying 
gel stiffness on cell response. It is clear that surfaces like glass or polyurethane membranes 
coated with a functional ligands are purely 2D, but once a surfaces is coated with a fibrin or 
polyacrylamide hydrogel layer, this changes to a pseudo 2 1/2 D layer  that does not 
completely encapsulate the cells (resulting in a limited dimensionality as the cells are 
exposed to air on the one side and a soft wet hydrogel on the other side). The HA based 
systems have been investigated both as 2 1/2D and completely 3D systems. Such HA based 
systems also generally contain gelatin and PEGDA crosslinkers to refine the material 
properties. Prestwich et al. synthesized HA membranes with different ratios of thiolated 
HA, thiolated gelatin, and crosslinkers. A wide range of gel stiffness (11 Pa - 3500 Pa) 
could be accessed by varying the concentration of the thiolated HA and the cross-linking 
density. In essence, addition of thiol-modified gelatin reduced bulk stiffness by diluting the 
thiolated HA concentration, increasing the percentage of gelatin (an ECM material that 
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promotes cell adhesion) decreased the overall stiffness, which led to a change in fibroblast 
phenotype (from rounded to fully spread) [98-99]. In another study, HA (1 wt%) gels with 
increasing PEGDA (cross-linker) and constant concentration of covalently bound 
fibronectin domains, adult human dermal fibroblasts (HDFs) modified their mechanical 
response in order to match hydrogel stiffness, meaning that the cells on stiffer substrates, 
had more organized actin cytoskeletons and more extended morphology [100-101]. 
Similarly, in the migration studies of HDFs, traction stresses correlated to the stiffness of 
the hydrogel, and high stresses led to nuclear distortion [102]. Young et al. found that the 
time-dependent stiffening of thiol-modified HA hydrogels enhanced cardiomyocyte 
differentiation in vitro. The increase of the elastic modulus mimicked the increase in 
modulus during embryo heart development, suggesting that time dependent dynamic 
material properties could enhance cell maturation in engineered tissues. This is an example 
of the mechanical feedback mechanism affecting directly cellular fate [95]. In another 
study, MSCs were cultured on ExtracelTM at elastic moduli that matched muscle (20 kPa) or 
brain (2 kPa) tissue stiffness  and over ninety MSC-secreted cytokines and growth factors 
were assayed, many of them exhibiting stiffness-dependent expression at constant ECM 
concentrations [103].  
The complex nature of hybrid hydrogels, hint at some design elements that are not 
present in current synthetic hydrogels such as: strain stiffening elements and combinations 
of cell adhesion ligands (not yet defined). The perfect synthetic system would therefore not 
only have variable bulk stiffness, but also variable fibre stiffness that can strain stiffen and 
be easily decorated with various cell adhesion ligands. 
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Fibre stiffness and its effect on cell fate, the stiffness of the fibre can be defined as its 
resistance to deformation under an applied force. Whereas strain stiffening describes the 
way a fibre’s stiffness increases either linearly or non-linearly under an applied force. 
What is strain stiffening? The major component of the ECM is composed of 
filamentous polymers attached to each other and to cells by a series of molecular links. A 
key property of these polymers such as fibrin and collagen is their tendency to stiffen with 
stretching. Importantly, cellular traction forces are sufficient to locally deform the ECM 
[104], whose stiffness is strain-dependent [105]. It is known that when a force (shear stress) 
is applied to the extracellular-matrix fibres, the networks stiffen and resist additional 
deformation, as a result of fibre entanglement (in which the displacement of one fibre is 
impeded by another) and the entropic elasticity of individual fibres [97]. Indeed, 
Kotlarchyk et al. demonstrated that the stiffness of the ECM can be tuned by external 
mechanical loads alone to study the effects of ECM stiffness on cell physiology in 3D [38]. 
Nonlinear stiffening means that the ECM can operate over stiffness regimes of several 
orders of magnitude, covering the entire mechanical spectrum with only a few materials 
[97,106]. 
The current proposed mechanisms of strain stiffening in natural, synthetic and 
hybrid hydrogels: Two different models are used to describe networks under strain. In 
general synthetic polymers experience linear stress to strain response while natural 
biopolymers experience non-linear stress to strain response (Figure 6).  
In the linear model it states that the network (polymers with short persistance lengths) 
follow the classical theory of rubber elasticity, which assumes uniform deformation due to 
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similar stretching of each fibre in a network of flexible fibres. In this model network 
elasticity comes from the entropic elasticity of individual Gaussian like coiled fibres, and 
the linear force extension relation of Gaussian coils gives rise to the linear elasticity of 
flexible polymer fibre networks [36,106].  
In the non linear model, force extension of individual polymers (long persistance 
lengths) leads to strain stiffening of the semi flexible polymer network. The fibres deform 
initially by bending at small strains and then by stretching at larger strains when their end-
to-end vectors align in the shear field [97,107]. This can also be described by fibre 
bending and enthalpic stretching which states that fibres with linear force–extension 
relationships produce strain stiffening in networks owing to the geometrical changes as 
they align in shear (Figure 6b) [108-110]. Essentially all this means is that in a network of 
polymers with long persistance lengths the deformation as a result to external force is 
additive and the deformation non uniform. 
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Figure 6. Schematics for two different mechanisms of network deformation on the application 
of an external force.(a) elastic or linear stress response, upon the application of external force 
the network deforms uniformly (not additive), (b) non-linear stress response as a result of 
cumulative alignment of fibres upon the application of external force the network deforms in 
the direction of shear (additive)[36] 
What is the effect of strain stiffening on cell-cell interactions? Cells exert forces on 
the ECM [106]. The resistance of the ECM to these forces and to the strain field that cells 
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generate within the ECM subsequently affect the cellular fate. Cell-generated force was 
first observed in fibrin gels, where cells generated traction fields and the effected cellular 
alignment in low density cultures to spontaneously polarize cells towards each other within 
400-600 µm [111].  In the work of Rudnicki et al. both fibrin and collagen hydrogels with 
varying stiffness and degrees of non-linearity were investigated. They observed that cell-
induced mechanical signals transmit hundreds of microns within the network to influence 
cell behaviour due to simultaneously non-linear strain stiffening and the topology within 
the fibrous network [112]. Therefore it is safe to conclude that mechanical deformation is 
locally distributed to induce/trigger cell emission as mechanical signals are affine and the 
transfer of cellular signalling occurs over micrometers but that the cell’s chemical 
emissions spread much further due to diffusion. 
State of the art on hydrogels that show strain stiffening: In Figure 7, the stiffness of 
a variety of networks, quantified by their differential moduli is plotted as a function of 
applied strain. The change in storage modulus may be defined by the differential modulus 
(K′). At low stress, the differential modulus (K′ ≡ dσ/d ) equals the plateau modulus G0, 
but beyond a critical stress σc, K′ becomes stress dependent. The systems considered here 
vary over orders of magnitude in stiffness and in the strains they tolerate without breaking. 
Synthetic elastomer polymers that strain stiffen are extremely rare. One example is of 
poly(methyl methacrylate) (PMMA) end blocks separated by a poly(n-butyl acrylate) 
(PnBA) midblock, a physically associating synthetic triblock co-polymer, shows strain 
stiffening behaviour at high degrees of strain. This synthetic material is however not 
suitable for biological applications due to insolubility in biologically relevant media [113]. 
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A biologically relevant strain stiffening synthetic hydrogel polyisocyanopeptide will be 
discussed in detail during this thesis. An example of its strain stiffening behaviour can be 
seen in Figure 7 by the differential modulus under increasing strain. 
 
Figure 7. Strain stiffening behaviour of natural and synthetic polymers, differential modulus K’ 
against shear stress [97,113-114], K’= ∂σ/∂γ, where γ is the shear strain, against shear stress. 
PIC falls well within the biologically accessible stress ranges and closely resembles natural ECM 
fibres with regards to strain stiffening behaviour. 
Apart from stiffness, the other parameter that effect cellular fate are: pore size, 
biological cues such as adhesion ligands, cellular landscape or topography. These factors 
will now be discussed.  
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How does pore size and bulk stiffness effect cellular mobility? In 3D systems 
successful tissue engineering hydrogels should be at least 90% porous [115], pores should 
be 50 – 200 µm in size [116] and inter-connected [117]. These pre-requisites enable the free 
diffusion of oxygen, nutrients, metabolites and the migration of cells themselves. 
Interestingly Zaman et al. observed cellular mobility though Matrigel a naturally sourced  
hydrogels that have nm pore sizes, no necking was observed indicating that cells move 
through the pores by deforming the matrix and creating open spaces to migrate through 
[76]. This was also observed in experiments with endothelial cells forming 3D networks in 
synthetic peptide hydrogels, the motility mechanism through sub-micrometer pores is 
therefore concluded to be dependent on the cells ability to remodel the tissue mimetic 
material hydrogel and on the pore size [52]. 
1-27 
 
The influence of cell-matrix interaction and the resulting biological triggers on 
cellular fate: All the important cellular events, for example, adhesion, spreading, 
proliferation and differentiation, are governed by the interactions of the cells with their 
surrounding matrix. In the process of integrin mediated cellular adhesion a cascade of 
events occurs (Figure 8), these are attachment, spreading, organization of actin cytoskeleton 
and the formation of focal adhesions [118].  
 Figure 8. Cells interact with the ECM, the ECM �ibres provide cells with topographical features that trigger morphogenesis. Adhesion proteins such as �ibronectin and laminin located on the 
�ibres interact with the cells through their integrin receptors to initiate intracellular signalling cascades, which affect most aspects of cell behaviour [119]. 
In the initial stages of cell-matrix interaction, focal adhesion complex formation occurs 
between the integrins and the extracellular matrix ligands (for example, RGD). It is through 
this complex that the mechanical information of the matrix is transmitted to the cytoskeletal 
Integrin
Cell-cell interaction
Growth factor
Extracellular matrix
Heparan sulphate
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actin. Simultaneously, chemical signals are also received through the focal adhesions (for 
example, in the case of integrin-growth factor binding). This event is basically the 
equivalent of the cells ‘sensing’ their surrounding microenvironment. Several cytoskeletal 
proteins, such as, talin, filamin, etc. that interact with integrin αβ cytodomain, are believed 
to be recruited in the focal adhesion complex [120]. Although the mechanisms of the force 
transmission pathway are still not well understood, talin binding to the integrin β 
cytoplasmic domain is believed to be the crucial step for the activation of integrins and to 
establish ECM-integrin-talin-actin link in the early stages of focal adhesion complex 
formation [121-123]. A key role for another protein, vinculin, in the stabilization of the 
focal adhesion complex and the effective force transmission from the matrix to the 
cytoskeletal actin, has been established [124].The globular head of talin connects to integrin 
in the focal adhesion complex and the rod-like tail is attached to actin in cytoskeleton. The 
transmission of signals (both mechanical as well as chemical) through the focal adhesion 
complex into the cytoskeleton initiates cascades of events and controls specific gene 
expression in the nucleus. Phosphorylation of non-muscle myosin II, a cytoskeletal motor, 
takes place which then leads to actin bundle formation and stress actin fiber generation. It 
has been speculated that this actomyosin contraction event unfolds the talin rod and exposes 
the buried binding sites for vinculin, which is then recruited into the focal adhesion 
complex through talin-vinculin interaction [125]. A feedback mechanism operates in 
executing the whole process of matrix mechanics ‘sensing’ by the cells. Thus, when the 
focal adhesions develop, the cells pull on the matrix by force generated through 
actomyosin contraction. If the matrix (fibre) is stiff, it will resist this deformation at the 
adhesion sites, the focal adhesions mature through the clustering of integrins and the cells 
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subsequently pull on the matrix with greater force than if the matrix was soft. Therefore 
the mechanical and chemical signals from the matrix operate in tandem in determining 
cellular fate. 
Cell adhesion complexes (integrin-ligand), what type of integrins are used in 
vasculogenesis? Cells are decorated with adhesion receptors that when bound to the 
relevant ligands impact on the cells anchoring, behaviour and survival. The most versatile 
of these adhesion receptors are the integrin family. Integrins play an important role as 
anchors and are involved in important cellular processes such as embryogenesis, 
differentiation, immune responses, wound healing and hemostasis [126]. Integrins consist 
of two supramolecular transmembrane subunits termed the α and β. Various combinations 
of these hetero dimers are known with the subunits defining the ligand specificity of the 
integrins. From a tissue engineering perspective however only the most promiscuous 
integrins are of interest e.g. αvβ3 integrin which binds to fibronectin, von Willebrand factor 
and many others.   
The optimum concentration of ligands inside the tissue mimetic material to affect 
cellular morphology has not been clearly defined in the past as the density in 3D can at best 
be described in concentration and not in a unit per/cm2, in Table 1 a few tissue mimetic 
hydrogels are summarized. The optimum concentration of ligand in 2D was in the pmol- 
µmol/cm2 range. In 3D the concentrations ranged in the µM-mM range.  
Another interesting aspect is the spacer length between the ligand (RGD) and its 
scaffold (polymer backbone). This length should influence the efficacy with which the 
ligand will bind into the active pocket of the integrins on cell surface. Figure 9 shows a 
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schematic of the polyisocyanide decorated with the ligand GRGDS; the polymer fibre core 
(pink), the spacer length between the adhesion ligand and the polymer fibre (black) and the 
ligand itself (GRGDS in purple), the measured distance between the fibre core and the start 
of the ligand is  approx 21 Å. 
 Figure 9. Schematic representation of oligoethylene glycol polyisocyanopeptide polymer �ibre decorated with adhesion ligand GRGDS. The oligoethylene glycol core is represented in pink, the spacer in grey, and the peptide in lilac. 
A summary of hydrogels used for vasculogenesis was collated and the spacer length 
between fibre and RGD calculated using a simplified chemical structures energy 
minimization algorithm in ChemBioDraw3D software (see, Table 1).  The spacer length of 
the fibre-ligands ranged between 2 –19 Å, regardless of whether the hydrogel was used for 
or a 2D or 3D cell culture. From this table it was concluded that in designing a synthetic 
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hydrogel for vasculogenesis, the spacer length between scaffold and adhesion ligand should 
be between 3-20 Å. 
Table 1. Overview of synthetic/hybrid hydrogels, the adhesion ligands used in the culture of 
cells  
Adhesion Ligand Tissue mimetic material 
Spacer 
length (Å) 
Concentration 
2D    
GRGDS [127-128] PLA, PLGA; PCU, PHBA 10.0; 6.2 0.3-3.0 µM 
YRGDG [129-131] PEG 2.4 66.0 pmol/cm2 
GRGDSY [132] PU  4.2  pmol/cm2 
GRGDVY [132] PU 4.2  pmol/cm2 
GRGDSPK [133] PS, STARCH 6.2  0.7 nmol/cm2 
RGDSPASSKP 
[129-131] 
PEG-based 2.4 66.0 pmol/cm2 
3D    
RGDS [15,81] PEG 2.7 3.7 µM/mL 
GRGDS [79] AGAROSE 10.1 2.1 µM 
RGDSP [134] GGGSSPHSRN(SG)5RGDSP 15.1-18.6 6.0 mM (dense) 
 
What is the influence of the hydrogels topography on cell fate? The optimum 
spacing (for cell adhesion) between RGD ligands of adsorbed cell adhesion proteins have 
been estimated to range from 15-30 nm for globular proteins such as vitronectin and from 
25-50 nm for rod shaped fibronectin molecules [135]. The role of nano scale surface 
topology appears to play a role in 2D culture of stem cells. Cellular responses were 
observed with nanoscale surface humps based on polymer demixing [136], ordered gold 
bundle arrays [137], clusters of adhesive ligands [138] or nanotubes [96,139] at distinct 
length scales. Nano/Micro-patterned surfaces also significantly influence the cellular fate. 
For example, PDMS surfaces containing nanogratings induced preferential neurogenic 
differentiation of mesenchymal stem cells [140]. In another recent example, culture of 
endothelial cells on polymer substrates micro-patterned with angiogenesis inducing peptide 
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sequence SVVYGLR led to tubulogenesis in 10-50 µm patterns, whereas, wider patterns 
(100 µm) failed to activate tubular differentiation [141]. Fibrous structures and finite 
bundling is present in all natural ECM fibres. It has been hinted at that the fibrillar 
nanoscale topological organization of fibrin and collagen gels play a role in cell activity and 
differentiation [112].  
What is the best bioconjugation strategy for the introduction of ligands into tissue 
mimetic materials? It is important to decouple the ligand concentration from the polymer 
concentration as to avoid issues with changing mechanical properties and mesh sizes [76]. 
Slightly outdated methods for introducing reactive groups such as streptavidin-biotin [142-
144]; thiols [145]; amines [146]; azides [147] may be used to introduce bioactive ligands 
into hydrogels. However the development of cyto-compatible, strain promoted azide-alkyne 
cycloaddition (SPAAC) reaction, a non toxic aqueous “click” chemistry results in a 
modular method for the introduction of bioactive ligands in a controlled manner e.g. the 
coupling of bicyclononynes to azides [148-150] without being affected by the hydrogel 
concentration. The use of SPAAC bioconjugation strategies and its effect on PIC will be 
investigated in Chapter 6 and the streptavidin-biotin bioconjugation in Chapter 5.  
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Conclusion 
The following parameters were identified in the design of synthetic extra cellular 
matrix for vasculogenesis. Ligands form cell adhesion sites with integrins that are located 
on the cellular surface. The conjugation strategy for ligand introduction into the synthetic 
extra cellular matrix should be modular, non-toxic and should not alter the pore sizes. For 
vasculogenesis in 3D the density of ligands in 3D should be at a concentration in the µM 
range and at a distance from the fibre to effectively penetrate the integrin binding pocket 
(ca 3 - 20 Å). Cell adhesion is required not only to provide chemical cues between cells but 
also to enable the formation of biomechanical sensors that dictate the density of focal 
adhesion which in turn effect the intra cellular chemical signals that are transported to the 
nucleus and dictate cellular fate. The pore size must be in the µm range or the hydrogel 
itself must be bioresponsive enough that the cells can remodel it to enable cellular mobility. 
The effect of aspect ratios in 2D confirmed the need for well defined structures that enable 
control over focal adhesion formation with one every 15 - 50 nm and that vasculogenesis is 
enhanced in systems consisting of a finite bundled topology. The bulk stiffness or storage 
modulus of the tissue mimetic extracellular matrix for vasculogenesis must be tuneable in 
the range 100 - 3000 Pa. To truly mimic nature the inclusion of strain stiffening elements in 
the synthetic extra cellular matrix is strongly advised. This is because cells encapsulated in 
hydrogels with similar bulk stiffness and ligand densities will have varied cellular fate 
dependent on the nature of the fibres stress strain response.   
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A synthetic hydrogel that meets these design characteristics is polyisocyanopeptide 
oligoethylene glycol, a new class of tissue mimetic material. This new class of tissue 
mimetic material consists of finite fibre bundles, that gelate at extremely low concentrations 
above their lower critical solution temperature, the fibres exhibit strain stiffening behaviour 
and have a storage modulus range that spans10 - 1000 Pa. This means that water soluble 
polyisocyanopeptides, have similar stiffnesses as those observed for fibrin hydrogels at 2 
mg/mL (200 Pa) [38] and Matrigel 8 mg/mL (440 Pa) [46] and similar fibre stiffness 
behaviour as natural fibres (strain stiffening). Polyisocyanopeptido oligoethylene glycols 
have pore sizes of 100-150 nm at 1 mg/mL similar to those observed for Matrigel [76] and 
ionic peptide stacking gels [52]. Cell adhesion ligands can easily be introduced by strain 
promoted acetylene azide “click” reaction through synthesis of copolymers with functional 
handles e.g. azides to enable decoration with ligands decorated with bicyclononyne 
functionalities, without altering the concentration of the polymer in solution.   
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Aim & Outline 
The aim of this thesis is to explore the possible biomedical applications of 
polyisocyanopeptide oligoethylene glycol. The biomedical applications to be investigated 
include the material in its gelled state as an artificial ECM and in a diluted solution as a 
therapeutic carrier. 
In this thesis research is presented to answer the following questions: Is it possible to 
synthesize water soluble PIC? Can the gelation temperature be tuned? Is PIC biologically 
inert? Is it possible to add copolymers with functional handles and what densities of 
handles are tolerable? Can PIC be used as a therapeutic carrier and how do they compare to 
the current state of the art? Is it possible to change the bulk stiffness of PIC hydrogels? Can 
a PIC hydrogel containing GRGDS be used as aECM for vasculogenesis (under cell culture 
conditions) e.g. what loading of GRGDS is required to induce vasculogenesis, what 
concentration of PIC results in a hydrogel that is strong enough to suspend cells in 3D, does 
the hydrogel itself survive, do cells survive in it and if the cells survive is vasculogenesis 
observed? In an animal model PIC is subcutaneously injected, is this a suitable technique 
for administration of the PIC and was the cellular response similar to that of observed in 
vivo? 
In Chapter 1 the current state of the art for artificial ECM was discussed and the design 
parameters for the ultimate aECM defined. In Chapter 2, the design, synthesis and 
characterization of isocyanide monomers for the synthesis of polyisocyanodipeptide 
oligoethylene glycol polymers will be performed. In Chapter 3, the monomers synthesized 
in Chapter 2 will be used to synthesize a broad range of (homo-;co-; ter-) polymers. Briefly, 
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homopolymers with di-alanine repeat units in LL, DL, LD tri- or tetra- ethylene glycol; 
copolymers of tri- and tetra- ethylene glycol (varied ratios of ethylene glycol sub units 
should affect the LCST [151]), tri- or tetra-co-azide- ethylene glycol (varied densities of 
functional handle), tri- or tetra-co-acetylene- ethylene glycol (varied densities of functional 
handle), the homopolymers of Abz-tetra-, and finally the terpolymers of tri-tetra-azide 
ethylene glycol (targeted LCST temperatures with functional handle) will be synthesized. 
The synthesized polymers will be characterized and the differences in material properties 
compared among them. Once the polymers are available the effect of crosslinking on the 
material properties to obtain for example higher bulk stiffness will be investigated in 
Chapter 4. Specifically covalent, dynamic, physical and ionic crosslinking strategies will be 
explored. The effect of the different crosslinking strategies on the hydrogels material 
properties will be analyzed.  The second biomedical application PIC as therapeutic carrier 
will be investigated in Chapter 5. In a dilute model system, PIC decorated with 
streptavidin-biotin-antibodies will be used to activate T-cells through the formation of an 
“immune synaps”. The copolymers of polyisocyanopeptide tetra ethylene glycol will be 
compared to short persistence length, spherical molecules similarly decorated with 
antibodies, to elucidate the effect of shape, stiffness and multivalency on T-cell activation. 
In Chapter 6, PIC hydrogels, decorated with varying densities of the cell adhesion ligand 
GRGDS will be investigated as a new type of artificial ECM both in vivo and in vitro. In 
Chapter 7, the main findings of Chapters 2-6 will be discussed and any potential future 
work briefly highlighted.  
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Chapter 2 : Monomer Synthesis 
 
Abstract 
Alanine-alanine triethylene glycol isocyanide monomers with varied enantiomers of 
alanine-alanine (LD;DL) were synthesized. Alanine-alanine (LD) tetraethylene glycol 
isocyanide monomer was synthesized. Isocyanide monomers of alanine-alanine (LD) 
oligoethylene glycol containing a functional handle appendage of either acetylene or azide 
were synthesized. A monomer containing non-natural amino acid of aminobenzoic acid-
alanine tetra ethylene glycol was synthesized successfully.   
 
Introduction 
Isocyanide monomers, from which polyisocyanides are synthesized, were first 
reported by Lieke in 1859 [1]. Later in 1867 Gautier published the synthesis of isocyanides 
from silver cyanide and alkyl iodides [2], whilst Hofmann found that isocyanides could be 
prepared by the reaction of an amine with chloroform [3]. One of the first indications of a 
successful synthesis of a (liquid) isocyanide is the characteristic pungent and repulsive 
odour of this compound [4] which hindered their widespread use. These rather toxic and 
cumbersome methods were not suitable for the large scale production of isocyanides, 
further limiting the research on isocyanides entirely. This all changed when Hagedorn and 
Ugi reported the facile synthesis of isocyanides from formamides using a dehydration 
reaction with diphosgene [5-8].  
The isocyanide monomers required to synthesize polymers that are biocompatible 
ECM mimics must form β-sheets and be soluble in water. Therefore the isocyanide 
monomer must contain a dipeptide and a water soluble element e.g. oligoethylene glycol. 
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Another important element that is required for most biomimetic materials are functional 
handles that can be used to attach biologically relevant signals e.g. RGD or growth factors.  
The functional handle of choice was the azide, as CuI-catalyzed Huisgen 1,3-dipolar 
cycloaddition simply known as click chemistry [9] is modular, wide in scope, high in yield, 
has little side products that are easily removed, is regioselective but not necessarily enantio 
selective, uses simple reaction conditions, is not sensitive to oxygen or water. In addition it 
uses easily accessible reagents, requires no solvent or a solvent that is easily removed or 
benign like water, enables simple product isolation, has a high thermodynamic driving 
force (greater than 20 kcal mol-1) and goes rapidly to completion [9-12]. A more recent 
click strategy that avoids CuI completely (which is ideal for biomedical materials), uses 
strain promoted acetylene azide cycloaddition (SPAAC) [13-16].  
A wide variety of different amino acids have been used in the past e.g. alanine, leucine 
[17] and glutamic acid [18] to prepare polyisocyanides. However the best results in terms of 
tertiary structure and helix stability were obtained with alanine di and tri peptide variants. It 
was hypothesized that by substituting one of the alanine subunits in the oligoethylene di-
alanine monomer with aminobenzoic acid it would be possible to obtain higher persistance 
length water soluble polymers. Yashima et al. polymerized an enantiomerically pure 4-
isocyanobenzoic acid derivative bearing an L-alanine group substituted with a n-decyl chain 
with the objective to generate polymeric liquid crystals [19]. When this monomer was 
polymerized with a Ni catalyst, a polymer with a broad molecular weight distribution was 
obtained. When the same monomer was polymerized with the μ-ethynediyl Pt-Pd catalyst, a 
polymer with a narrow molecular weight distribution was formed [20]. Once synthesized it 
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would be possible to compare the water soluble polyisocyanides from the Ni catalyst with 
the Pt-Pd catalyst in terms of material properties and dispersity (Ð). 
In this chapter, the synthesis of isocyanide monomers that contain different lengths of 
oligoethylene glycol, different chiralities with regards to the dipeptide alanine-alanine core 
and functionalizable handles that consist of acetylene or azides will be investigated (Figure 
1&2).  
 Figure 1: Oligo(ethylene glycol) substituted polyisocyanopeptides. The isocyanide monomer with alanine-alanine dipeptide core, oligoethylene spacer and functionalizable chain end.  
N
N
H
O
O
O
O
R
mn
m= 3 or 4
n = DL or LL or LD alanine-alanine
R= azide or acetylene or CH3
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Figure 2. A schematic summary of the monomers synthesized in this chapter.  
.
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Results and discussion 
1. Monomer synthesis 
1.1. 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl-(L)-alaninyl-(D)-isocyanoalanine 
(M1) 
Tetraethylene glycol was mono-tosylated in the presence of pyridine by the addition of 
one equivalent of 4-toluenesulfonyl chloride. The remaining alcohol group was coupled to 
tert-butyloxycarbonyl (BOC)-L-alanine using the Steglich esterification [21]. The purified 
compound was deprotected yielding the free amine. The free amine was used in a DCC 
coupling with BOC-D-alanine in the presence of dicyclohexylcarbodiimide (DCC) and 
hydroxybenzotriazole (HOBt) to limit racemization. The free amine was obtained after de-
BOCylation. It was found that higher yields were obtainable if the amine was first 
converted to the formyl prior to nucleophilic substitution of tosyl with sodium azide. The 
dehydration reaction of 5 with diphosgene at -40 °C was the lowest yielding step of the 
entire synthesis. The azide monomer M1 was synthesized over six steps with an overall 
yield of 1.3% (Figure 3).   
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 Figure 3. Synthesis of M1: i)pTosCl, pyridine, 0 °C  rt, 12 h, 29 % ; ii) Boc-L-Ala, DCC, DMAP, CH2Cl2, 0 °C  room temperature, 4 h, 76 % ; iii a) ~2 M HCl in ethyl acetate, CH2Cl2 room temperature, 1 h, quantitative yield b) Boc-D-Ala-OH, DIPEA, HOBt, CH2Cl2, 0 °C room temperature, 14 h, 60% , iv a) 2 M HCl in ethyl acetate, CH2Cl2 room temperature, 1 h, quantitative yield b) ethyl formate/sodium formate was re�luxed for 8 h at 66 °C 54 % v) absolute EtOH, sodium azide was re�luxed 16 h , 78% vi) N-methylmorpholine (NMM) -40 °C diphosgene (0.04 M) over 2 h  27% . 
1.2. Synthesis of 2-(2-(2-methoxyethoxy)ethoxy)ethyl (L)-alaninyl-(D)-
isocyanoalanine (M2) 
The commonly used route in our group for obtaining 6, was a DCC coupling of Boc-L-
alanine to triethylene glycol monomethyl ether under alkaline conditions [22]. The 
alternative synthetic route depicted in Figure 4, was prefered  as the starting compounds L-
alanine and p-toluene sulfonic acid (PTSA) were significantly cheaper , similar yields were 
obtained and the synthesis time was significantly shortened.  
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Figure 4. Synthetic scheme for synthesis of M2 i) L-Ala, PTSA, 126 °C, 4h, 62%; ii) Boc-D-Ala, 
DCC, HOBt, DIPEA, 0 °C rt, 16 h, 52 %  ; iii) a. HCl in dioxane, ethyl acetate, 2h, quantitative b. 
Sodium formate/Ethyl formate 66 °C, o/n, 56 % ; iv) diphosgene/NMM, CH2Cl2, - 40 °C, 2 h, 
51%. 
 
Figure 5. 1H-NMR spectrum of M2 ( in-house) in deuterated chloroform. 
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Since large quantities of compound M2 were required it was decided to outsource the 
synthesis of the compound as the low overall yield and a turnaround time of two to three 
weeks from starting the synthesis till obtaining the monomer was deemed too slow to 
generate large batches of polymers. The M2 monomer was purchased from Chiralix B.V. as 
95 % pure; the synthetic strategy used to produce their monomer was not disclosed to me. It 
was however important to compare the two monomers M2 Chiralix with M2 in-house 
(synthesized by me) before using them as reactants. M2 Chiralix required an additional 
silica column purification step prior to use. After purification the monomer  was light 
yellow in colour whereas the in-house monomer was colourless. The LC-MS was the same 
for both monomers. The optical rotation of M2 from Chiralix after purification via silica 
column chromatography  was -0.44° and that of in-house M2 was -0.34°. The occurrence of 
a low percentage of racemisation is therefore likely for both monomers as the optical 
rotation should be zero for a D-L-monomer. Upon closer inspection of the nuclear magnetic 
resonance spectra, the two monomers differ slightly in the range (1.7-1.4 ppm) for the 
alanine CH3 (2 from Figure 5) doublet of doublets (Figure 6). A broad doublet is visible for 
the Chiralix monomer at 1.6 ppm, which could be indicative of a trace racemic impurity of 
around 0.09 % according to 1H-NMR. The in-house monomer contains some unidentified 
possible starting material or racemic impurities at 1.40- 1.45 ppm of around 0.07%. Both 
types of monomers were deemed pure enough to continue. 
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Figure 6. Zoom in of 1H-NMR spectra of M2 Chiralix vs in house in deuterated chloroform. 
1.3. Synthesis of 3,6,9,12-tetraoxapentadec-14-yn-1-yl (L)alaninyl-(D)-
isocyanoalanine (M3) 
Mono-functionalization of tetraetylene glycol was achieved using a SN2 nucleophilic 
substitution reaction with 3-bromoprop-1-yne in dry THF with good yields. The rest of 
the synthetic route towards M3 was similar to that of M1 (Figure 7). The rate limiting 
step for the entire synthesis was again the final dehydration step in the presence of 
diphosgene. The acetylene monomer M3 was synthesized over seven steps with an 
overall yield of ~5%.  
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Figure 7. Synthesis of M3: i) NaH, THF, rt, 17 h, 73%; ii) Boc-L-Ala-OH, DMAP, DCC, CH2Cl2, 0 
°C rt, 16 h, 82%; iii) 2 M HCl in dioxane, CH2Cl2, rt, 1 h, quantitative yield; iv) Boc-D-Ala-OH, 
DiPEA, HOBt, DCC, DMAP, CH2Cl2, 0 °C rt, 14 h, 60%; v) 2 M HCl in dioxane, CH2Cl2, rt, 1 h, 
quantitative yield; vi) sodium formate, ethyl formate, reflux, 18 h, 47%; vii) NMM, diphosgene, 
CH2Cl2, Ar, -50 °C, 40 min, 31% . 
1.4. Synthesis of 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethyl-(L)-alaninyl-(D)-
isocyanoalanine (M4) 
The Fischer esterification was performed between the alcohol group of tetraethylene 
glycol monomethyl ether and the carboxylic acid group of L-alanine catalysed by p-toluene 
sulfonic acid, the reaction was driven to completion by using a Dean-Stark setup in which 
water was continuously removed from the reaction mixture. This intermediate strategy 
enabled the use of cheaper starting products and increased yields as it removed the need for 
an additional deprotection and purification via silica column chromatography  step. The 
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reaction steps ii-v was similar as to those previously described for monomer M2. Monomer 
M4 was synthesized over five steps with an overall yield of 4 % (Figure 8).  
 
Figure 8. Reagents and conditions: i) L-alanine, p-toluene sulfonic acid, toluene, reflux, 4 h, 46%; 
ii) Boc-D-Ala-OH, DMAP, DCC, DIPEA, HOBt CH2Cl2, 0 °C rt, 16 h, 68%; iii) HCl in dioxane, 
CH2Cl2, rt, 2 h, quantitative yield; iv) sodium formate, ethyl formate, reflux, 16 h, 33%; v) NMM, 
diphosgene, CH2Cl2, Ar, -70 °C, 35 min, 43% . 
1.5. Synthesis of 2-(2-(2-methoxyethoxy)ethoxy)ethyl (D)-alaninyl-(L)-
isocyanoalanine (M6) 
The enantiomeric inverse of M2 was synthesized to see what effect the inverse 
chirality would have on polymer synthesized from this monomer. The same synthesis route 
as that for M2 was followed with the only difference being that D-alanine was esterified 
with triethylene glycol monomethyl ether in the presence of p-toluene sulfonic acid and 
after purification, 24 was combined with L-alanine through nucleophilic substitution in the 
presence of DCC. Monomer M6 was synthesized over four steps with an overall yield of 3 
% (Figure 9).  
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Figure 9. Reagents and conditions: i) D-alanine, p-toluene sulfonic acid, toluene, reflux, 4 h, 44 
%; ii) Boc-L-Ala-OH, DMAP, DCC, HOBt, CH2Cl2, 0 °C rt, 16 h; iii) a. HCl in dioxane, CH2Cl2, rt, 2 
h, quantitative yield, b. Sodium formate, ethyl formate, reflux, 8 h, 13 %;  iv) NMM, diphosgene, 
CH2Cl2,  -40 °C, 120 min, 53 % . 
2. Synthesis of 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethyl (L)-alaninyl-4-
isocyanobenzamine (M5) 
N-boc-4 aminobenzoic acid (Boc-4Abz-OH) was activated with DCC and underwent 
nucleophilic substitution with 17 to obtain 22. After de-protection and standard formylation 
compound 23 was obtained in excellent yield. The dehydration of formyl to isocyanide was 
also successful. Monomer M5 was synthesized over four steps with an overall yield of 20 
% (Figure 10; Figure 11), the higher yields with regards to the other monomers is probably 
due to the larger hydrophobicity of 22-23 compared to 18 and 20, resulting in lower product 
losses during purification step using multiple extractions with water.  
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 Figure 10. Reagents and conditions: i) L-alanine, p-toluene sulfonic acid, toluene, re�lux, 3 h, 85 %; ii) Boc-4Abz-OH, DIPEA, DMAP, DCC, HOBt CH2Cl2, 0 °C rt, 16 h, 37 %; iii) a. HCl in dioxane, CH2Cl2, rt, 2 h, quantitative yield, b. Sodium formate, ethyl formate, re�lux, 16h, 94 %; iv) NMM, diphosgene, CH2Cl2, Ar, -35 °C, 90 min, 70 % . 
 
Figure 11. 1H-NMR spectrum of M5  in deuterated chloroform, unassigned peaks are acetone (2.0 ppm), water (1.67 ppm) and TMS (0.0 ppm). 
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Conclusion/Discussion 
As a whole, all the functional isocyanide monomers were synthesized successfully 
with overall yields comparable to the conventional alanine-alanine monomers with an 
average total yield of 5%. To increase the yields it would be advisable to investigate the use 
of a different dehydration method (Figure 12). For example, McCarthy et al. [23] and Mal 
with co-workers [24] reported on the use of Burgess Reagent, and Fuchs et al. [25] used 
phosphoryl trichloride as dehydration agent. Other reported dehydration agents include 
thionyl chloride [26-27] and cyanuric chloride [28-29].  
 
Figure 12. The proposed mechanism for the dehydration of 8 to obtain M2 by using Burgess 
Reagent in a basic solvent system. 
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Experimental: 
Instrumental: 
1H NMR and 13C NMR spectra were recorded on a Bruker AC-300 MHz 
instrument operating at 300 MHz and 75 MHz, respectively. J values are given in Hz and 
chemical shifts are reported in ppm. TMS was used as the internal standard. The used 
abbreviations are s = singlet, d = doublet, bs = broad singlet, t= triplet q =quartet, dd= 
doublet of doublets. FT-infrared spectra of the compounds were measured using a Thermo 
Nicolet IR300 FT-IR spectrometer (Thermo Fisher Scientific, Breda, The Netherlands) 
equipped with a Harrick ATR unit. UV-VIS measurements were done using a Varian Cary 
50 spectrometer (Agilent Technologies, Amstelveen, The Netherlands). For mass 
spectrometry a LCQ Advantage MAX instrument (Thermo Fisher Scientific) was used. 
Materials: Toluene was distilled over sodium. Dichloromethane was distilled over 
phosphorous pentoxide. N-methylmorpholine was freshly distilled over sodium prior to use. 
Water was purified with a Milipore MiliQ system, (mQ water 18.2 MΩ). All the other 
chemicals were used as received. Column chromatography was performed using silica gel 
(0.060–0.200 mm) provided by Baker. Thin layer chromatography (TLC) analyses were 
carried out on silica 60 F254 coated glass obtained from Merck and the compounds were 
visualised using Ninhydrine or basic aqueous KMnO4 solutions. All glassware was soaked 
in a 0.5 M aqueous NaOH solution prior to use. Alumina Brokman grade III was used in all 
cases unless stated otherwise. 
 
Synthesis 
2. Monomer synthesis  
 2.1) Preparation of the comonomer M1 
 
 
Tetraethylene glycol (28.5 mL, 164.3 mmol) was dissolved in 50 mL pyridine. The solution 
was subsequently cooled to 0 °C while stirring. Argon was bubbled through the solution for 
15 minutes. Tosylchloride (21.9 g, 115 mmol) was added portion wise to the stirring 
solution. The mixture was further stirred at room temperature for 12 hours. The reaction 
mixture was diluted with 50 mL of a 10 % aqueous citric acid solution. The mixture was 
extracted three times with 250 mL of chloroform. The combined organic layers were dried 
over anhydrous Na2SO4, filtered and the solvent was evaporated. The resulting yellow oil 
was purified using column chromatography (SiO2, 0.060 - 0.200 mm; ethyl acetate as 
eluent) to yield 1 as a pale yellow oil (11.7 g, 33.6 mmol, 29 %)[30] 
 Rf = 0.4 (ethyl acetate); 
1
H NMR δH (CDCl3, 300 MHz) = 7.8 (dd, J = 7.81 Hz, 2H, 
-CHAr-), 7.33 (d, J = 7.8 Hz, 2H, -CHAr-S), 4.17 (m, 2H, HO-CH2-CH2-), 3.65 (m, 16H, -
CH2-), 2.45 (s, 3H, -CH3); 
13
C NMR δC  (CDCl3, 75 MHz ) =  21.16 (1C, CCH3), 61.0 (1C, 
COH), 68.13(1C, COS), 69.0 (1C, OCH2), 70.0, 70.1, 70.1, 70.2 (4C, OCH2), 70.8, 72.0 
(2C, OCH2), 127.5 (2C, CHCCH), 129.5 (2C, CHCCH), 139.7 (1C, CCH3), 144.5 (1C, 
CHCS); FT-IR υ (cm-1, ATR) = 3442 (O-H), 2870 (C-H), 1597 (C=CAr), 1453 (C-H), 1352 
(S=O), 1175 (S=O), 1096 (C-O). 
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Compound 1 (5.2 g, 15.0 mmol), N-Boc-(L)-alanine (2.9 g, 15.0 mmol) and 4-
dimethylaminopyridine (DMAP) (0.2 g, 1.6 mmol) were dissolved in 25 mL of freshly 
distilled CH2Cl2 and cooled to 0 °C while stirring. N,N'-dicyclohexylcarbodiimide (DCC) 
(3.1 g, 15.0 mmol) was added portion wise. The mixture turned yellow and was stirred for 1 
h at 0 °C and thereafter it was stirred for 3 h at room temperature. The precipitated 
dicyclohexyl urea was removed by filtration and washed with ethyl acetate (3 x 20 mL) to 
remove any possible product that was adsorbed to it. The organic layer and ethyl acetate 
washings were concentrated under vacuum. The crude product was purified using column 
chromatography (SiO2, 0.060 - 0.200 mm; 1% MeOH/CH2Cl2 as eluent) to yield 2 as a light 
orange oil (5.5 g, 11.4 mmol, 76%) 
 Rf = 0.4 (10 % MeOH/CH2Cl2); 
1
H NMR δH (CDCl3, 300 MHz) =  7.79 (d, J = 8.4 Hz, 
2H, -CHAr-), 7.33 (d, J = 8.1 Hz, 2H, -CHAr-), 5.02 (s, 1H, -NH), 4.28 (m, 3H, -CH(CH3), 
COOCH2-), 4.15 (m, 2H, O-CH2-CH2), 3.69 (m, 14H, O-CH2-CH2), 2.44 (s, 3H, --CH3), 
1.44 (s, 9H, -OC(CH3)3), 1.37 (d, J = 7.2 Hz, 3H, -CH(CH3)); 
13
C NMR δC  (CDCl3, 75 
MHz) = 18.8 (1C, CHCH3), 21.7 (1C, CCH3), 28.4 (3C, C(CH3)3), 49.4 (1C, 
O(C=O)CHNH), 64.5 (1C, Boc-OCH2), 68.9 (2C, OCH2), 69.4 (1C, OCH2), 70.7 (4C, 
OCH2), 80.3 (1C, C(CH3)3), 128.2 (2C, CHCCH), 130.0 (2C, CHCCH), 145.0 (1C, CCH3), 
155.4 (1C, CHCS), 173.6 (1C, CH(C=O)NH), 176.7 (1C, CH(C=O)O); FT-IR υ (cm-1, 
ATR) = 2924 (C-H), 1745 (C=O ester), 1712 (C=O amide), 1597 (N-H), 1452 (C-H), 1352 
(S=O), 1173 (S=O), 1120 (C-O) MS (ESI) m/z [M+Na]+ (C23H37NO10SNa) calcd 542.2; 
found 542.2. 
 
 
Compound 2 (5.9 g, 11.4 mmol) was dissolved in 60 mL HCl saturated ethyl acetate and 
stirred for 2 h at room temperature. The solvent was evaporated under vacuum and the 
excess HCl was removed by adding 30 mL CH2Cl2 and 1 mL n-BuOH followed by 
evaporation. The residual n-BuOH was removed via azeotropic distillation with 3x 30 mL 
CH2Cl2. The resulting HCl salt of 2, N-Boc-(D)-alanine (2.1 g, 11.4 mmol) and N-
hydroxybenzotriazole monohydrate (1.7 g, 11.4 mmol) were dissolved in 40 mL freshly 
distilled CH2Cl2. DIPEA (2.0 mL, 11.4 mmol) was added dropwise and the mixture was 
stirred at room temperature until everything was dissolved. The solution was cooled to 0 °C 
and DCC (2.4 g, 11.4 mmol) was added portion wise. A white precipitate was formed and 
the mixture was stirred for 1 h at 0 °C followed by 3 h of stirring at room temperature. The 
precipitate which was identified as a mixture of DCU and starting compounds was filtered 
off, and subsequently washed with ethyl acetate (3 x 30 mL) to remove any possible 
product that was adsorbed to its surface. The filtrate and ethyl acetate washings were 
evaporated under vacuum. The crude product was purified using column chromatography 
(SiO2, 0.060 - 0.200 mm; 2 % MeOH/CH2Cl2 as eluent) to yield 3 as a pale yellow oil (3.4 
g, 5.7 mmol, 52 %);  
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Rf = 0.3 (10 % MeOH/CH2Cl2); 
1
H NMR δH (CDCl3, 300 MHz) 7.80 (d, J = 8.4, 2H, -
CHAr- C-S), 7.36 (d, J = 8.1, 2H, -CHAr-), 6.91 (s, 1H, -NH), 5.00 (s, 1H, -NH), 4.58 (m, 
1H, -NHCH(CH3)-), 4.28 (m, 2H, -COOCH2-), 4.14 (m, 2H, O-CH2-CH2-), 3.61 (m, 12H, 
-C(O)OCH2CH2O(CH2CH2O)3-), 2.45 (s, 3H, -CH3), 1.45 (s, 9H, -OC(CH3)3), 1.40 (d, J = 
7.2, 3H, -CH(CH3)-), 1.35 (d, J = 7.2, 3H, -CH(CH3)-); 
13
C NMR δC (CDCl3, 75 MHz) 
18.2 (2C, CHCH3), 21.7 (1C, CCH3), 28.4 (3C, C(CH3)3), 47.2 (1C, NCH), 50.0 (1C, 
NCH), 64.5 (1C, Boc-OCH2), 68.7 (2C, OCH2), 69.3 (1C, OCH2), 70.6 (4C, OCH2), 80.2 
(1C, C(CH3)3), 128.0 (2C, CHCCH), 129.9 (2C, CHCCH), 133.1 (1C CCH3), 144.9 (1C, 
CHCS), 172.7 (2C, C=O); FT-IR υ (cm-1, ATR) 2876 (C-H), 1740 (C=O ester), 1718 
(C=O amide), 1667 (N-H), 1522 (N-H), 1452 (C-H), 1365 (S=O), 1161 (S=O), 1105 (C-O); 
MS (ESI) m/z [M+Na]
+
 (C26H42N2O11SNa ) calcd 613.2; found 613.1. 
 
 
Compound 3 (1.7 g, 2.9 mmol) was deprotected following the same procedure as described 
for compound 2 and used without further purification. The crude product was dissolved in 
25 mL ethyl formate. Sodium formate (1.0 g, 14.3 mmol) was added and the mixture was 
refluxed for 8 hours at 66 °C. The mixture was cooled to room temperature and the excess 
sodium formate filtered-off. The filtrate was concentrated under reduced pressure. The 
crude product was purified using column chromatography (SiO2, 0.060 - 0.200 mm; 4 % 
MeOH/CH2Cl2 as eluent) to yield 4 as a light yellow oil (0.8 g, 1.5 mmol, 54 %) 
 Rf = 0.3 (10 % MeOH/CH2Cl2); 
1
H NMR δH (CDCl3, 300 MHz) 8.18 (s, 1H, HC(O)NH-), 
7.79 (d, J = 8.3, 2H, -CHAr- C-S), 7.35 (d, J = 8.4, 2H, -CHAr-), 6.78 (s, 1H, -NH-), 6.55 (s, 
1H, -NH-), 4.55 (m, 2H, -NHCH(CH3)), 4.30 (m, 2H,- COOCH2-), 4.13 (m, 2H, O-CH2-
CH2), 3.61 (m, 12H, (CH2CH2O)3), 2.44 (s, 3H, -CH3), 1.42 (m, 6H, -CH(CH3)); 
13
C NMR 
δC  (CDCl3, 75 MHz) 17.9 (1C, CHCH3), 18.2 (1C, CHCH3), 21.7 (1C, CCH3), 47.2 (1C, 
O(C=O)HNCH), 48.1 (1C, HNHC(C=O)), 64.5 (1C, OCH2), 68.7 (2C, OCH2), 69.3 (1C, 
OCH2), 70.6 (4C, OCH2), 128.0 (2C, CHCCH), 129.9 (2C, CHCCH), 133.1 (1C, CCH3), 
144.9 (1C, CHCCH), 161.0 (1C, H(C=O)NH)), 172.6 (1C, CH(C=O)NH), 173.2 (1C, 
CH(C=O)O); FT-IR υ (cm-1, ATR) 2873 (C-H), 1738 (C=O), 1653 (N-H), 1532 (N-H), 
1452 (C-H), 1352 (S=O), 1174 (S=O), 1097 (C-O); MS (ESI) m/z [M+Na]+ 
(C22H34N2O10SNa ) calcd 541.2; found 541.2. 
 
Compound 4 (0.6 g, 1.1 mmol) was dissolved in 40 mL absolute EtOH. Sodium azide (0.4 
g, 5.9 mmol) was added and the mixture was refluxed overnight. Once cooled to room 
temperature, the solids were removed by filtration and the filtrate was dried under vacuum. 
The crude product was purified using column chromatography (SiO2, 0.060 - 0.200 mm; 
4% MeOH/CH2Cl2 as eluent) to yield 5 as a pale orange oil (0.3 g, 0.8 mmol, 78%)  
Rf = 0.4 (10% MeOH/CH2Cl2); 
1
H NMR δH (CDCl3, 300 MHz) 8.20 (s, 1H, HC(O)NH-), 
6.84 (s, 1H, -NH), 6.60 (s, 1H, -NH), 4.60 (m, 2H, NHCH(CH3)), 4.26 (m, 2H, -
C(O)OCH2-), 3.68 (m, 12H, -(CH2CH2O)3-), 3.40 (m, 2H, N3CH2-), 1.42 (m, 6H, -
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CH(CH3)-); 
13
C NMR δC  (CDCl3, 75 MHz) 17.9 (1C, CH3), 18.2 (1C, CH3), 47.4 (1C, 
CH2N3), 48.4 (1C, H(C=O)HNCH), 50.7 (1C, HNC(CH3)C=O), 69.0 (1C, CH2CH2O), 70.1 
(1C, OCH2CH2), 70.6 (2C, OCH2), 70.7 (2C, OCH2), 161.4 (1C, H(C=O)NH), 172.7 (1C, 
CH(C=O)NH), 172.9 (1C, CH(C=O)O); FT-IR υ (cm-1, ATR) 3309 (N-H), 2875 (C-H), 
2105 (N3), 1737 (C=O), 1651 (N-H), 1529 (N-H), 1453 (C-H), 1133 (C-O); MS (ESI) m/z 
[M+Na]
+ (C15H27N5O7Na ) calcd 412.2; found 412.2. 
 
 
Compound 5 (221.0 mg, 0.6 mmol) and N-methylmorpholine (NMM) (0.2 mL, 2.3 mmol) 
were dissolved in 150 mL freshly distilled CH2Cl2 and cooled down to -40 °C (dry acetone 
bath) under an argon atmosphere. A solution of diphosgene (0.1 mL, 0.4 mmol) in 10 mL 
freshly distilled CH2Cl2 was added dropwise over 1 h while maintaining the argon 
atmosphere. While adding diphosgene, the mixture was stirred and kept strictly at -40 °C. 
Once the mixture began to turn yellow, the reaction was rapidly quenched with an excess of 
sodium bicarbonate (5.0 g). The quenched mixture was stirred for 5 minutes at -40 °C. The 
reaction mixture was passed over a short silica column (SiO2, 0.060 - 0.200 mm). The 
column was packed using CH2Cl2 as eluent, but the desired compound was eluted with 
CH2Cl2/acetonitrile (3:1) to yield M1 as a pale yellow oil (48.1 mg, 0.5 mmol, 27%); 
 Rf = 0.5 (10% MeOH/CH2Cl2); 
1
H NMR δH (CDCl3, 300 MHz) 7.00 (bd, 1H, -NH-), 4.59 
(m, 1H, -NHCH(CH3)C(O)O-), 4.32 (m, 3H, (-C(O)OCH2CH2O-), -C≡NCH(CH3)C(O)NH-
), 3.67 (m, 12H, -(OCH2CH2)3), 3.39 (m, 2H, N3CH2-), 1.65 (d, J = 7.2, 3H, 
C≡NCH(CH3)C(O)-), 1.48 (d, J = 7.2, 3H, C≡NCH(CH3)C(O)-); 
13
C NMR δC (CDCl3,75 
MHz) 170.69 (1C, CH(CH3)C(O)OCH2), 165.72 (1C, CH(CH3)C(O)NH), 70.69, 70.65, 
70.61, 70.56, 70.02, 68.81 (1 C, CH2CH2O), 50.66 (1C, CH2N3), 48.56 (C≡NCH), 19.66, 
18.04 (1C, CH(CH3)CO); FT-IR υ (cm
-1
, ATR) 3318 (N-H), 2875 (C-H), 2142 (C≡N), 
2105 (N3), 1744 (C=O), 1540 (N-H), 1453 (C-H), 1123 (C-O); MS (ESI) m/z [M+Na]
+ 
(C15H25N5O6Na), calcd 394.17; found 394.1. 
 
2.2) Preparation of the comonomer M2 
 
Triethylene glycol monomethyl ether (25.0 mL, 156.2 mmol), L-alanine (13.9 g, 156.2 
mmol), p-toluene sulfonic acid (32.7 g, 171.8 mmol) and 250 mL toluene were added in a 
round bottom flask. The reaction mixture was refluxed at 126 °C for 4 h in a Dean-Stark 
setup and 3 mL water was collected. The excess p-toluene sulfonic acid was filtered off, 
and the filtrate was evaporated under reduced pressure. The crude product was dissolved in 
300 mL chloroform, and the organic layer was extracted three times with a saturated 
aqueous solution of NaHCO3. Thereafter, the basic water layer was extracted twice more 
with chloroform. The organic layers were combined, dried with Na2SO4, and the solvent 
was evaporated under reduced pressure, obtaining 22.7 g of 6 in a 62% yield. No further 
purification was performed. 
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1
H NMR (CDCl3, 300 MHz): 4.29-4.26 (t, J=4.8 Hz, 1H, -CH(CH3)-); 3.71-3.52 (m, 12H, 
(-OCH2CH2-)3); 3.37 (s, 3H, -CH3); 1.35-1.32 (d, J=7 Hz, 2H, -NH2). 
 
Boc-D-Ala-OH (18.3 g, 96.4 mmol), DCC (21.9 g, 106.1 mmol) and 100 mL DCM were 
combined in a separate container to form a white paste. The DMAP (0.1 g, 0.8 mmol), 
DIPEA (1.7 mL, 9.6 mmol), HOBt (14.8 g, 96.4 mmol), 6 (22.7 g, 96.4 mmol) and 150 mL 
CH2Cl2 were mixed together. The mixture was stirred at room temperature to ensure the 
HOBt was completely dissolved before being cooled in an ice bath to 0 oC. The pH of the 
cooled mixture was checked to be above 8.0. Once confirmed pH and temperature were 
reached the white slurry of DCC-Boc-Ala-OH was added and the reaction was stirred for 
16 hours. The excess starting material and dicyclohexylurea side product was filtered off. 
The filtrate was diluted with 200 mL chloroform, and the mixture was extracted three times 
with a saturated aqueous citric acid solution. These acidic water washings in turn were 
combined and extracted with chloroform (1 x 200 mL). The now slightly acidic filtrate was 
washed twice with a saturated aqueous NaHCO3 solution. The alkaline water washings 
were combined and extracted twice more with chloroform. All the organic layers were 
combined, dried over Na2SO4, and concentrated under reduced pressure. At this point the 
resulting crude product oil was covered with a 2 cm layer of ethyl acetate and placed in the 
fridge for a few hours to remove any residual starting compounds and dicyclohexylurea, 
which crystallized out. Once the side product was filtered off the filtrate was concentrated 
and the crude product purified with column chromatography (2% MeOH in CH2Cl2), 
obtaining 20.4 g of 7 in a 52% yield. 
Rf = 0.53 (10% MeOH/CH2Cl2) ) 
1
H NMR (CDCl3, 400 MHz): δ = 6.77 (s, 1H, -NHCH-); 
5.09 (s, 1H, - NHCH) -; 4.60 (quin, J = 7.4, 1H, -NHCH(CH3)-); 4.31-4.28 (m, 3H, -
C(O)OCH2CH2O-, -CH(CH3)COO-); 3.70-3.56 (m, 10H, -C(O)OCH2CH2O(CH2CH2O)2-); 
3.38 (s, 1H, -OCH3); 1.46 (s, 9H, -OC(CH3)3); 1.41 (d, J = 7.2, 3H, -NHCH(CH3)-; 1.38 (d, 
J = 7.2, 3H, -NHCH(CH3)-);  
13
C NMR (CDCl3, 75 MHz): δ =172.9 (CH(CH3)COO); 
172.3 (CH(CH3)CONH); 156.0 (NHCOO); 79.9 (OC(CH3)3) ; 71.9; 70.6; 70.5; 70.3; 68.9; 
64.5 (COOCH2CH2); 59.2 (OCH3);49.7; 48.2 (CH(CH3)); 28.0 (OC(CH3)3); 18.0 
(CH(CH3)CONH; CH(CH3)COO )  
To obtain the HCl salt, compound 7 (13.2 g, 32.4 mmol) was dissolved in 20 mL of ethyl 
acetate and treated with 20 mL 4 M HCl in dioxane. The mixture was stirred for 1 hour at 
room temperature. After checking via TLC with starting compound another 20 mL 4 M 
HCl in dioxane was added and the solution was stirred further for 1 hour at room 
temperature. The residual t-BuOH was removed by addition of 20 mL of CH2Cl2 and 
azeotropic distillation under reduced pressure. Another 60 mL CH2Cl2 was added in 20 mL 
aliquots and removed under reduced pressure.  
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The HCl salt of 7 (13.2 g, 32.3 mmol) and sodium formate (8.8 g, 129.3 mmol) were 
dissolved in 250 mL ethyl formate. The reaction mixture was boiled for 14 h at 66 °C. A 
precipitate was filtered off, and the filtrate was concentrated by removing excess solvent 
under reduced pressure. Column chromatography (4% MeOH in CH2Cl2) was used to 
purify the crude product, obtaining 6.0 g of oil of 8 in a 56% yield. 
Rf = 0.54 (10% MeOH/CH2Cl2)
 1
H NMR (CDCl3, 400 MHz): δ = 8.23 (s, 1H, HC(O)NH-
); 6.94 (br.d, J = 7.8, 1H, -NHCH-); 6.79 (br.d, J = 8.1, 1H, -NHCH-; 4.57 (m, 2 H, 
NHCH(CH3)-, -NHCH(CH3)-); 4.26 (m, 2H, -C(O)OCH2-); 3.67-3.54 (m, 10H, -
C(O)OCH2CH2O(CH2CH2O)3-); 3.43 (s, 3H, -OCH3); 1.45 (m, 6H, -NHCH(CH3)-, -
NHCH(CH3); 
13
C NMR (CDCl3, 75 MHz): δ = 172.4 (CH(CH3)COO); 171.4 
(CH(CH3)CONH); 161.3;160.6 (NHCHO); 71.8; 70.5; 70.5; 70.1; 68.8; 64.5 
(COOCH2CH2); 59.0 (OCH3); 48.2; 46.8 (CH(CH3); 18.4 (CH(CH3)CONH); 17.6 
(CH(CH3)COO) 
 
Compound 8 (6.0 g, 18.1 mmol) was degassed for 1 hour with N2. Then NMM (5 mL, 45.2 
mmol) was dissolved with freshly distilled CH2Cl2 (50 mL), and added to the solution. The 
reaction mixture was cooled to -40 °C (dry ice/ isopropanol). A solution of diphosgene (1.5 
mL, 12.6 mmol) in CH2Cl2 (50 mL) was added drop wise over 2 h. The reaction mixture 
was stirred until it turned to a yellow-orange colour, and quenched with NaHCO3 (3.0 g). 
The product was purified by column chromatography. The column was packed with DCM 
(0.3% triethylamine) and the product was eluted with (1:2 ACN/CH2Cl2), obtaining 3.3 g of 
M2 in a 51% yield. Optical rotation -0.34 
Rf = 0.50 (10% MeOH/CH2Cl2)
 1
H NMR (CDCl3, 400 MHz): δ = 7.00 (br.d, J = 7.0, 1H, -
NH-); 4.58 (m, 1H, CNCH(CH3)C(O)NH-); 4.28 (m, 2H, -C(O)OCH2CH2O-); 4.26 (m, 
1H, -NHCH(CH3)C(O)O-); 3.74-3.53 (m, 10H, -OCH2CH2(OCH2CH2)3OCH3); 3.41 (s, 3H, 
-OCH3); 1.67 (d, J = 7.0, 3H, CNCH(CH3)C(O)-); 1.49 (d, J = 7.0, 3H, -
NHCH(CH3)C(O)O-); 
13
C NMR (CDCl3, 75 MHz): δ = 171.94 (CH(CH3)COO); 165.71 
(CH(CH3)CONH); 161.25 (NC); 71.88; 70.51; 70.51; 68.77; 64.66 (COOCH2CH2); 58.98 
(OCH3); 53.26; 48.53 (CH(CH3)); 19.62 (CH(CH3)CONH); 18.00 (CH(CH3)CONH) MS 
(ESI): m/z ([M+Na]+: C14H24N2O6Na ), calcd 339.15; found 339.2 
 
2.3) Preparation of the comonomer M3 
 
NaH (2.8 g, 46.7 mmol, 60% mineral oil) was added to a solution of 8 (12.0 mL, 69.5 
mmol) in dry THF (250 mL). A solution of 9 (5.0 mL, 56.1 mmol) in dry THF was added 
dropwise and the reaction mixture was stirred for 17 h. The side product was filtered off 
and the residue was washed with water (1 × 15 mL), brine (3 × 15 mL) and dried with 
Na2SO4. After the solvent was removed, the crude product was purified by column 
chromatography using ethyl acetate as eluent.  The product 10 was obtained as a yellow oil 
(8.5 g, 73%). 
 Rf = 0.2 (EtOAc) 
1
H NMR (CDCl3, 300 MHz): δ = 4.18 (d, J = 2.3 Hz 2H, -OCH2CCH); 
3.65-3.42 (m, 16H,C(O)OCH2CH2O(CH2CH2O)3-); 2.84 (br.s, 1H, HO-CH2-); 2.42 (t, J = 
2-21 
 
2.4 Hz 1H, -OCH2CCH) 
13
C NMR (CDCl3, 75 MHz): δ = 80.8 (CCH); 75.9 (CCH); 
73.6; 71.6; 71.7; 71.7; 71.7; 70.2 (CH2); 62.7(HOCH2); 59.6 (CH2CCH); FT-IR (cm
-1
, 
ATR): 3429 (O-H); 3251 (CC); 1455 (C-H); 1349; 1089(C-O) MS (ESI): m/z ([M+H]+: 
C11H20O5), calcd 232.13; found 233.13 
 
DMAP (0.5 g, 4.1 mmol), Boc-L-Ala-OH (8.5 g, 44.9 mmol) and DCC (9.3 g, 44.9 mmol) 
were added to a cooled solution (0 °C, ice bath) of 3 (9.5 g, 40.9 mmol) in CH2Cl2 (300 
mL). The reaction mixture was stirred at 0 °C for 4 h and subsequently at room temperature 
for 12 h. A white solid was filtered off and the residue (colourless) was washed with water 
(3 × 100 mL) and the water layer was extracted with DCM (1 × 100 mL).  The combined 
organic layers were dried with Na2SO4 and concentrated. The excess starting product and 
DCU was filtered off and the filtrate was concentrate under reduced pressure. The crude 
product was purified using column chromatography using a 1% MeOH in CH2Cl2 as eluent. 
The product 11 was obtained as a yellow oil (13.4 g, 82%).  
Rf = 0.3 (5% MeOH/CH2Cl2) 
1
H NMR (CDCl3, 300 MHz): δ = 5.08 (bd, J = 7.4 Hz, 1H, -
NHCH-); 4.29-4.25 (m, 3H, -NHCH-, -C(O)OCH2CH2O-); 4.18 (d, J = 2.3 Hz, 2H, -
OCH2CCH); 3.70-3.63 (m, 14H, -C(O)OCH2CH2O(CH2CH2O)3-); 2.42 (t, J = 2.4 Hz, 1H 
-OCH2CCH); 1.42 (s, 9H, -OC(CH3)3); 1.39 (d, J = 7.3 Hz, 3H, -NHCH(CH3)-)) 
13
C 
NMR (CDCl3, 75 MHz): δ = 173.5 (CH(CH3)COO); 74.6 (CCH); 70.8; 70.6; 69.2; 69.1; 
64.5  (CH2); 58.6  (CH2CCH); 49.5(CH(CH3); 28.5 (OC(CH3)3); 18.8 (CH(CH3)NH); FT-
IR (cm
-1
, ATR): 2869 (C-N), 1710 (C=O), 1164, 1100 (C-O), 609 MS (ESI): m/z 
([M+Na]+: C19H33NO8Na), calcd 426.22; found 426.21 
 
Compound 11 (13.4 g, 33.3 mmol) was dissolved in 20 mL DCM and to this 20 mL 4 M 
HCl/dioxane was added. The mixture was stirred for 1 h. The progress of the deprotection 
was followed by thin layer chromatography and staining with ninhydrine solution. Upon 
completion of the deprotection, 1 mL of n-BuOH and 20 mL of CH2Cl2 was added to the 
crude product. The excess solvent was evaporated under reduced pressure. Subsequently 60 
mL CH2Cl2 was added in 20 mL aliquots and evaporated under reduced pressure to obtain 
compound 12 (quant. yield) as a yellow oil. 
Rf = 0.1 (0.1% Et3N 5% MeOH/CH2Cl2) 
1
H NMR (CDCl3, 300 MHz): δ = 4.30-4.22 (m, 
1H, -NHCH(CH3)-); 4.20 (d, J = 2.4 Hz, 2H, -OCH2CCH); 3.70-3.60 (m, 14H, -
C(O)OCH2CH2O(CH2CH2O)3-); 2.47 (t, J = 2.4 Hz, 1H, -OCH2CCH) 
13
C NMR (CDCl3, 
75 MHz): δ=169.37 (CH(CH3)COO); 79.08(CCH); 74.32(CCH); 74.03; 70.09; 69.96; 
69.91; 69.7; 68.52; 57.89; 48.78 (CH2); 27.81 (CH2O); 15.58(CH(CH3)CONH); FT-IR 
(cm
-1
, ATR): 2873 (C-N); 1745 (C=O); 1246; 1207; 1098; 1030 (C-N); 909; 728 MS 
(ESI): m/z ([M+Na]+: C14H25NO6Na), calcd 326.34; found 326.3 
2-22 
 
 
DMAP (0.4 g, 3.3 mmol), Boc-D-Ala-OH (6.9 g, 36.6 mmol), DIPEA (66.2 mL, 389.0 
mmol) and DCC (7.6 g, 36.7 mmol) were added to a cooled solution (0 °C, ice bath) of the 
HCl salt of 12 (10.1 g, 33.3 mmol) in CH2Cl2 (250 mL). The reaction mixture was stirred at 
0 °C for 3 h and subsequently at room temperature for 14 h. A white solid was filtered off 
and the residue (colourless) was washed with a saturated aqueous citric acid solution (3 × 
75 mL). The water layer was backwashed with chloroform (1 × 100 mL). A white side 
product was filtered and washed with ethyl acetate, the filtrate and ethyl acetate washings 
were concentrated under reduced pressure. Two consecutive columns were performed, first 
the crude product was eluted with 2% MeOH in CH2Cl2 similar Rf fractions combined and 
concentrated under reduced pressure. The second column was eluted with ethyl acetate to 
yield compound 6 (9.4 g, 60%) as a yellow oil.  
Rf = 0.2 (2% MeOH/CH2Cl2) 
1
H NMR (CDCl3, 300 MHz): δ = 7.25 (s,  1H, NHCH); 5.1 
(br.s., 1H, NHCH); 4.58 (q, J = 7.5 Hz 1H, NHCH(CH3)); 4.27 (m, 3H, C(O)OCH2CH2O); 
4.19 (d, J = 2.4 Hz, 2H, OCH2CCH); 3.72-3.65 (m, 14H, C(O)OCH2CH2O(CH2CH2O)3); 
2.42 (t,  J = 2.4 Hz, 1H, CCH); 1.44 (s, J = 7.2 Hz 9H, OC(CH3)3); 1.40 (d, 3H, 
NHCH(CH3); 1.34 (d, 3H, NHCH(CH3)) 
13
C NMR (CDCl3, 75 MHz): δ = 172.2 
(CH(CH3)COO); 171.8 (CH(CH3)COO); 155.0 (NHCOO); 74.1; 70.1; 68.6; 68.4; 63.9; 
57.9; 49.5; 47.6 (CH2); 27.8 (OC(CH3)3); 17.7 (CH(CH3)NH) MS (ESI): m/z ([M+Na]
+: 
C22H38N2O9Na), calcd 497.25; found 497.24 
 
A solution of 13 (9.4 g, 19.9 mmol) in 20 mL DCM was treated with 30 mL 4M HCl in 
dioxane. The mixture was stirred for 1 h. The mixture was concentrated by removing 
excess solvent under reduced pressure. The oil was diluted with 20 mL DCM and any 
residual t-BuOH removed via azeotropic distillation, this procedure was repeated three 
times. Once dry, a yellow oil 14 was obtained with quantitative yield.  
Rf = 0.06 (5% MeOH/CH2Cl2)
 1
H NMR (CDCl3, 300 MHz): δ = 4.50-4.30 (m, 4H, -
NHCH(CH3), -NHCH(CH3), -C(O)OCH2CH2O-); 4.25 (d, J = 2.4 Hz, 2H, -OCH2CCH);  
3.79-3.61 (m, 14H, -C(O)OCH2CH2O(CH2CH2O)3); 2.46 (t, J = 2.4 Hz, 1H, -OCH2CCH); 
1.54   FT-IR (cm-1, ATR): 3235 (C-Halkyne) ; 2880; 2245; 1736 (C=O); 1681 (C=O); 1099 
(C-O); 910; 730 MS (ESI): m/z ([M+Na]+: C17H30N2O7Na), calcd 397.42; found 397.5 
 
To a solution of 5g (13.5 mmol) of product 7 in ethyl formate (25 mL) was added sodium 
formate (3.7 g, 53.8 mmol). The reaction mixture was refluxed for 18 h at 70 °C. The 
excess sodium formate was filtered off and the filtrate was evaporated under reduced 
pressure. The crude product was purified with column chromatography using 5% methanol 
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in ACN/CH2Cl2 as eluent. From the column a red-brown oil was obtained and to remove the 
colour, the oil was filtered over basic alumina. The oil was concentrated on top of a 10 cm 
alumina plug in a glass filter and carefully washed with ethyl acetate. The ethyl acetate was 
removed under reduced pressure. An amount of 2.3 g of pure 15 (slightly yellow-colourless 
oil) was obtained with a yield of 42%. 
Rf = 0.2 (5% MeOH in ACN/CH2Cl2 (1:2, v/v)) 
1
H NMR (CDCl3, 300 MHz): δ = 8.18 (s, 
1H, HC(O)NH-); 6.86 (bd, 1H, -NHCH-); 6.66 (bd, 1H, -NHCH-; 4.58 (m, 2 H, -
NHCH(CH3), -NHCH(CH3)); 4.25 (m, 2H, -C(O)OCH2-); 4.18 (d, 2H, -OCH2CCH); 3.72-
3.59 (m, 14H, -C(O)OCH2CH2O(CH2CH2O)3-); 2.42 (t, 1H, -OCH2CCH); 1.39 (t, 6H, -
NHCH(CH3), -NHCH(CH3))
 13
C NMR (CDCl3, 75 MHz): δ = 172.0 (C(O)OCH2); 171.0 
(C(O)NH); 160.9 (C(O)H); 74.2; 70.0; 69.8; 68.6; 68.5 63.9; 57.9 (CH2); 47.9 (CH(CH3)); 
46.7 (CH(CH3)); 17.4 (CH(CH3)); FT-IR (cm
-1
, ATR): 3282 (C-Halkyne); 2872 (C-
Hformamide); 1738 (C=O); 1654 (C=O); 1100 (C-O) MS (ESI): m/z ([M+Na]
+: 
C18H30N2O8Na), calcd 425.19; found 425.2 
 
To a solution of 15 (2.3 g, 5.7 mmol) in freshly distilled CH2Cl2 (40 mL), NMM (1.6 mL, 
14.2 mmol) was added. The reaction mixture was cooled to -80 °C (dry ice/acetone). A 
solution of diphosgene (0.5 mL, 3.7 mmol) in CH2Cl2 (30 mL) was added dropwise very 
slowly to the cooled alkaline mixture of 15. The reaction mixture was stirred for 60 min, 
quenched with an excess of solid NaHCO3 and poured directly on a silica plug (0.3% Et3N 
in DCM). The plug was eluted with 0.3% Et3N in 1:2 ACN/CHCl3. The product M3 was 
obtained (1.1 g, 3.1 mmol, 55%) as a yellow oil.  
Rf = 0.5 (10% MeOH/DCM)) 
1
H NMR (CDCl3, 300 MHz): δ = 7.00 (bd, 1H, -NH-); 4.58 
(m, 1H, -NHCH(CH3)C(O)O); 4.32 (m, 2H, -C(O)OCH2CH2O); 4.25 (m, 1H, 
CNCH(CH3)); 4.19 (d, 2H, -OCH2CCH); 3.72-3.61 (m, 14H, -
OCH2CH2(OCH2CH2)3OCH2CCH); 2.42 (t, 1H, -CCH); 1.65 (d, 3H, 
CNCH(CH3)C(O)-); 1.49 (d, 3H, -NHCH(CH3)C(O)O-) 
13
C NMR (CDCl3, 75 MHz): δ = 
171.5 (C(O)OCH2); 165.3 (C(O)NH); 160.9 (CN); 74.6 (-CH2CCH); 73.9 (-CH2CCH); 
70.4, 70.8, 70.8, 70.8, 69.8, 68.3, 68.0; 64.2; 57.9 ( CH2); 48.2 (CNCH(CH3)); 48.0 (-
NHCH(CH3)); 19.3 (CH(CH3)CONH ); 19.0 (CH(CH3)CONH) FT-IR (cm
-1
, ATR): 3250 
(N-H); 2890 (C-H); 2140 (CN); 1750 (C=O); 1690 (C=O); 1095 (C-O) MS (ESI): m/z 
([M+Na]+: C18H39N2O7Na), calcd 407.18; found 407.2. 
 
2.4) Preparation of the comonomer M4 
 
 
L-Ala-OH (5.0 g, 89.0 mmol), p-toluene sulfonic acid (11.9 g, 62.6 mmol), tetraethylene 
glycol monomethyl ether (10) (12 mL, 56.9 mmol) and 200 mL of toluene were added in a 
round bottom flask. The mixture was refluxed for 4 h using a Dean-Stark trap (~3 mL of 
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water was collected).The residual p-toluene sulfonic acid was filtered off and the filtrate 
was concentrated under reduced pressure. The concentrated crude product was re-dissolved 
in 100 mL CH2Cl2 and then three extractions with a saturated aqueous solution of NaHCO3 
were done. The organic washings were combined and was dried over Na2SO4. The product 
was purified via filtration over alumina with CH2Cl2 as eluent to obtain 7.3 g of 17 as a 
colourless oil in a 46% yield. 
1
H NMR (CDCl3, 300 MHz): 4.28-4.25 (t, J=4.81 Hz, 1H, -CH(CH3)-); 3.73-3.53 (m, 
16H, (-OCH2CH2-)4); 3.37 (s, 3H, -CH3); 1.35-1.32 (d, J=6.9 Hz, 2H, -NH2) FT-IR (cm
-1
, 
ATR): 3462 (N-H); 2872 (C-H); 1734 (C=O ester); 1104 (C-O ether). 
 
 
DMAP (0.1 g, 0.8 mmol), Boc-D-Ala-OH (4.9 g, 26.1 mmol), DIPEA (0.5 mL, 2.6 mmol), 
HOBt (4.0 g, 26.1 mmol) and DCC (5.9 g, 28.7 mmol) were added to a cooled solution (0 
°C, ice bath) of 17 (7.3 g, 26.1 mmol) in CH2Cl2 (250 mL). The reaction mixture was 
stirred at 0 °C for 3 h and subsequently at room temperature for 15 h. Residual starting 
compounds and DCU was filtered off. The filtrate was washed with a 10 % aqueous citric 
acid solution (3 × 50 mL) and the water washings extracted with chloroform (1 × 75 mL). 
All the organic layers were combined and dried with Na2SO4. The dried organic layer was 
filtered and concentrated under reduced pressure. The crude product was purified with 
column chromatography using alumina with chloroform as the eluent. The product 18 was 
yielded (8.0 g, 68%) as a yellow oil.  
Rf = 0.5 (10% MeOH/CH2Cl2) 
1
H NMR (CDCl3, 300 MHz): δ = 6.80 (s, 1H, -NHCH-); 
5.11 (br.s, 1H, - NHCH) -; 4.60 (quin, J = 7.2, 1H, -NHCH(CH3)-); 4.28-4.28 (m, 3H, -
C(O)OCH2CH2O-, -CH(CH3)COO-); 3.73-3.64 (m, 14H, -C(O)OCH2CH2O(CH2CH2O)3-); 
3.39 (s, 1H, -OCH3); 1.46 (s, 9H, -OC(CH3)3); 1.43 (d, J =7.0, 3H, -NHCH(CH3)-; 1.36 (d, 
J = 7.4, 3H, -NHCH(CH3)-) FT-IR (cm
-1
, ATR): 3317 (N-H); 2876 (C-H); 1739 (C=O 
ester); 1671 (N-H); 1517 (N-H); 1452 (C-H); 1163 (C-O) 
 
A solution of 18 (8.0 g, 17.7 mmol) in 20 mL ethyl acetate was treated with 20 mL 4 M 
HCl in dioxane solution. The mixture was stirred for 1 h. TLC still showed the presence of 
compound 18, and therefore another 20 mL HCl in dioxane was added and the stirring 
continued for an additional 1 h.  The solvent was evaporated under reduced pressure to 
obtain 19 (quant. yield) as a yellow oil.  
Rf = 0.8 (10% MeOH/CH2Cl2) 
 
To a solution of 19 (6.2 g 17.7 mmol) in ethyl formate (50 mL) sodium formate (4.8 g, 70.8 
mmol) was added. The reaction mixture was refluxed for 14 h at 70 °C. The excess sodium 
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formate was filtered off and the solvent was evaporated under reduced pressure. The crude 
product was a red oil. Column chromatography (4% MeOH in CH2Cl2,) was used to purify 
the product yielding 20 as a light yellow oil (2.2 g, 33%).  
1
H NMR (CDCl3, 300 MHz): δ = 8.21 (s, 1H, HC(O)NH-); 6.96 (bd, J=7.5Hz, 1H, -
NHCH-); 6.79 (bd, J=7.5Hz, 1H, -NHCH-; 4.58 (m, 2 H, -NHCH(CH3), -NHCH(CH3)); 
4.31 (m, 2H, -C(O)OCH2); 3.67-3.56 (m, 14H, -C(O)OCH2CH2O(CH2CH2O)3); 3.39 (s, 
3H, -OCH3); 1.43 (t, 6H, -NHCH(CH3), -NHCH(CH3)
 13
C NMR (CDCl3, 75 MHz): δ 
=172.42 (C(O)NH); 171.42(C(O)OCH2); 161.32 (HC(O)); 160.55; 71.82; 70.51; 70.11; 
68.76; 64.47; 61.65; 59.01 (CH2); 48.24 (CH(CH3)CONH); 46.78 (CH(CH3)CONH); 18.42 
(CH(CH3)CONH); 17.63 (CH(CH3)CONH) FT-IR (cm
-1
, ATR): 3297 (N-H); 2875(C-H); 
1739 (C=O ester); 1653 (N-H); 1529(N-H), 1452 (C-H), 1101 (C-O) 
 
To a solution of 20 (3.2 g, 8.5 mmol) in freshly distilled CH2Cl2 (40 mL), NMM (2.3 mL, 
21.2 mmol) was added. The reaction mixture was cooled to -78 °C (dry ice/acetone). A 
solution of diphosgene (0.7 mL, 5.9 mmol) in CH2Cl2 (30 mL) was added dropwise over 
the course of 2 h to the cooled alkaline solution of 20. The reaction mixture was quenched 
with solid NaHCO3 (3 g) and poured directly on a silica plug (0.3% Et3N in DCM). The 
compound was eluted with 1:2 ACN/CH2Cl2 to obtain 1.3 g of M4 (3.6 mmol, 43%) as a 
colourless oil.  
Rf = 0.4 (10% MeOH/DCM)) 
1
H NMR (CDCl3, 300 MHz): δ = 6.99 (bd, 1H, -NH-); 4.58 
(quin, J = 7.2, 1H, -NHCH(CH3)); 4.32 (m, 2H, -C(O)OCH2CH2O-); 4.25 (m, 1H, 
CNCH(CH3)C(O)NH-); 3.73-3.53 (m, 14H, -OCH2CH2(OCH2CH2)3OCH3); 3.37 (s, 3H, -
OCH3); 1.64 (d, J = 7.0, 3H, CNCH(CH3)C(O)); 1.49 (d, J = 7.0, 3H, -
NHCH(CH3)C(O)O);  
13
C NMR (CDCl3, 75 MHz): δ = 171.98 (CH(CH3)C(O)OCH2); 
165.73 (CH(CH3)C(O)NH); 160.9 (CN); 71.92 (-CH2CCH); 70.60, 70.60, 70.60, 70.51, 
70.51, 68.8, 65.55; 64.72 (CH2); 59.00 (OCH3); 48.58 (CNCH(CH3)CON-); 48.58 
(NHCH(CH3)C(O)O); 19.66 (CH(CH3)CNH); 18.02 (CH(CH3)C(O)O) FT-IR (cm
-1
, 
ATR): 3250 (N-H, amide); 2875 (C-H); 2140 (CN, isocyanide); 1741 (C=O, ester); 1682 
(C=O, amide); 1100 (C-O, ether) MS (ESI): m/z ([M+Na]+: C18H39N2O7Na), calcd 383.18; 
found 383.2 
 
2.5) Preparation of the comonomer M5  
 
 
Compound 21 (5.0 g, 17.9 mmol), HOBt (2.7 g, 17.9 mmol), DIPEA (0.3 mL) and DMAP 
(spatula tip) were dissolved in CH2Cl2 (100 mL) and stirred until all the solids were 
dissolved. The solution was cooled to 0 ºC and a mixture of Boc-4Abz-OH (4.3 g, 17.9 
mmol) and DCC (4.1 g, 19.7 mmol) in CH2Cl2 (~50 mL) was added portion wise. The 
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reaction was stirred o/n and allowed to slowly warm up to room temperature. The DCU was 
filtered off and the filtrate concentrated under reduced pressure. The crude product was 
subsequently dissolved in CHCl3, washed with a 10% aqueous solution of citric acid (3x) 
and a saturated aqueous solution of NaHCO3. The water layers were combined and 
extracted with CHCl3 (3x).  All the organic layers were combined and dried over Na2SO4. 
The solvent was removed under reduced pressure and the crude product was purified via 
column chromatography (SiO2 0.060-0.200 mm) using CHCl3 as eluent to yield a yellow oil 
(3.3 g, 6.6 mmol, 37%). 
1
H NMR (CDCl3, 300 MHz): 7.66 (m, 2H, -CHAr-); 7.38 (m, 2H, -CHAr-); 6.75 (s, 1H, -
NH-); 6.60 (s, 1H, -NH-); 4.65 (m, 1H, -CH(CH3)), 4.23 (m, 2H, -COOCH2-); 3.61 (m, 2H, 
-COOCH2CH2-), 3.55-3.47 (m, 10H, -OCH2CH2OCH2CH2OCH2-); 3.43-3.40 (m, 2H, -
CH2OCH3); 3.25 (s, 3H, -OCH3); 1.42 (m, 12H, C(CH3)3, CH(CH3)). FT-IR (cm
-1
, ATR): 
3286 (N-H); 2880 (C-H); 1726 (C=O ester); 1640 (amide I); 1523 (amide II); 1236 (C-O 
ester); 1158 (C-O ester); 1052 (C-O ether); 771 (Ar-H). 
 
Compound 22 (3.3 g, 6.6 mmol) was treated with 20 mL 4M HCl in dioxane at room 
temperature. The deprotection was followed by TLC. When the deprotection was 
completed (1 h), the solvent was evaporated. The compound was dissolved in n-BuOH (0.5 
mL) and CHCl3 (20 mL) and evaporated under reduced pressure. The crude product was 
used without further purification. 
The deprotected compound was dissolved in ethyl formate (~100 mL) and sodium formate 
(1.8 g, 26.6 mmol) was added. The mixture was refluxed o/n. The excess sodium formate 
was filtered off and the filtrate concentrated via evaporation under reduced pressure. The 
crude product was purified using column chromatography (SiO2 0.060-0.200 mm)   with 
CH2Cl2/10% MeOH as eluent. After evaporation of the solvent under reduced pressure, the 
product was obtained as a yellow oil (2.7 g, 6.2 mmol, 94%). 
1
H NMR (CDCl3, 300 MHz): 8.40 (d, J=1.8 Hz, 1H, CHO); 7.87-7.78 (m, 2H, -CHAr-); 
7.68-7.65 (m, 2H, -CHAr-); 7.17-7.14 (d, J=8.7 Hz, 1H, -NH-); 6.84-6.82 (d, J=6.9 Hz, 1H, -
NH-); 4.79-4.69 (q, J=7.4 Hz, 1H, -CH(CH3)); 4.31 (m, 2H, -COOCH2-); 3.70 (t, J=4.7 Hz, 
2H, -COOCH2CH2-); 3.62-3.54 (m, 10H, -OCH2CH2OCH2CH2OCH2-); 3.53-3.50 (m, 2H, -
CH2OCH3); 3.34 (s, 3H, -OCH3); 1.53-1.51 (d, J=7.2 Hz 3H, -CH(CH3)) 
13
C NMR 
(CDCl3, 75 MHz): 199.1 (C(O)OCH2), 187.6 (C(O)NH); 155.0 (C(O)NH) ; 148.1 (CAr); 
143.5(CAr); 141.4(CAr); 135.1(CAr); 122.5(CAr); 112.2(CAr); 111.6(CAr); 110.9(CAr); 
110.2(CAr); 101.3; 99.4; 53.9; 52.5; 50.9; 46.5; 40.6; 36.2; 35.8; 35.5; 35.1(CH2); 
34.7(CH(CH3); 30.8(OCH3); FT-IR (cm
-1
 ATR): 3278 (N-H); 3053 (Ar-H); 2875 (C-H); 
1739 (C=O ester); 1640 (amide I, formamide I); 1526 (amide II, formamide II); 1256 (C-O 
ester); 1171 (C-O ester); 1095 (C-O ether); 731 (Ar-H) MS (ESI): m/z ([M +Na]+: 
C20H30N2O8Na), calcd 449.5; found 449.3. 
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Compound 23 (1.0 g, 2.3 mmol) was dissolved in 200 mL dry CH2Cl2, NMM (591.4 mg, 
645 µL, 5.9 mmol) was added and the mixture was cooled to -35 ºC in a dry ice/isopropanol 
bath. The setup was flushed with argon prior to and during the reaction. Diphosgene (324.7 
mg, 197 µL, 1.6 mmol) was diluted in 50 mL of CH2Cl2 and added dropwise over a period 
of 90 min to the cooled alkaline mixture of 23 under vigorously stirring. The reaction was 
quenched with ~5.0 g of solid NaHCO3 and stirred for an additional 10 min. The mixture 
was poured directly onto a column (SiO2 0.065 - 0.200 mm, CH2Cl2) and allowed to 
concentrate at the top. The eluent was switched to acetonitrile/CH2Cl2 (1:2) to obtain a dark 
yellow oil (670.0 mg, 1.6 mmol, 70%). 
 1H NMR (CDCl3, 400 MHz): 7.89-7.87 (m, 2H, -CHAr-); 7.47-7.45 (m, 2H, -CHAr-); 6.99-
6.97 (d, J=7.4 Hz, 1H, -NH-); 4.86-4.79 (q, J=7.1 Hz, 1H, -CH(CH3)); 4.39-4.30 (m, 2H, -
COOCH2-); 3.74-3.72 (t, J=5.1 Hz, 2H, -COOCH2CH2-); 3.66-3.62 (m, 10H, -
OCH2CH2OCH2CH2OCH2-); 3.55-3.52 (m, 2H, -CH2OCH3); 3.38-3.35 (s, 3H, -OCH3); 
1.55-1.54 (d, J=7 Hz, 3H, -CH(CH3)) FT-IR (cm
-1
 ATR): 3323 (N-H); 2877 (C-H); 2123 
(C=N); 1742 (C=O ester); 1659 (amide I); 1538 (amide II); 1173 (C-O ester); 1107 (C-O 
ether); 859 (Ar-H); 615 (Ar-H) MS (ESI): m/z ([M +Na +K]+: C20H28N2O7NaK), calcd 
470.54; found 469.0. 
 
2.6) Preparation of the comonomer M6 
 
Triethylene glycol monomethyl ether (22.0 mL, 156.2 mmol), D-alanine (12.0 g, 134.6 
mmol), p-toluene sulfonic acid (28.2 g, 163.5 mmol) and 250 mL toluene were added in a 
round bottom flask. The reaction mixture was refluxed at 126 ºC for 4 h in a Dean-Stark 
setup and 3 mL of water was collected. A solid precipitate was filtered off, and the solvent 
was evaporated under reduced pressure. The product was dissolved in 300 mL chloroform 
and was extracted three times with a saturated aqueous solution of NaHCO3. Thereafter, the 
water layer was extracted twice with chloroform. The combined organic layers were dried 
with Na2SO4, and the solvent was evaporated under reduced pressure, obtaining 14.0 g of 
24 with a 44% yield. 
 
Boc-L-Ala-OH (11.2 g, 59.4 mmol), DMAP (spatula tip), HOBt (9.1 g, 59.4 mmol), DCC 
(13.5 g, 65.3 mmol), 24 (14.0 g, 59.4 mmol) and 250 mL of CH2Cl2 were mixed together, 
cooled in an ice bath to 0 ºC and stirred for 3 h. Thereafter, the mixture was allowed to 
reach room temperature and subsequently stirred for 15 h. The solid was filtered off, the 
product was dissolved with 200 mL chloroform, and the solution was extracted three times 
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with a saturated aqueous solution of citric acid. The water layer was extracted with 
chloroform (1 x 200 mL). The combined organic layers were washed twice with a saturated 
aqueous solution of NaHCO3, and the water layer was extracted with chloroform two more 
times. All organic layers were combined and dried with Na2SO4, and the solvent was 
evaporated under reduced pressure. The crude product 25 was used for the next step 
without any further purification.  
Compound 25 (24.2 g, 59.4 mmol) was dissolved in 20 mL ethyl acetate and treated with 
20 mL 4 M HCl in dioxane. The mixture was stirred for 1 h at room temperature. TLC still 
showed the presence of starting compound, therefore, another 20 mL 4 M HCl in dioxane 
was added and the solution was stirred for 1 additional hour at room temperature. The 
residual t-BuOH was removed by addition of 20 mL DCM and azeotropic distillation under 
reduced pressure. This procedure was repeated three times.  
 
The HCl salt of 25 (13.2 g, 32.3 mmol) and sodium formate (8.8 g, 129.3 mmol) were 
dissolved into 250 mL ethyl formate. The reaction mixture was boiled for 14 h at 66 ºC.  
The residual sodium formate was filtered off, and the filtrate concentrated under reduced 
pressure. The crude product was purified by column chromatography (4% MeOH in 
CH2Cl2), followed by filtration over a short alumina grade III column using ethyl acetate as 
eluent, obtaining 2.5 g of 26 in a 13 % yield. 
Rf = 0.5 (10% MeOH/CH2Cl2)
 1
H NMR (CDCl3, 400 MHz): δ = 8.19 (s, 1H, HC(O)NH); 
7.02 (br.d, J = 7.8,1H, NHCH); 6.75 (br.d, J = 7.0, 1H, NHCH; 4.60 (m, 2 H, NHCH(CH3), 
NHCH(CH3)); 4.31 (m, 2H, C(O)OCH2); 3.67-3.54 (m, 10H, 
C(O)OCH2CH2O(CH2CH2O)3); 3.38 (s, 3H, OCH3); 1.42 (d, 3H, J = 7.0 , -NHCH(CH3); 
1.39 (d, J = 7.0, 3H -NHCH(CH3) 
 
Compound 26 (2.5 g, 7.6 mmol) was degassed for 1 h with N2. Then NMM (2.1 mL, 19.0 
mmol) was dissolved in freshly distilled CH2Cl2 (100 mL), and added to the solution. The 
reaction mixture was cooled to -40 ºC (dry ice/ isopropanol). A solution of diphosgene (0.6 
mL, 4.6 mmol) in CH2Cl2 (50 mL) was added dropwise over 2 h. The reaction mixture was 
stirred until it turned to a yellow-orange colour, and was quenched with solid NaHCO3 (3.0 
g). The quenched solution was immediately poured onto a silica column mixed with DCM 
(0.3% triethylamine) and eluted with (1:3 ACN/CH2Cl2), obtaining 1.3 g of M6 in a 53% 
yield. 
Rf = 0.5 (10% MeOH/CH2Cl2)
 1
H NMR (CDCl3, 400 MHz): δ = 7.01 (br.d, J = 7.4, 1H, 
NH); 4.58 (quant, J = 7.2 , 1H, CNCH(CH3)C(O)NH); 4.33 (m, 2H, C(O)OCH2CH2O); 
4.26 (q, J = 7.0, 1H, NHCH(CH3)C(O)O); 3.74-3.53 (m, 10H, 
OCH2CH2(OCH2CH2)3OCH3); 3.39 (s, 3H, OCH3); 1.67 (d, J = 7.4, 3H, 
CNCH(CH3)C(O)); 1.48 (d, J = 7.0, 3H, NHCH(CH3)C(O)O) MS (ESI): m/z ([M+Na]
+: 
C14H24N2O6Na), calcd 339.4; found 339.1  
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Chapter 3 : Polymer synthesis and characterization 
Abstract 
In Chapter 1, the network and fibre characteristics, which are desirable for a synthetic 
ECM, were discussed. A synthetic ECM material must be fibrous, have finite bundling, 
should exhibit strain stiffening mechanics and it should be able to form a cell supporting 3D 
biocompatible network. In this chapter we will take a closer look at the synthesis of helical 
stiff water-soluble polyisocyanide hydrogels. The synthesis of tri and tetra ethylene glycol 
isocyanide monomers with and without functional handles will be investigated. The 
difference between homo- and copolymers on the polymer characteristics will be presented. 
The effect of introducing monomers with functional handles (acetylene or azide) appended 
to the polymer backbone and the highest possible loading, whilst still retaining polymer 
characteristics similar to the non-functional polymer will be discussed. Finally in a route 
towards stiffer polymers, the inclusion of π-π stacking monomers into the polymer by the 
introduction of aminobenzoic acid instead of the conventional alanine and its effect on the 
polymerization will be investigated. 
 
Introduction 
As defined in Chapter 1, the mechanical properties of the ECM fibrous scaffolds are 
essential in translating the biomechanical environmental signals to cells suspended in it to 
stimulate a cellular response. These ECM fibres have very specific characteristics such as 
finite bundles of self-assembled helical fibrils with non-linear stress strain behaviour setting 
them apart from all current synthetic systems. In this chapter, a completely new class of 
synthetic ECM fibre mimic based on polyisocyanopeptides (PICs) will be discussed [1]. 
These helical polymers possess a 41 (four repeat units per turn) β-helical architecture, in 
which a hydrogen bond network is formed among the peptidic side groups parallel to the 
polymer backbone [2] (Figure 1), resulting in exceptionally stiff chains with  persistence 
lengths lp comparable to that of dsDNA [3]. Some derivatives of this family of polymers are 
amongst the stiffest manmade materials known to date with an lp up to 200 nm [4]. In this 
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chapter homopolymers, copolymers and terpolymers will be synthesized from the 
monomers synthesized in Chapter 2. By modifying the monomer building blocks whilst 
keeping the monomer to catalyst molar ratio constant at 1:10,000, the ability to tune the 
properties of the synthesized polymers was studied. Changing the molar ratio of tri- and 
tetra-ethylene glycol sub units present in a polymer the sol to gel transition temperature can 
in principle be tailored. In addition, the effect of using different enantiomeric states of the 
alanine amino acid, DL, LD and LL upon the helicity of the individual fibres and how this 
chiral change would affect the bundling and eventually the hydrogels mechanical properties 
will be presented. In order to develop a genuine ECM, the introduction of functional 
handles to enable modular methods for bioconjugation of biologically relevant ligands to 
the polymers was studied. In the hope of varying the stiffness of the polymers, the effect of 
π-π stacking on the polymer fibre through the addition/substitution of alanine with the non 
natural 4- amino benzoic acid was investigated. 
 Figure 1. Oligo(ethylene glycol) substituted polyisocyanopeptides. (a) the isocyanide monomer with alanine-alanine dipeptide core, oligoethylene spacer and functionalizable chain end, (b) representation of the hydrogen-bond network that stabilises the secondary helical structure, (c) Schematic illustration of the 41 β–sheet helix. The arrow represents the peptide substituents. 
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Results and discussion 
1. Polymer synthesis 
1.1. Homopolymers 
1.1.1. Poly(DL-isocyanopeptide)-graft-tri(ethylene glycol) (M2)  
 
Polymers were synthesized from a triethylene glycol (M2) monomer derivative 
catalyzed with nickel in a dry environment for three days. Compound M2 was dissolved in 
freshly distilled toluene. A volume of the 1 mM catalyst stock solution equivalent to 10-4 of 
the total M2 mols was transferred via pipette into the mixture of M2 and toluene. The flask 
was placed in an ice bath and fitted with a CaCl2 drying tube. The mixture was diluted with 
distilled dry toluene to obtain a final concentration of 50 mg/mL monomer. After 2-3 h the 
mixture became extremely viscous and additional solvent was added to obtain a 
concentration of 25 mg/mL. This mixture was allowed to stir for a total of 72 h. The 
polymer was isolated via precipitation into diisopropylether. This precipitation cycle was 
repeated three times to obtain a broad range of yields. The polymers were analysed by 
measuring the intrinsic viscosity to determine molecular weight (      ), rheology (G’) and 
circular dichroism. They were visualized by drop casting from solution onto freshly cleaved 
mica via atomic force microscopy (AFM). 
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During repetitive syntheses at the same monomer to catalyst molar ratio (1:10,000) it 
was observed that a broad range of yields and       were obtained within the group. To 
investigate the reproducibility of the method it was decided to keep the protocol constant 
and evaluate the reproducibility among different people. The obtained homopolymers had 
gravimetric yields ranging between 50-93 % and molecular weights ranging from 369 – 796 
kg/mol (Table 1). It was therefore concluded that the synthetic method is extremely 
sensitive to slight variations. 
Table 1. Homopolymer synthesis summary: molecular weight and yield. 
Sample        (kg/mol)  Yield (%) 
P1 498 89 
P2 590 50 
P3* 491 ~ 
P4 722 93 
P5* 586 67 
P6* 444 60 
P7 796 78 
P8* 369 72 
*: Chiralix monomer 
The only other known variable between synthesized polymers was the source of the 
monomer. By using statistical analysis software the molecular weights obtained using the 
same catalyst ratio per monomer source was compared. This comparison can be seen in 
Figure 2, overlaying the probability plots of the molecular weights per monomer source the 
distribution of molecular weight were normal. The average molecular weight per monomer 
source was determined along with the standard deviations. When the two averages were 
compared the standard deviation (error bars) overlapped meaning that although the 
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monomer sources were different there was no statistical difference between the obtained 
average molecular weights. 
The two sets of data were also compared by performing a standard two-sample t test 
and it was found that P= 0.069 which means that there was no significant deviation between 
the molecular weight distributions (Table 15).    
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Figure 2. The probability plots at a 95% confidence interval of the molecular weights obtained 
from a 1:10,000 catalyst ratio, using isocyanide monomer M2 from two different sources. 
Spectroscopic results 
The resulting polymers, although of differing length were found to have similar CD 
spectra varying only in intensity as a function of the concentration. No difference in spectra 
of polymers obtained from in-house or Chiralix monomers was observed (Figure 3). 
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Figure 3. The CD spectra for P8 (M2 from Chiralix) vs P7 (M2 in-house) 4 mg/mL in DCM. 
Therefore it was concluded that the only deviation in polymer behaviour was as a result 
of difference in molecular weight and that comparing all further results would be performed 
ignoring the monomer source.  
Rheology 
During linear rheology experiments it was observed that molecular weight affected the 
LCST temperature, a difference of up to 5 °C was possible as observed when comparing P8 
(369 kg/mol) 18 °C with P7 13 °C (796 kg/mol) (Figure 4).  
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Figure 4. Storage modulus as a function of temperature of two homopolymers , P8 with a 
molecular weight of  369 kg/mol and P7 with a molecular weight of  796 kg/mol at 1.6 mg/mL 
in PBS. 
The rheology of mixtures of these two polymers was also studied to see how the 
storage modulus of the low molecular weight polymer solution would change by the 
addition of high molecular weight polymer. To investigate this P8 (369 kg/mol) was 
systematically enriched with increasing amounts of P7 (796 kg/mol), see Figure 5. The 
stiffness of the resulting mixture gradually increased as the ratio of P7 to P8 was increased. 
The sol-gel transition temperature decreased with increasing percentages of P7. This earlier 
sol-gel transition temperature for the high molecular weight polymers is believed to occur 
because the longer the average polymer length the faster the rate of polymers entanglement 
resulting in polymer precipitation or the onset of an earlier sol-gel transition and therefore a 
lower sol-gel transition temperature is observed. The relationship between the percentage of 
P7 by weight and the increase in storage modulus was found to be linear (Figure 5). This 
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rather surprising result reveals that it would be possible to combine polymers from different 
batches to obtain a uniform material with controlled bulk stiffness circumventing prior 
issues of batch variation in stiffness at the same sample concentration. This level of 
controlled material properties is important if the material should ever be used as a 
marketable material.  
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Figure 5. The stiffness of a mixture of P8 and P7 at 25 °C as determined with rheology 
measurements. On the x-axis the percentage of P7 in the mixture is plotted. All samples were at 
a concentration of 1.6 mg/mL. (y=4.13(2.96)+0.98(0.05)x; adj R2=0.98) 
AFM Analysis of the hydrogels  
Bundle dimensions from AFM measurements.  
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As depicted in Figure 6, to measure bundle dimensions as a function of concentration, 
gels were prepared at concentrations ranging from 0.13−3.0 mg/mL were transferred to 
mica substrates and subjected to AFM [5]. 
 
Figure 6. AFM images of P1 obtained from samples of different polymer concentration: (A) 0.13 
mg/mL(scale bar: 400 nm, height range 0.9–8.5 nm), (B) 0.25 mg/mL (scale bar: 400 nm, height 
range 3.3–11.4 nm), (C) 0.50 mg/mL (scale bar: 1.0 μm, height range 1.2–6.4 nm), (D) 0.75 
mg/mL (scale bar: 1.0 μm, height range -3.0–4.7 nm), (E) 1.0 mg/mL (scale bar: 1.0 μm, height 
scale 0.7–7.0 nm), (F) 3.0 mg/mL (scale bar: 400 nm, height scale 0.2–0.2 nm).  
Statistical analysis of the images yielded distributions of bundle heights and bundle 
widths, see Figure 7. The height profiles in samples prepared from a simple gel transfer 
showed strong variations with the position in the sample. The fibre height was used to 
define bundle properties as the z-axis measurements were more reliable than the data 
obtained from the xy width profiles. Despite the broad distributions per sample, the gels at 
all concentrations typically formed ~30 nm wide bundles with a possible tip broadening of 
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10 nm per edge that would mean ~20 nm originating solely from the tip broadening [6] and 
the residual 10 nm would be closer to 6-9 fibre thickness of ~7-10 nm. 
 
Figure 7. Fibre width (left) and height (right) determined from statistical analysis of AFM 
results at c = 0.13 – 3.0 mg/mL. The sample size of the analysis is shown in the top panel. 
AFM Length 
To analyze the difference in length between low molecular weight and high molecular 
weight polymers, the polymers were visualized by AFM and analyzed by measuring the 
length of individual polymers.  
The polymer samples with low molecular weight as determined by viscometry had 
associated lower average lengths when observed by AFM when compared to the higher 
molecular weight sample. See, Figure 8 the histogram overlay of the AFM length data of 
P8 vs. P7. It was possible to derive the dispersity (Đ) from the AFM lengths by dividing 
the weighted average polymer length by the number average polymer length (Lw/Ln). The Đ 
was determined to by 1.5 for P8 and1.6 for P7.  
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Figure 8. The histogram of polymer lengths as determined by analyzing AFM height profiles of 
P8 and P7. 
 Pore size analysis by single particle tracking.  
The effect of concentration on the pore size of the PIC above the sol-gel transition 
temperature was investigated by tracking the Brownian movement of platinum 
nanoparticles of a known size (smaller than pore size as determined by AFM) for over 200 
steps through a PIC solution of a known concentration, through a known volume. The PIC 
concentration was systematically increased and the effect of this on the movement of the 
particle measured. As the concentration increased the platinum particles diffusion 
coefficient decreased indicating that the pore size was decreasing with increasing 
concentration of polymer (Figure 9). 
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Figure 9. Tracking analysis. Average diffusion coefficient as a function of concentration of P1 at 
T = 22 °C. 
From the data generated by the NanoTracking analysis, platinum nanoparticle of mean 
size of 184 nm in P1 solutions with varying concentrations (0.13 – 3.0 mg/mL), it was 
possible to analyze the trajectory of individual platinum particles and calculate the mean 
square displacement per particle. A particle in a solution with large pores will exhibit 
isotropic random walk through Brownian motion. If the particle is inside a porous network 
where the pore size is equal to its own size this random walk will change to a confined 
random walk in which free movement is only possible in pores larger than its own 
diameter. It follows that if the pores are smaller than the particle diameter, the particle will 
become completely confined appearing to be “stuck” in a hole (Figure 10). MATLAB 
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software was used to automatically calculate the mean square displacement of the particles 
per PIC concentration, in Figure 10 one particle per concentration is highlighted for clarity. 
With increasing concentration of PIC, the mean square displacement of the particles 
decreases and the Brownian motion of the particles change from isotropic random walk 
(0.13 mg/mL), partially confined random walk (0.75 mg/mL) to a confined random walk 
(3.0 mg/mL) [7-8]. This confirmed that the pore size was slowly decreasing as the 
concentration of PIC was increased.  
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Figure 10. The platinum nanoparticles were visualized moving through the PIC hydrogel with 
increasing concentration of P1 by Nanosight. In the above image one particle per concentration 
is highlighted and the mean square displacement in a defined space tracked over time. 
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1.1.2.  Poly(DL-isocyanopeptide)-graft-tetra(ethylene glycol) (M4)  
 
Homopolymers with the same chirality as in 1.1.1 but with one additional ethylene 
glycol subunit in the isocyanide monomer were synthesized to investigate the effect of the 
additional ethylene glycol unit on the polymers material properties. The same synthesis 
strategy and 1:10,000 catalyst ratio was used as in 1.1.1 with the only difference being the 
monomer used (see, Table 2 for details).  
Table 2. Homopolymer synthesis summary: molecular weight and yield. 
Sample        (kg/mol)  Yield (%) 
P9 430 55 
 
 Spectroscopic results 
The polymer was dissolved in DCM at a concentration of 1 mg/mL and the circular 
dichroism measured over a range of 500 – 220 nm (see, Figure 11). 
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Figure 11. The CD spectrum for P9 at concentration of 1 mg/mL in DCM. 
 Rheology 
Similar LCST behaviour was observed as for the homopolymers with triethylene 
glycol substitution, but the sol-gel transition was at a higher temperature of 42 °C (See 
Figure 16 for the temperature ramp of P9).  
1.1.3. Poly(LL-isocyanopeptide)-graft-tetra(ethylene glycol) (M7)  
 
To investigate the effect of chirality on the homopolymer, the LL-di-alanine isocyanide 
monomer was polymerised using the same synthetic strategy as employed in 1.1.1. The 
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mixture was stirred at room temperature in a flask fitted with a CaCl2 drying tube. The 
solution was left to stir over a series of days (see, Table 3). The length of stirring affected 
the molecular weight obtained. The polymer was isolated via precipitation into 
diisopropylether. The polymer was then re-dissolved in DCM and the precipitation cycle 
was repeated three times. The polymer was analysed by measuring the intrinsic viscosity 
and circular dichroism (see, Figure 12). 
Table 3. Homopolymers synthesis summary: Molecular weight and Yield 
Sample Reaction time 
(days) 
       (kg/mol)  Yield (%) 
P10 4  22 16 
P11 24 135 32 
 
At four days the LL variant had a significantly lower molecular weight than the 
conventional DL P9 (430 kg/mol). Even when the reaction time was increased to 24 days 
the molecular weight was still four times lower than the DL variant. 
Spectroscopic results 
CD spectra confirm that the appropriate LL polymer (P10; P11) was successfully 
synthesized as both peaks are now in –Ɛ as is characteristic for the L stereoisomer (see, 
Figure 12). 
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Figure 12. The CD spectra for homopolymers P10 and P11 at concentrations of 4 mg/mL in 
ACN. 
In conclusion, the inverted monomer affected the polymerization kinetics negatively, 
possibly by limiting the initial self assembly structure that drives the polymerization 
forward. To better understand the nickel catalyzed polymer mechanism, this effect should 
be investigated in more detail in the future. However, for the goal of this thesis simply 
observing retarded polymer formation with limited to low monomer to polymer conversion 
was enough to discontinue this avenue of investigation.  
1.1.4. Poly(LD-isocyanopeptide)-graft-tri(ethylene glycol) (M6) 
Reversing the chirality of the alanine subunits in the isocyanide monomer would result 
in polymers with inverted helixes. The same synthesis strategy and monomer to catalyst 
ratio was used as in 1.1.1. but with monomer M6 (see, Table 4 for details).  
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Table 4. Homopolymer synthesis summary: molecular weight and yield 
Sample        (kg/mol)  Yield (%) 
P12 626 73 
 
Spectroscopic results 
The CD spectrum (see, Figure 13) confirmed that the inverse enantiomer polymer was 
synthesized. 
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Figure 13. The CD spectrum for homopolymer P12 at a concentration of 4 mg/mL in ACN. 
Rheology 
To investigate the effect of ‘handedness’ on the gelation behaviour, a homopolymer 
with LD orientation was mixed with a homopolymer with DL orientation. It was postulated 
that the inverted handedness might affect bundling behaviour, which in turn may alter the 
gelation behaviour. The two polymers were combined 1:1 mass ratio 1 mg/mL in MQ. The 
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individual polymers went through a sol-gel transition upon heating (P1 18 °C vs. P12 22 
°C) and the mixture showed an intermediate sol-gel transition temperature of 20 °C (see, 
Figure 14). This behaviour was observed previously in polymers with similar handedness 
but different molecular weights (Figure 4), which is probably the explanation in this case 
also as P12 has a molecular weight of 626 kg/mol and P1 498 kg/mol. Therefore the effect 
of chirality on the PIC sol-gel transition seems negligible.  
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Figure 14. Storage modulus as a function of temperature for homopolymer LD (P12), DL (P1) 
and a 1:1 mixture of the two polymers (LD:DL) at 1,0 mg/mL in MQ. 
To conclude the LD monomer did not inhibit the polymerization as was observed with 
the LL variant. Although the homopolymer P12 did have an inverted handedness to the 
conventional DL polymer P1 there was no clear difference in LCST behaviour neither in its 
pure form nor mixed in equal amounts with the DL variant. This would seem to suggest that 
3-21 
 
the two networks are completely miscible and that bundle formation is unaffected by the 
polymer fibres’ handedness. In the future to verify whether the two polymers form a 
completely mixed system, two dyes (FRET pair) could be coupled to each polymer type, if 
sufficiently close to each other a FRET response would be observed, which would probably 
not occur in a phase-separated system.   
1.2. Synthesis of Copolymers 
1.2.1. Polymerization of Tri-Tetra ethylene glycol copolymers (M2:M4) 
 
The same synthesis strategy was used as in 1.1.1 with the only difference being two 
different monomers were used. It was postulated that by varying the ratio of oligoethylene 
units it would be possible to control the LCST temperature [9] to obtain a targeted 
transition temperature between 18 °C and 42 °C.  
Table 5. Copolymers synthesis summary: molar ratios, molecular weight and yield 
Sample M2:M4 (mol 
ratios) 
sol-gel (°C)        (kg/mol)  Yield (%) 
P13 25:75 25 597 54 
P14 50:50 30 551 57 
P15* 38.9:61.1 39 296 18 
P16* 27.9:72.1 30 523 61 
P17* 20.8:79.2 32 525 44 
*M2 from Chiralix  
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 Spectroscopic results 
The CD spectra (Figure 15) of all the copolymers described in Table 5 show a similar 
pattern. The P15-17 polymers are at the same concentration of 4 mg/mL in ACN and it is 
clear that P15 is lower in intensity. 
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Figure 15. The CD spectra for copolymers separated into polymers from different monomer 
sources a) 4 mg/mL in ACN. 
 Rheology 
It was observed that by changing the length of the polymers the sol-gel transition 
temperature could be modified but also by changing the ratios of oligoethylene monomers 
triethylene glycol (M2) to tetraethylene glycol (M4) (Figure 16) in a random copolymer it 
should be  possible to change the sol-gel transition temperature between 18 - 42 °C [9].  
A) 
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Figure 16. Storage modulus as a function of temperature for two copolymers and two 
homopolymers synthesized from the same monomer source for both M2 and M4 (in-house) and 
possessing similar molecular weights. 
Care should be taken however when interpreting data such as seen in Figure 17, as the 
molecular weight also affects the gelation temperature (Figure 4 and Figure 23), therefore 
only copolymers with similar molecular weights may be compared in this way. 
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Figure 17. Storage modulus as a function of temperature for three copolymers synthesized from 
the same monomer source M2 (Chiralix) and M4 (in-house) but with dissimilar molecular 
weights. 
The ball drop test [5] was used to confirm the sol-gel transitions observed in rheology. 
It is a very robust technique in which the gel is formed inside a temperature controlled 
water bath above its gel point. A small sphere with known diameter and weight is placed on 
top the gel. The water bath is cooled down and the exact temperature of gel-sol is noted as 
the sphere falls to the bottom of the gel container. In Figure 18 the result of this 
measurement is plotted against the rheology transitions. As rheology is more sensitive than 
the ball drop test, the sol-gel transition occurs at a slightly lower temperature. Nevertheless, 
both techniques show a linear dependency of sol-gel transition versus molar ratio of the 
comonomers. In the rheology data, the transition of P17 and P16 was included as it has a 
similar molecular weight as compared to the other polymers. From these experiments it was 
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possible to determine a linear relationship that could be used to tune the sol-gel transition of 
the hydrogels.  
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Figure 18. Sol-gel transitions of PIC copolymers with different % molar fractions of tri ethylene 
glycol monomer M2 to tetra ethylene glycol monomer M4, but similar molecular weight 
polymers. 
1.2.2. Polymerization of azide functional tri or tetra ethylene co-polymers 
(M1:M2 and M1:M4) 
As the polyisocyanides with biological relevant ligands were required, polymers with 
bioconjugation handles were needed. The bioconjugation strategy that seemed most 
promising in terms of ease, biological inertness, limited to no side products and high 
reactivity was the use of strain promoted acetylene-azide cycloaddition. Varying molar 
fractions of azide were introduced into the PIC backbone to create a library of possible 
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polymer scaffolds. The same synthetic strategy was used as in 1.1.1 with the only 
difference being the monomers used, i.e. the azide functional monomer (M1) and tri 
ethylene glycol (M2) or tetra ethylene glycol (M4) monomer. 
Table 6. Azide appended copolymers synthesis summary: molar ratios, molecular weight and % 
yield. 
Sample M1: M2 (mol)        (kg/mol)  Yield (%) 
P18 1:100 688 57 
P19 1:225 866 67 
P20 1:400 1143 83 
P21 1:570 948 83 
P22 1:850 1042 47 
P23 1:1140 1168 47 
P24* 1:50 570 66 
P25* 1:100 492 65 
P26* 1:150 629 62 
P27* 1:200 503 59 
P28* 1:100 451 70 
P29* 1:100 444 70 
P30* 1:100 361 75 
P31 1:50 755 72 
P32 1:100 735 74 
P33 1:200 714 68 
P34 1:100 331 83 
P35 1:400 378 62 
P36 1:550 835 70 
P37 1:1730 791 72 
P38 1:25 733 87 
P39 1:200 569 50 
P40 1:100 674 50 
P41 1:100 516 91 
 M1:M4 (mol)   
P42 1:100 421 78 
P43 1:100 616 88 
*: monomer M2 source Chiralix 
The ratio of azide to spacer monomer did not seem to affect the obtainable molecular 
weight (1:50 molar ratio of azide to spacer monomer). As observed previously 
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(homopolymers), the source of monomer affected the obtainable molecular weights (Figure 
19).  
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Figure 19. The probability plots at a 95% confidence interval of the molecular weights obtained 
from a 1:10,000 catalyst ratio, using isocyanide monomer M2 from two different sources and 
the same in-house azide monomer M1. 
Per monomer source the molecular weights were normally distributed. The average 
molecular weight per monomer source was determined to be 473 kg/mol for Chiralix M2 
monomer and 786 kg/mol for in-house M2, when the standard deviation was added to the 
lowest average Mw and subtracted from the highest average Mw the two averages (error 
bars) did not overlap and therefore the difference between monomer sources was 
significant. The two ranges were also compared by using two-sample t-test, a t-value of -5.4 
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and resulting P-value of 0.00 was obtained for degrees of freedom = 19, this value is 
smaller than 0.05 and therefore the difference between the two ranges is significant.  
 Spectroscopic results 
The quantification of azide loading on the backbone of PIC could not be performed 
accurately with 1HNMR, therefore it was decided to label the PIC with a dye and determine 
the concentration of the dyes spectroscopically. For this strategy to be effective, a 
conjugation strategy with near quantitative yields and easy purification was required. It was 
opted to use the strain promoted acetylene-azide click (SPAAC) reaction as it is known to 
be rapid and efficient. The PIC itself has a slight absorption peak around 350 nm and 
therefore any dye used for quantification should not adsorb at this wavelength. The label 
opted for was the bicyclononyne functional fluorescein derivative, commonly known as 
TokyoGreen, which absorbs at 506 nm (Figure 20). The polymer dye conjugate did suffer 
from solubility issues and therefore a mixed solvent system of ACN:DMSO:MQ was 
required. The extinction coefficient in this solvent system was determined experimentally 
as seen in Figure 20. 
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Figure 20. The calibration curve for TokyoGreen in ACN:DMSO:MQ (0.75:0.25:1.00) was 
constructed (y=3.49x adj. R2=0.98) from the UV absorbance at 506 nm. 
The polymers were dissolved in ACN, to which molar excess of TokyoGreen dissolved 
in DMSO was added. After conjugation the polymer-dye conjugate was purified via 
precipitation from diisopropyl ether until the diisopropyl ether solution no longer turned 
yellow. The polymer was dried under nitrogen flow. A known mass of the labelled polymer 
was dissolved in DMSO:ACN:MQ and the UV spectrum measured. The absorbance at λ = 
506 nm was used to determine the concentration of dye in mol/L, based on the extinction 
coefficient 35493 M-1 cm-1 experimentally determined in the same solvent system (Figure 
20). The azide ratio was determined by dividing the dye concentration by the monomer 
concentration (polymer weight divided by average monomer weight per L Table 7). 
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Table 7. A comparison between the targeted molar ratio (m/n) and that obtained from the dye 
test. 
Sample M1: M2 (mol) Molar ratio m/n 
#
  
P18 1:100 1:85 
P19 1:225 1:187 
P21 1:570 1:494 
P24 1:50 1:63 
P25 1:100 1:107 
P26 1:150 1:475 
P27 1:200 1:219 
P28 1:100 1:98 
P29 1:100 1:95 
P30 1:100 1:128 
P31 1:50 1:62 
P32 1:100 1:98 
P33 1:200 1:556 
P36 1:550 1:360 
P38 1:25 1:50 
P39 1:200 1:250 
P40 1:100 1:126 
P41 1:100 1:144 
#: As determined by the dye test 
IR spectroscopy was used to follow the depletion of the isocyanides around υ = 2100 
cm-1 during polymerization. The azide peak around υ = 2150 cm-1 is very weak due to the 
relatively low concentration of azide dangling off the polymer backbone. The azide peak 
was therefore not used to determine the amount of reacted azide after conjugation 
quantitatively (Figure 21). 
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Figure 21. IR spectra of various ratios of azide PIC (a) 4000-850 cm-1 (b) 2200-2000 cm-1. 
Circular dichroism spectroscopy was used to investigate the secondary structure of the 
polymers. The CD spectra in phosphate buffered saline (PBS) were similar to those found 
in previous studies of the same material [10] and showed a Cotton effect with a maximum 
A) 
B) 
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around λ = 270 nm and a minimum around λ = 360 nm, indicating that the polymers form 
the secondary left handed helix structure (see, Figure 22). The azide ratio did not affect the 
CD signal. This indicates that the azide and the conjugations on the outside of the polymer 
do not influence the helical backbone structure that causes the CD signal.  
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Figure 22. CD spectra of azide functiona PICs in ACN at: a) 4 mg/mL P20, P33-32, P36-38; b) 2 
mg/mL P28-30, P34; c) 1 mg/mL P39-40. 
Linear Rheology results 
As the hydrogels are intended for biological applications, their mechanical properties 
in biologically relevant media need to be fully characterized e.g. phosphate buffered saline 
(PBS). To investigate the thermo responsive gel properties, the rheology of samples 
dissolved in PBS was measured with a standard temperature ramp (Figure 23). The storage 
modulus was observed to increase at the sol-gel transition temperature around 15-18 °C and 
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continues to rise with increasing temperature. This behaviour is in accordance with the 
rheological behaviour for similar polymers in MQ [5]. What has not been reported before is 
the sudden drop of the storage modulus that can be seen for some samples in Figure 23 
(Figure 4) at increased temperatures. Why this drop-off is observed predominantly in high 
molecular weight homo- and copolymers (714-796 kg/mol) remains unclear. Separation of 
the rheology plates shortly after the drop-off occurred showed that there was still an intact 
(shrunken) layer of gel in the rheometer, but also an excess of water was excreted. The 
plate-plate geometry of the rheometer would slip because of the excreted water which is 
why the storage modulus drops rapidly if too much water is excreted. Cooling the sample 
down in the rheometer to re-dissolve it did not restore the sample. Possibly this was 
because the water excreted from the hydrogel was lost by evaporation and the homogeneity 
of the sample permanently disturbed. The excretion of water was also observed when 
heating a gel sample to 37 °C (mimicking the temperature ramp conditions) in a closed vial. 
Cooling the sample down at 0 °C for 5 minutes restored the sample and the rheology 
temperature ramp looked the same as a similar sample that was not heated. This indicates 
that the water excretion is reversible as long as there is no loss of excreted water. The 
excretion of liquid from gels is common in both natural [11] and synthetic polymer [12-13] 
systems. This phenomenon is known as syneresis and is caused by changes in interaction 
between the liquid and solid components of the solution [14]. It is also known that strain 
stiffening networks consisting of crosslinked semi flexible filaments exhibit negative 
normal stress when deformed in simple shear geometry [15-16], if this is not sufficiently 
incorporated into the rheometer settings the sample will contract away from the plate 
geometry and give senseless results. It is expected that this phenomenon would also be 
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present in the PIC network resulting in the expulsion of water and the contraction of the 
network above its LCST. 
Temperature ramps were performed on polymers with exactly the same sample history 
in terms of dissolving time and freeze thaw cycles. An overlay for all these polymers at 1.6 
mg/mL is shown in Figure 23. High molecular weight polymers (P31-33) 714-755 kg/mol 
exhibited higher stiffness and lower sol-gel transition temperatures (~12 °C) than the lower 
molecular weight polymers (P24-P28; P30) 361-629 kg/mol (see, Table 8).  
Table 8. Storage moduli of azide functional PIC 1.6 mg/mL PBS at 37 °C 
Samples Storage modulus G’ (Pa) 
P24 101 
P25 109 
P26 76 
P28 61 
P30 79 
P31 481 
P32 279 
P33 395 
P41 34 
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Figure 23. Storage modulus as a function of temperature for PICs at 1.6 mg/mL in PBS. 
Interestingly the a LCST of  ~12 °C (P31-P33) high molecular weight and ~18 °C (P24-P28 and 
P30) low molecular weight PICs.  
To avoid influencing the data by the effect of syneresis, the stiffness values at 25 °C 
were used to compare different samples. In Figure 24 it is observed that not only does the 
stiffness depend on concentration but on the molecular weight. The log of the modulus 
linearly with molecular weight (Figure 24) with adjusted R2 values between 0.88-0.96.  
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Figure 24. The storage modulus of the different molecular weights PICs in PBS at 25 °C at two 
different concentrations show similar trend in linear fit. (3.2 mg/mL: y=0.7(0.1)+0.003(1.9x10-
4)x adj. R2=0.96; 1.6 mg/mL: y=-0.2+0.003(3.7x10-4)x adj. R2=0.88) 
Non-linear rheology 
As discussed in Chapter 1 most of the extracellular matrix proteins exhibit non linear 
strain stiffening behaviour under an applied force [6,12]. This behaviour was also observed 
in the synthetic PIC hydrogel system when exposed to similar strain conditions in the 
rheometer [7].  
By plotting the differential modulus versus shear stress of a range of polymers the 
curves are not identical. In fact the critical stress (the point at which the differential 
modulus deviates from the linear regime) increases as molecular weight of the polymer 
increased (Figure 25).  
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Figure 25. The differential modulus relative to the shear stress for a range azide functional PICs 
(1 mg/mL in MQ) with different molecular weights. 
By plotting the critical stress values against the molecular weight, a linear relationship 
was observed. In the same graph the storage moduli of the same polymers were plotted 
against their molecular weight, here the relationship between stiffness and molecular 
weight is unclear (Figure 26). It would therefore appear that it would be possible to tailor 
the critical stiffness of the PIC by changing the molecular weight. It must be stated however 
that the polymers used to draw this conclusion were not synthesized from the same 
monomer sources. 
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Figure 26. A graphical summary the of hydrogels mechanical properties: critical stress relative 
to the molecular weight and storage modulus relative to molecular weight. The homopolymers 
(P6 & P7) and the copolymers are shown. Polymers were freshly dissolved in MQ at 1 mg/mL 
for each measurement.  
AFM length 
To obtain a large enough batch of 1 in 100 azide polymer for both cell culture and 
animal studies it was investigated whether it would be possible to combine two relatively 
small batches of polymer to obtain one large batch with exactly the same characteristics as 
the individual batches. P28 and P29 were analyzed individually and as a combination by 
AFM. P28 and P29 showed mean lengths of 210 nm vs. 222 nm and the deviation between 
the median values was deemed small enough to be irrelevant 179 vs. 192 nm. After 
combination P28/29 exhibited a slightly higher average length of 257 nm but the median 
was relatively unchanged 178 nm. This is clearly visualized by overlaying their individual 
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histograms (Figure 27). It was possible to calculate the Đ from the AFM lengths by 
dividing the Lw/Ln : P28 1.4, P29 1.6, P28/29 1.7. It is therefore clear that the mixing of the 
two different batches did result in an increase in Đ.  
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Figure 27. Histogram overlay of polymer lengths as determined by AFM height image analysis 
P28, P29 and the mixed sample P28/29 appear to have nearly the same mean and median 
distributions. 
The high molecular weight polymers such as P32 (azide: 1 in 100) and P7 (homopolymer) 
exhibited a much large mean and median value compared to P28/29 which is clearly visible 
by overlaying their histograms. Also by comparing two polymers of the same relative 
molecular weight P7 (Đ 1.6) with P32 (Đ 1.5) it is clear that the presence of 1 in 100 azides 
does not affect the Đ adversely (Figure 28).  
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Figure 28. Histogram overlay of polymer lengths as determined by AFM height image analysis 
copolymer P28 (Đ 1.4); homopolymer P7 (Đ 1.6); azide copolymer m/n 1:100 P32 (Đ 1.5).  
1.2.3. Synthesis of terpolymers 
The same synthesis strategy was utilized as previously mentioned with the only 
exception being the ratios of monomers used. The equivalents used were based on the 
equation determined in 1.1.1 and M1 being deemed as equal to M2 as its structure also 
consists of three ethylene glycol sub-units (see, Figure 29).  
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Figure 29. Oligo(ethylene glycol) isocyanopeptides terpolymers, the molar ratio of m/n/q was 
used to tailor the LCST. 
Table 9. Terpolymer synthesis summary: molar fractions, molecular weight and yield. 
Sample M2:M4 :M1 (mol) m/n/q sol-gel (°C)        (kg/mol)  Yield (%) 
P44 49.2:49.7:1 32 296 67 
P45 41.1:57.9:1 35 304 63 
 
Spectroscopic results 
CD spectra (Figure 30) were consistent with those obtained from homopolymers and 
conventional copolymers. 
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Figure 30. CD spectra of terpolymers (P44;P45) at 4 mg/mL in ACN. 
Rheology 
The rheological behaviour of the terpolymers was consistent with that of the 
copolymers (Figure 31).  
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Figure 31. Storage modulus as a function of temperature for terpolymers (P44; P45) at 2 
mg/mL in MQ. 
The accuracy of the equation y=40.3-0.21x is summarized in the Table 10. The average 
deviation between the theoretical and actual sol-gel transition was 6.4 °C where the 
experimental value was consistently higher than the predicted value. As the equation was 
based on polymers synthesized from in-house monomer and with a high molecular weight 
(ca 500 kg/mol). The effect of molecular weight on sol-gel temperature was not 
incorporated in this equation, probably resulting in the observed systematic deviation of the 
calculated sol-gel temperature from the experimental one.  
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Table 10. Ratio of M2:M4 theoretical vs. Experimental Sol-Gel transition temperatures in °C 
Samples M2 M4 
       (kg/mol) sol-gelPredicted 
(y) 
sol-gelActual Difference 
P15 61.1 38.9 296 27.5 39 11.5 
P16 72.1 27.9 523 25.2 30 4.8 
P17 79.2 20.8 525 23.7 32 8.3 
P35 43.2 2.0 378 20.2 25 4.8 
P44 49.7 50.2 296 29.9 32 2.1 
P45 57.9 42.1 304 28.1 35 6.9 
 
1.2.4. Acetylene copolymers 
 
To introduce chemical handles that could later be used for the conjugation of specific 
dyes (e.g. Atto647N) through copper catalyzed Huisgen cycloaddition reactions copolymers 
with an acetylene functional isocyanide monomer M3 were synthesized. These polymers 
would later be used for reptation and single molecule fluorescence studies. The molar ratio 
of acetylene (M3) to spacer monomer (M4 or M2) was varied to create a library of possible 
polymers (Table 11). The same synthesis strategy was used as in 1.1.1 with the only 
difference being the monomers used. 
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Table 11. Copolymers synthesis summary: molar ratios, molecular weight and yield 
Samples M3: M4 (mol)        (kg/mol)  Yield (%) 
P46 1:1000 169 90 
P47 1:1500 172 87 
P48* 1:50 181 85 
P49* 1:100 172 91 
P54 1:50 99 34 
 M3:M2 (mol)   
P55 1:100 352 73 
P56 1:225 640 87 
P57 1:400 677 53 
P58 1:570 688 70 
P59 1:850 669 70 
P60 1:1140 642 70 
P61 1:1000 571  
* Catalyst ratio of 1:1000, the rest of the polymers were all synthesized with a catalyst ratio 
of 1:10,000. 
 
The molecular weight of the P55-P60 was clearly affected by the addition of the 
acetylene functional monomer as the highest ratio of 1 in 100 resulted in a significantly 
different molecular weight with all monomers from the same source and prepared by the 
same person. It would therefore be fair to postulate that at densities higher than 1 in 100, 
acetylene incorporation into the polymer scaffold is possible but that this would result in 
chain termination, which would explain the lower average molecular weight at higher 
densities of acetylene. 
Spectroscopic results 
Surprisingly from comparing the CD of polymers with the same sample history but 
varied densities of acetylene monomer, no clear difference between the higher loading 
acetylene PIC was observed (Figure 32). In fact the highest density acetylene P55 appeared 
slightly more intense than the other PIC in the series at the same concentration, which 
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suggests that although molecular weight was lowered due to the higher amount of acetylene 
functional monomer the helicity of the polymer was not affected.  
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Figure 32. CD spectra of acetylene functional PIC at 1 mg/mL in DCM. 
Rheology 
The sol-gel transition seems to be unaffected by acetylene loadings since at m/n of 1 in 
1500 and of 1 in 1000 tetra etylene glycol the transition temperature was 42 °C (P47 and 
P46) and for 1 in 570 tri ethylene glycol (P58) it was 18 °C as was expected based on 
previous results obtained from the homopolymer of M4 (tetra ethylene glycol 42 °C) and 
M2 (tri ethylene glycol 18 °C) respectively (see, Figure 33).  
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Figure 33. Storage modulus versus temperature for copolymers containing tetra ethylene glycol 
monomer (P46 and P47 1 mg/mL MQ) and copolymers containing tri ethylene glycol monomer 
(P58 at 1.8 mg/mL MQ) acetylene functional polymer. 
Polymer chain length determined via AFM 
Analysis of the acetylene functionalized polymer lengths indicate the same pattern as 
before, polymers with similar molecular weights have the same average length and shorter 
polymers have a lower average length. Polymer P46 m/n 1:1000 had a Đ of 1.6, whereas 
polymers P47 m/n 1:1500 had a Đ of 1.2 and P54 m/n 1:50 had a Đ of 1.4. This can be 
visualized by overlaying the AFM length histograms (Figure 34). 
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Figure 34. Histogram overlay acetylene functional polymer lengths as determined by AFM. 
To conclude it was possible to vary the density of acetylene to spacer monomer up to a 
density m/n of 1:100 without adversely affecting the molecular weight at a catalyst ratio of 
1:10,000. The lowered molecular weight did however not affect the Đ and therefore it is 
likely that although acetylene inclusion into the polymer scaffold is probable it results in 
chain end termination. 
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1.3. Synthesis of polymers with non natural aminoacids (M5) 
 
It would be very interesting to change stiffness of the PIC backbone especially when 
using it as a therapeutic carrier for biological applications as it would affect integrin 
clustering which is known to effect cellular fate [13]. In the group of Yashima et al. 
complex block-copolyisocyanides have been successfully synthesized in the presence of a 
platinum-palladium catalyst [14]. A monomer suitable for this system was designed that 
contains both the required para benzene isocyanide and the oligo ethylene glycol spacer to 
facilitate water solubility.  
Compound M5 (670 mg, 1.64 mmol) was dissolved in 5 mL dry toluene and a solution 
of Ni(ClO4)2·6H2O (0.1 mM, 164 µL) was added. The reaction mixture was stirred for 5 
days under air fitted with a CaCl2 drying tube. This reaction was repeated in duplo, both 
times yielding dark brown, sticky solids with low yields. 
Table 12. Homopolymers synthesis summary: molar ratios, molecular weight and yield 
 Ni(ClO4)2.6H2O 
(mol): M (mol) 
Nanosight (nm)              (kg/mol)  Yield (%) 
P62 1:100.000 228 226 22 
P63 1:100.000 171 249 25 
 
The polymers had no appreciable viscosity in either ACN or toluene at the 
concentration range used to analyse P1-P61. The solutions P62-63 at 1 mg/mL in MQ did 
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not form hydrogels which is not uncommon for the homopolymers M2 with a molecular 
weight of 200 kg/mol and lower. The low yield obtained for this polymerization indicates 
that this monomer suffered from some form of inhibition. Even though low molecular 
weight polymers were obtained, a substantial amount of time would be needed to optimize 
this system and it was decided that this would be outside the scope of this thesis.  
Chain length distribution as determined via AFM 
It is clear that the lengths of two different batches have the same mean and median, the 
polymers are short, but the synthesis was successful. The Đ for both were calculated by 
deviding Lw/Ln from the AFM lengths, P62 2.0 and P63 1.3. 
Spectroscopic results 
An intense Cotton effect centred at 364 nm in circular dichroism (CD) spectroscopy. 
Polymer P62 showed a higher intensity than P63 at the same concentration, indicating that 
the signal intensity increases with increasing molecular weight. Both spectra show a 
positive signal which is indicative of single handedness and the presence of a helical 
polymer (Figure 35).  
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Figure 35: CD spectra of Abz-alanine homopolymers P62 and P63 at a concentration of 1 
mg/mL in DCM. 
In conclusion it was possible to synthesize a water soluble polyisocyanide di peptide 
based on the non natural aminobenzoic acid. In the future this monomer could be reacted 
using the platinum-palladium catalyst described in the work of Yashima et al.  
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2. Comparison of molecular weight determining techniques 
Over the years it has become common practice in our group to determine the molecular 
weight of polyisocyanides from AFM image analysis and viscometry Mv. In general the 
polymer molecular weights are obtained from size exclusion chromatography (SEC) Mw. It 
was decided prudent to compare the molecular weight values obtained from the different 
techniques with each other. The viscometry technique is based on the flow rate of a dilute 
polymer solution over a known distance in a frictionless environment which after 
conversion with the Mark-Houwink equation was used to determine the molecular weight.  
The SEC technique relates to the hydrodynamic volume of a polymer and the time it takes 
the polymer to pass through a porous channel is relatable to its molecular weight as small 
polymers will permeate the porous medium more completely and therefore elute slower 
than larger polymers that will simply follow the path of least resistance.  
By plotting the data obtained from SEC with viscometry a linear relationship between 
the molecular weights was obtained regardless of polymer composition (see Table 13 and 
Figure 36). The most noticeable difference was that the molecular weight obtained by SEC 
was consistently higher than that obtained by viscometry.  
Table 13. Comparison of two molecular weight characterization techniques, viscometry vs. SEC 
 Composition        (kg/mol)         (kg/mol) Difference 
P1 Homo tri 498 707 209 
P64 Homo tri 571 786 215 
P61 Acetylene tri 650 795 145 
P65 Azide tetra 421 588 167 
P36 Azide tri 835 967 132 
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The average Mv was 595 kg/mol with a standard deviation of 159 kg/mol and the 
average Mw was 769 kg/mol with a standard deviation of 139 kg/mol, which means that the 
the values from the two techniques were not statistically different from each other. The 
probability plot of each individual method was normally distributed and by comparing the 
two distributions with a standard two sample t-test a P value = 0.11 was obtained as this 
value is larger than 0.05 the two distributions are not statistically different from each other. 
 
Figure 36. Probability plot at 95% confidence interval of molecular weight obtained by 
viscometery and SEC. 
Comparing viscometery determined molecular weight (Mv) to molecular weight 
obtained by measuring the length of polymers visualized through atomic force microscopy 
(MAFM), a more eratic comparison between techniques was observed (Table 14 and Figure 
37).  
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Table 14. Comparison of two molecular weight characterization techniques, viscometry vs. AFM 
Samples Composition        (kg/mol)              (kg/mol) 
P29 Azide tri 444 471 
P28 Azide tri 451 502 
P32 Azide tri 735 1752 
P54 Acetylene tetra 99 652 
P46 Acetylene tetra 169 940 
P8 Homo tri 369 626 
P7 Homo tri 796 1473 
 
 
 
Figure 37. Box plot visual comparison of the molecular weights obtained from AFM and 
Viscometery. 
The values obtained from manual AFM measurements are prone to human error as 
each polymer worm is measured manually by tracing the pixel length from the height image 
using Image J software. Based on a known scale bar these pixel values were converted to 
length values. The molecular weight range obtained by AFM measurement was also 
normally distributed. The average molecular weight obtained from MAFM (916.6±505.5 
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kg/mol) and Mv (437.6±261.0 kg/mol) overlapped, which means that the average values 
from the two techniques were not statistically different from each other. When comparing 
the two data sets from AFM vs. viscometery using the two sample t-test a P value = 0.06 
was obtained indicating that the two techniques is not statistically different from each other 
(see, Figure 38). 
 
Figure 38. Probability distribution at 95% confidence interval of molecular weights obtained for 
the same samples using Viscometry and AFM. 
3. Macrocopic observations of hydrogels  
A rather unexpected observation of the polymer was made that during storage in its 
solvated state above its sol-gel temperature the hydrogels appear to shrink and expel water. 
It is proposed that this phenomenon is as a result of syneresis. Syneresis is a known to 
occur in synthetic PNIPAM hydrogels [9] and natural Agar hydrogels [8]. Syneresis is not 
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necessarily a negative phenomenon, but it does result in a dynamic environment which 
would affect cellular response as the forces the cells experience on their surfaces would be 
changing as the network they are attached to.  
In the PIC system syneresis was quantified by measuring the loss of water from a 
hydrogel solvated in PBS over time. The water loss of gel samples in closed vials stored at 
37 °C was measured by decanting at several time points and measuring the weight of the 
remaining sample. The results are shown in Figure 39 for gels of a low molecular weight 
(P8 369 kg/mol) and high molecular weight (P7 796 kg/mol) polymers at 1.6 and 3.2 
mg/mL concentrations respectively. The expulsion of water was more pronounced in the 
beginning but never really ceased over the period of 8 days. At higher polymer 
concentrations and higher molecular weight this affect was more pronounced.  Short 
polymers and lower concentrations provide more polymer mobility, which allows for 
enhanced macroscopic rearrangement that results in larger syneresis effect. Samples with 
higher molecular weight and higher concentrations would be less mobile, kinetically 
trapped resulting in reduced syneresis effect. In the PNIPAM system shrinking kinetics 
could be expressed in terms of the Tanaka-Fillmore equation Eq1and 2 [10] 
           
           
 
                 
                 
 
 
  
  
  
 
 
 (Eq 1) 
Where,     the gel diameter at time t and τ is the characteristic time of swelling. If it is 
assumed that a loss of solvent can be directly correlated to a loss in sample volume, 
therefore Eq 1 rearranged in terms of height yields Eq 2.  
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 (Eq 2) 
The proposed equation for the PIC hydrogel in terms of volume is:  
 
 
   
    
 
   
    
 
 
   
    
 
   
    
 
 
 
   
    
  
    
 
 
   
    
  
    
 
 
 
   
    
   
    
 
 
   
    
  
    
 
 (Eq 3) 
This can be re organized as: 
           
           
 
   
        
      
   
        
      
    
  
 
 
 (Eq4) 
Where, A is a constant dependent on the volume change of the sample in terms of 
radius change. PIC hydrogel consists of 99.995 % solvent, the solvent is water which has a 
density of 1 mg/mL, therefore a change of volume can be defined as a loss in mass. The 
data was fitted to standard Exponential equation (Figure 39). 
       
    (Eq 5) 
Where, y0 is the initial sample mass and    
 
τ
 the rate of swelling. A negative    
would therefore be indicative of the rate of de-swelling.  
Therefore, τ was equal to -48.1 for P7 and -107.9 for P8 (Figure 39), meaning P8 (369 
kg/mol) decreases in volume 2.24 times faster than P7 (796 kg/mol). This is almost exactly 
the ratio of their molecular weight 2.16, further research in determining the rate of decay 
with regards to the molecular weight needs to be performed in the future to determine the 
statistical relevance of this mass loss result.  
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Figure 39. Loss of water from PIC hydrogels when stored at 37 °C. Sample mass after decanting 
excreted water is plotted against time.  
For applications this effect should be taken into account when the polymers are used in 
a solvated hydrogel form e.g. cell culturing as this requires incubation at 37 °C for a 
prolonged time. The rate of syneresis decreases over time, perhaps a preconditioning 
incubation step would be advisable.  
 Rheology 
The rheology of the PIC undergoing syneresis was measured by measuring the stiffness 
of three different polymers over the course of two weeks while storing the stock solutions 
in the refrigerator (4-7 °C). It was observed that the PIC hydrogels decrease in stiffness 
over time when stored in their liquid state. This meant that a PIC above its sol-gel 
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temperature would have a higher storage modulus on day one than the same stock solution 
of PIC measured after three days in the refrigerator. Comparing P29, P8, P30 and P32 was 
used to investigate the effect of molecular weight and azide ratio while exposed to the same 
environmental conditions. In Figure 40 the relative stiffness at 25 °C is plotted against the 
number of days stored in the refrigerator. The relative stiffness was determined by dividing 
the storage modulus of the sample on the day of the measurement by the storage modulus 
of the sample on the first day. P8 homopolymer (369 kg/mol), P30 1:100 azides (361 
kg/mol) and P29 (444 kg/mol) exhibited a similar decrease in stiffness over time, indicating 
that azide ratio is not involved in this process. P32 1:100 azides (735 kg/mol) exhibited a 
smaller decrease in stiffness, indicating that higher molecular weight polymers may be less 
affected by syneresis. The storage effect was the most pronounced in the first four days and 
then seemed to stabilize. After two weeks the lower molecular weight polymers retained 
less than half of their original storage modulus. It was attempted to restore the hydrogels by 
re-dissolving them by stirring on ice, but the effect appears to be irreversible. The data was 
fitted by the exponential equation (Eq 5) and    
 
τ
 in terms of stiffness determined for 
P8; P29-30 to be average -0.3 compared to the -8.1x10-5, which would suggest that the 
higher molecular weight polymers would take 4000 times longer to de-swell and reduce in 
stiffness when compared to their low molecular weight counterparts.  
3-60 
 
0 2 4 6 8 10 12 14
0.2
0.4
0.6
0.8
1.0
1.2
R
e
la
ti
v
e
 s
ti
ff
n
e
s
s
Storage time (days)
 P29 444 kg/mol                                                             
 P8   369kg/mol
 P30 361 kg/mol
 P32 735 kg/mol
y = 0.4(0.01)+1.1e
-0.6(0.05)x
   R
2
= 1.0
y = 0.3(0.1)+0.8e
-0.2(0.06)x
 R
2
= 0.96
y = 0.3(0.1)+0.8e
-0.2(0.05)x
   R
2
= 0.97
y = -236+237e
-8.1E-5x
             R
2
= 0.45
 
Figure 40. The relative stiffness of P29, P8 and P30 at 3.2 mg/mL at 25 °C, plotted against the 
storage time in days.  
The decreased stiffness over time when stored in the solvated form is possibly caused 
by the increased flexibility of the individual polymer fibres below their sol-gel temperature 
causing increased mobility resulting in a higher probability of entanglement. These floppy 
pre-entangled fibres do not participate in bundle formation when finally heated above their 
sol-gel temperature decreasing the effective concentration of polymer present in the 
solution. This effect would critically effect the stiffness of the hydrogel as is clear from the 
following equations [7].  
       
  
  
       
       (Eq 6) 
  
       
 
      
      
 (Eq 7) 
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Where c is the concentration, N is the bundle number which for this system was 
experimentally determined to be 9,   
 is the length between crosslinks (110 nm) and   
  is the 
persistence length (460 nm); R is the gas constant (8.3 LPaK-1mol-1), and T is the absolute 
temperature at 25 °C (298 K). Therefore in the case of P8 the initial stiffness at day one 
was 52 Pa and the stiffness after 13 days in the fridge was 17 Pa the concentration had 
effectively decreased from 1.8x10-13 mol/L to 5.9x10-14 mol/L which translates to a 3 fold 
decrease in concentration over a two week time period which is in good agreement with the 
calculated average de-swelling value    
 
τ
             . 
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Conclusions 
Several polyisocyanide homo-, co- and terpolymers were successfully synthesized. For 
the homo- and co-polymers containing tri ethylene glycol monomer, the range of molecular 
weights at a catalyst to monomer molar ratio of 1 in 10,000 was affected by the triethylene 
glycol monomer source. Statistically however the molecular weight ranges do not 
significantly deviate from each other and it can be concluded that even though the 
commercially sourced monomer does appear to result in polymers with lower average 
molecular weights this effect is consistent and the resulting polymers do not have any other 
difference in polymer properties that cannot be attributed to their lower average molecular 
weight.  
The bulk stiffness and critical stress of homo- and co-polymers (at the same solution 
concentration) above their sol-gel transition temperature was shown to be linearly related to 
their molecular weights.  
The sol-gel temperature of tri-ethylene glycol based homo and co-polymers were 
shown to be effected by up to 5 °C as a direct consequence of the average molecular 
weight. Polymers with molecular weights of <700 kg/mol showed LCST of ~12 °C and 
between 300-630 kg/mol showing LCST of 18 °C. 
The addition of azide co monomer did not affect the overall mechanical characteristics 
of the polymer up to a density of 1:50. In co-polymers with acetylene handles, the highest 
loading of acetylenes that did not disrupt the obtainable molecular weight and mechanical 
properties was 1:100 acetylenes.  
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It was possible to synthesize co and tri-copolymers with targeted sol-gel transition 
(standard deviation 6.4 °C) temperatures by varying the ratio of tri- to tetra ethylene glycol 
monomer. The accuracy of this targeted sol-gel transition could be improved by 
synthesizing polymers with a lower average molecular weight to derive a new variable 
oligo ethylene glycol ratio for targeted LCST equation.  
The effect of syneresis was observed in homo and co-polymer hydrogels with low and 
high molecular weights, above their LCST. The rate of de-swelling determined 
gravimetrically by measuring both the loss of sample mass and by using the rheometer to 
measure the reduction of stiffness over time. Regardless of the measuring technique the 
effect was more pronounced in low molecular weight polymers. 
 It was possible to synthesize a completely new PIC containing a non-natural  
aminobenzoic acid oligo ethylene glycol monomers.  
Finally it was possible to reliably determine the molecular weight of the synthesized 
water soluble PIC with two non standard techniques (viscometry and AFM) that compared 
well with standard SEC technique. 
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Materials and Methods 
Instrumental: The rheology measurements were performed on a TA Instruments 
Discovery HR-1fitted with a 40 mm Aluminium parallel plate geometry generally set to a 
gap of 750 µm for 1 mL of sample.  
 
Procedure:  
 
AFM 
 
Hydrogels were deposited by direct contact with freshly cleaved HOPG or Muscovite Mica. 
All images were recorded with the AFM operating in Tapping Mode (TM) in air at room 
temperature, with a resolution of either 1024 x 1024 or 512 x 512 pixels, using scan rates of 
1–1.5 lines/s. Commercial tapping-mode golden-coated silicon tips (NT-MDT) were used 
with a typical resonance frequency around 300 kHz.  
 
Polymer chain lengths were evaluated using ImageJ (v1.43I) softwareS2 [17] to generate 
lengths in pixels, this could easily be converted to nm via scale bar on the original image. 
The length data was evaluated by Minitab16 statistical software (Minitab 16 Statistical 
Software (2010). State College, PA: Minitab, Inc. (www.minitab.com)).  
 
The polymer chains heights and widths were measured using the Nanoscope software 
(v6.14r1) from Digital Instruments. Raw pictures were compensated for drift using the 
Nanoscope software (v6.14r1); no other processing was applied on the data used for the 
analysis. 
 
Viscometry 
 
To obtain the intrinsic viscosity of polymers, an Ubbelohde viscometer (Schott Instruments, 
Mainz, Germany) was used. A stock solution (4 mg/mL) of polymers was prepared in 
acetonitrile. From this stock solution, 4 mL of the following concentrations were prepared: 
0.6; 0.5; 0.4; 0.3; 0.2 and 0.1 mg/mL. The solutions were loaded into a viscometry tube (nr. 
1053431; Schott Instruments). The tube was placed into the water bath (25 °C) and allowed 
to equilibrate for 15 min before the measurement was started. The flow speed for each 
sample was measured four times and used to determine the kinematic viscosity . From this 
data, the reduced viscosity red and the inherent viscosity inh were calculated and plotted 
against the polymer concentration. The intrinsic viscosity [] represents the limiting value 
of red or inh at infinite dilution of the polymer, i.e.             . From extrapolation 
of red to c = 0, [] = could be obtained. Based on [], a molecular weight could be 
determined using the Mark-Houwink equation 
           
 
 (Eq 8) 
Where                        a) and        [18] 
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Rheology 
 
The polymer was dissolved in purified water (milliQ); PBS; cell culture medium by first 
swelling the polymer in a cooled solution before stirring for 16-72 hrs at 4 °C. Samples 
were inserted in the rheometer at 5 °C (i.e. as a liquid) and gelation occurred between the 
parallel plates by raising the temperature ( 2 °C/min). Drying of the sample was prevented 
by maintaining a moist atmosphere. 
The measurements in the linear response regime were conducted at 2% strain at a frequency 
of 1 Hz. Temperature sweeps were recorded at a heating or cooling rate of 2 °C /min. 
The measurements in the nonlinear regime were performed at 37 °C (25 minutes 
equilibrated) prior to starting measurement. Samples were exposed to a pre-stress protocol 
and superposing a small oscillatory stress with an amplitude of |δσ| < 0.1 σ at a frequency 
of 0.1 − 10 Hz and allowed to equilibrate between consecutive steps for 3 min.  
 
Single particle tracking analysis  
 
Particle tracking studies were carried out on a Nanosight LM10 instrument equipped with 
an Electron Multiplication Charge Coupled Device (EMCCD) camera mounted on an 
optical microscopic system to track light scattered by particles that are present in a focused 
(80 μm) beam generated by a single mode laser diode with a 40 mW red laser illumination 
(640 nm). The cold polymer solutions containing platinum nanoparticles (average diameter 
186 nm, concentration 106 particles/mL) were injected in a sample chamber of 0.5 mL size 
from which a volume of 120x80x20 microns was visualized under the microscope. The 
Brownian motion of the nanoparticles was tracked at 30 frames/s. NTA 2.3 software was 
used to evaluate the mean squared displacements of each visible particle (calibration 166 
nm/pixel). Averaging over multiple particles (N > 50) yielded an average diffusion 
coefficient. 
 
Mean square displacement (µm2 vs Δt/s) was calculated by evaluating only the data of true 
particles with at least 30 steps. The mean square displacement of each particle was 
automatically calculated by using Matlab. The code for which can be supplied if needed. 
 
Polymer Synthesis 
Compound M2 was dissolved in 2 mL of freshly distilled toluene. The catalyst stock 
solution of 1 mM was prepared by dissolving 39 mg of Ni( ClO4)2 • 6 H2O in 10 mL 
absolute ethanol and 90 mL of toluene. A volume of this stock solution equivalent to 10-4 of 
the total M2 mols was transferred via pipette into the mixture of M2 and toluene. The flask 
was placed in an ice bath and fitted with a CaCl2 drying tube. The mixture was diluted with 
distilled dry toluene to obtain a final concentration of 50 mg/mL monomer. After 2-3 h the 
mixture became extremely viscous and additional solvent was added to obtain a 
concentration of 25 mg/mL. This mixture was allowed to stir for a total of 72 h. The 
polymer was isolated via precipitation into diisopropylether. This precipitation cycle was 
repeated three times to obtain a broad range of yields. 
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The dye test and how the azide concentration was determined by using UV: 
 
A TokyoGreen stock solution was made by dissolving BCN-TokyoGreen (2.2 mg, 43.7 
μmol) in DMSO (1 mL). The polymer to be tested was dissolved in ACN at a concentration 
around 3 mg/mL, with a total volume of 3 mL. The polymer solution was stirred for one 
hour at 5 °C to completely dissolve it. A volume of the TokyoGreen stock solution 
corresponding to 2 equivalent of BCN-TokyoGreen per azide was pipetted to the polymer 
solution. The mixture was stirred overnight at room temperature and was then precipitated 
in diisopropyl ether (40 mL). The diisopropyl ether was decanted of and the remaining 
polymer was air dried for one hour. This precipitation process was repeated two times. 
After the third precipitation the polymer was air dried over night under a nitrogen flow.  
 
UV analysis protocol used for P18-21;42: PIC were dissolved in ACN:DMSO:MQ in a 
ratio of 0.75:0.25:1. The extinction coefficient of the TokyoGreen in this mixture was 
determined to be 35493 M-1 cm-1. 
  
The UV analysis protocol used on P24-31: An alkaline methanol solution was made by 
dissolving KOH (5 mg, 0.125 mmol) in methanol (100 mL) and diluted by pipetting 1 mL 
of this solution to 100 mL methanol. The pH of the resulting solution was around 9 as 
indicated by pH paper and was alkaline enough to make sure all the TokyoGreen that is 
added will be deprotonated. The polymer was weighed and dissolved in the alkaline 
methanol at 1.00 mg/mL and multiple UV-vis spectra were recorded, starting with this 1 
mg/mL polymer solution and then diluting down until the TokyoGreen absorption at λ = 
500 nm was in between an absorbance of 0.1 and 1 The absorption at λ = 500 nm of the dye 
conjugated polymer sample is then used to calculate dye concentration with the 
TokyoGreen extinction coefficient. The extinction coefficient of the deprotonated 
TokyoGreen in methanol was determined to be 87812 M-1 cm-1 by calculating the slope of 
the absorption at λ = 500 nm over concentration after measuring solutions of TokyoGreen 
in the alkaline methanol at different concentrations.  
 
Statistical calculations 
 
Homopolymers: 
 
The two sample t-test was performed on two data sets obtained from homopolymers 
synthesized from M2 from different sources using Minitab17 statistical software. 
 
Table 15. Two sample t-test comparing homopolymers obtained from Chiralix vs. in-house M2. 
Data Set N Mean StDev Mean 
Chiralix 4 466 90 45 
in-house 4 652 133 67 
 
Difference = μ (Chiralix homo tri) - μ (in-house homo tri) 
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Estimate for difference:  -185.5 
95% CI for difference:  (-392.1; 21.1) 
t-test of difference = 0 (vs ≠): t-value = -2.31  P-value = 0.069  degrees of freedom (DF) = 5 
 
Azide functional co-polymers: 
The two sample t-test was performed on the molecular weight ranges obtained for azide 
functional co-polymer using different sources of M2. 
 
Table 16. Two sample t-test comparing azide co-polymers from Chiralix vs. in-house M2. 
Data Set N Mean StDev Mean 
Chiralix 8 472.6 99.3 35 
in-house 14 786 171 46 
 
Difference = μ (Azide PIC Chiralix) - μ (Azide PIC in-house) 
Estimate for difference:  -313.7 
95% CI for difference:  (-434.5; -192.9) 
t-test of difference = 0 (vs ≠): t-value = -5.44  P-value = 0,000  DF = 19 
 
Molecular weight determination techniques  
The two sample t-test was performed on the two methods of determining molecular weight 
viscometery and SEC. 
 
Table 17. Two sample t-test comparing two techniques for determining molecular weight (Mv 
vs. Mw) 
Data Set N Mean StDev Mean 
viscometry 5 595 159 71 
SEC 5 769 139 62 
 
Difference = μ (viscometry) - μ (SEC) 
Estimate for difference:  -173.6 
95% CI for difference:  (-396.5; 49.3) 
t-test of difference = 0 (vs ≠): t-value = -1.84  P-value = 0.108  DF = 7 
 
The two sample t-test was performed on the two methods of determining molecular weight 
viscometery and AFM. 
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Table 18. Two sample t-test comparing two techniques for determining molecular weight (MAFM 
vs. Mv) 
Data Set N Mean StDev Mean 
AFM 7 917 505 191 
viscometry 7 438 261 99 
 
Difference = μ (viscometry) - μ (AFM) 
Estimate for difference:  479 
95% CI for difference:  (-17; 975) 
t-test of difference = 0 (vs ≠): T-value = 2.23  P-value = 0.056  DF = 8 
 
Mean square displacement: Analyzing the effect of changing polymer concentration 
on pore size   
The cold solution of hydrogel with concentrations of either 3.0, 1.0, 0.75, 0.25 and 0.13 
mg/mL polymer was doped with PtnP of an average size 186 nm in a final concentration of 
106 particles/mL. The hydrogel PtnP mixture was injected in a sample chamber/gasket of 
100 µl size from which a volume of 120x80x20 microns was visualized under the 
microscope. The Brownian motion of the nanoparticles was tracked at 30 frames/s.  NTA 
2.3 software was used to determine the average size of the particles based on the Strokes-
Einstein equation. The mean square displacement of individual platinum nanoparticles was 
determined by Matlab the code can be supplied if required.  
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Chapter 4 : Crosslinking PIC as a means to increase 
bulk stiffness 
Abstract 
The influence of mechanical stiffness of fibrous gels on the cellular fate was shown and 
discussed in previous chapters. It has been shown that for the PIC system bulk stiffness can 
be controlled through the concentration of polymer in solution. It would be desirable to 
access even higher bulk stiffness, therefore crosslinking as a means to increase this bulk 
stiffness was investigated using both covalent and physical crosslinking strategies. The 
covalent chemistries investigated were: copper catalyzed and thiolyne click chemistry, 
SPAAC, dithiobridge and Schiff base formation, and the Schmidt reaction. The physical 
crosslinking strategies investigated were: pore blockage with gelatine spheres, Host-guest 
chemistry and ionic interactions. There was no significant increase in stiffness observed for 
any of the applied crosslinking strategies. It is fair to conclude that even in the bundle 
dominant state (crosslinking above sol-gel temperature) inter polymer fibre crosslink was 
dominant resulting in “frayed” bundles that adversely affected bulk stiffness. 
 
Introduction 
As highlighted in previous chapters the PIC hydrogel closely resembles in many ways 
the mechanics and architecture of an extra cellular matrix (ECM), but the bulk stiffness at 
37 °C resides well within brain tissue matrix stiffness. If the differentiation of cells involves 
integrin cluster formation, then it would hold that to access muscle and bone phenotypes, 
the PIC bulk stiffness Pa range [1] would need to be increased to the kPa range [2]. The 
stiffness of the initial family of PIC hydrogels is depended on the concentration of the 
material in solution and the stiffness ranges from 10-102 Pa. The stiffness of the ECM 
however can range from 102 -104 Pa [3]. Stiffer gels are expected to have more physical 
interactions and different dynamics with the cell affecting proliferation and differentiation 
[4-5]. It was hypothesized that the addition of crosslinks would result in increased bulk 
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stiffness to approach the ranges possible in ECM. In Nature, crosslinks are either covalent 
or physical, but impermanent as the ECM makes room for the newly formed tissue 
(enzymatic bond cleavage) [6]. In synthetic materials covalent crosslinks are usually 
permanent, while physical crosslinks are based on non-covalent interactions between the 
polymer chains making them dynamic [7]. Physical crosslinking could be investigated by 
looking into ionic interactions through the addition of suitable counter ions [8-9], the 
formation of interpenetrating networks [10-11], physical blocking of the pores with suitable 
particles and dynamic bond formation through host-guest chemistry [12].  
In Figure 1 covalent crosslink with and without a spacer (pink), physical blockers 
(spheres), dynamic crosslinks formed between cucurbit[8]uril (CB8 host) and 2 
phenylalanine (guest) molecules and physical entanglements cross bundle crosslinking 
possibilities are schematically summarized. It is known from previous work that in the PIC 
system as the distance between crosslinks (l0) decreases, the bulk stiffness will be increased 
[1], therefore the introduction of crosslinks should result in change in bulk stiffness 
(Equation 1). 
       
  
  
       
       (Eq 1) 
Where N is the bundle number which for this system was experimentally determined to 
be 9,   
    is the length between crosslinks and   
  is the persistence length of the 
individual polymer (AFM); R is the gas constant, and T is the absolute temperature.  
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Figure 1. Network structure of PIC showing diverse crosslinks: entanglements, dynamic bonds, 
covalent bonds and physical blockages [7]  
In a system of rigid polymers (such as PIC) with flexible crosslinks, the length and 
flexibility of these crosslinks strongly affect the network elasticity (Figure 2). Affine theory 
predicts a linear scaling of bulk stiffness with the crosslink density ( Equation 2) [13].  
    
 
 
 
      
       
 (Eq 2) 
Where G1D is the shear modulus G normalized by the linear modulus G0 as a function 
of strain ϵ (1D),   is the number of flexible crosslinkers,     is the spring constant of the 
crosslinker and     is the spring constant of the system. Therefore it was expected that if 
the stiff filament of length (L) has a constant persistence length and the persistent length of 
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the bundle is the same as for the individual polymers [1] a change in crosslink density 
should directly affect the bulk stiffness.  
 
Figure 2. Schematic representation of an isotropic stiff polymer network with highly compliant 
cross-linkers. The inset illustrates the proposed nonuniform deformation of the crosslinkers on 
a single filament in a sheared background medium [13]. 
  
4-5 
 
Results and discussion 
To avoid affecting the bundle formation, which is inherent to this system which gels 
upon heating above its lower critical solution temperature, it would be preferable to form 
crosslinks in the gelled (bundle dominant) state. However it is not possible to perform the 
crosslinking reactions since the dynamics of crosslinking in a static system are slow. In 
addition, it is not possible to transfer a gelled sample to the rheometer as it resulted in 
sample damage and uneven sample heights were formed which prevents reliable rheology 
experiments. Crosslinking experiments were therefore performed by mixing the reagents 
together at 5 °C in its liquid (fibre dominant) state and heating instantly to either 25 °C or 
37 °C. As the loading and heating was performed rapidly after the mixing of reactants it 
was assumed that most of the crosslinking occurred during the gelling process or in the 
gelled state. 
1. Covalent crosslinking: 
A variety of covalent bond formation reactions were explored to form crosslinks 
(Figure 3): A. Schiff base formation [14], B. the Schmidt reaction [15], C/D. dithio-bridge 
formation [16], E. strain promoted acetylene to azide cycloaddition [17-18] and F. thiolyne 
UV catalyzed click chemistry[19]. 
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Figure 3. A schematic summary of the covalent crosslinks investigated in this chapter. For 
individual chemical reactions see the appropriate subsection.  
A. Schiff base formation 
The formation of a Schiff base as a means of rapidly forming crosslinks has been 
explored for injectable hydrogel formulation in the past [14,20-21]. The nucleophilic attack 
of the amine on the aldehyde forms an imine which without the use of a reducing agent 
forms labile crosslinks. 
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Figure 4. Schematic representation of Schiff base formation between PIC-NH2 and 
gluteraldehyde, both inter bundle and intra bundle crosslinking is shown. 
In the polyisocyanide system imines were obtained by reacting amine functional 
polyisocyanide with a bis functional aldehyde. It was opted to use gluteraldehyde as an 
easily accessible water soluble bis-aldehyde. The amine functional PIC 1 was obtained in 
good yields 58-87% by the chemical reduction of the azides of azide functional PIC P36 in 
the presence of a slight excess of triphenylphospine and water over the course of two weeks 
at room temperature. The amines were quantified utilizing a fluorescein NHS dye test 
which revealed conversions ~75 % (Table 1, Experimental section). Nucleophilic attack of 
the amine on the bis-aldehyde (0.5 molar equivalents relative to amines present), followed 
by loss of water then forms the imine crosslinked network 2. Crosslinking may occur either 
intramolecularly meaning between free amines on the same polymer fibre, which is not 
likely in the gelled state, due to the long persistence length of the polymer. Intermolecular 
crosslinking between two different polymer fibres is possible but it is more likely that 
crosslinking would occur predominantly in the bundled state due to proximity. In the 
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bundled state two different possibilities (not depicted in Figure 3) arise either crosslinking 
will occur between two different bundles or within the same bundle as the crosslinking 
reaction was performed above the sol-gel temperature. 
The polymer 1 (n/m of 1:625; triethylene glycol based; 835 kg/mol) the ratio of 
“spacer” monomers was 625 to every 1 amine. The polymer was dissolved in a slightly 
acidic pH 6 phosphate buffer over night at 0 °C. Once dissolved, the gluteraldehyde was 
added, the mixture loaded onto a cooled (5 °C) plate-plate geometry and heated rapidly to 
25 °C at which temperature the time sweep experiment was performed. Somewhat 
surprisingly the storage modulus of the sample was lower as a result of the presence of 
gluteraldehyde when compared to the 1 without gluteraldehyde under the same reaction 
conditions (Figure 5). It was hypothesized that the intra bundle crosslinking was 
dominating; a consequence of the short length of the gluteraldehyde spacer. A possible 
solution for this would be to use a longer bis-functional aldehyde crosslinker which would 
allow for inter-bundle crosslinking. In addition it is also possible that the crosslinking 
reaction was not complete within 3 h.  
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Figure 5. Storage modulus as a function of time at 25 °C for 1 in pH 6 phosphate buffer with 
gluteraldehyde (0.5 equivalent) and without. Both samples were at a concentration of 1.6 
mg/mL. 
B. Azide-gluteraldehyde 
Aubé et al. [15] showed that the covalent bond formation between azides and 
aldehydes can give high yields and that the reactivity of the reaction can be increased by 
warming or by the addition of an acid. The reactions were carried out with the water soluble 
gluteraldehyde as a bis-aldehyde linker in a pH 6 phosphate buffer to activate the aldehydes 
for nucleophilic attack. The mechanism is shown in Figure 6. 
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Figure 6. Schmidt reaction between PIC-azide and gluteraldehyde. The azide first attacks the 
carbonyl, followed by a hydride transfer that causes nitrogen to leave. 
 As with the Schiff base reaction the rheology experiment was performed by cooling 
the polymer solution (P30; m/n of 1:128; triethylene glycol based; 361 kg/mol) on ice and 
placing the solution (with and without gluteraldehyde) in plate-plate geometry at 5 °C. The 
mixture was heated rapidly to the measuring temperature of 37 °C for 3 h. An increase in 
stiffness was initially observed in both samples during the time sweep experiment (after 
rapid temperature ramp 5- 37 °C), it was postulated that this was due to the dynamic 
rearrangement of the lower molecular weight polymers into stable bundled state at 37 °C 
(Figure 7). If this “blanco” behaviour is ignored it is still clear that the crosslinked polymer 
3 has the same stiffness as the blanco at 0 s (~ 50 Pa), higher stiffness at 2500 s (96 vs. 86 
Pa) and a lower stiffness at 7500 s ( 86 vs. 92 Pa). This was interpreted as a change in 
crosslink sites from a predominantly inter bundle crosslinked system to a predominantly 
inter polymer crosslinking system which would result in a false assumption about the 
persistence length of the bundle being equal to that of the single polymer.  
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Solving this problem by increasing the temperature to increase reactivity of the 
reaction was felt not to be ideal as the effect of syneresis could not be excluded at higher 
temperatures and increasing the acidity of the solution could result in destabilization of the 
helix itself. Therefore this reaction does not appear to be suitable for the design constrains 
of the PIC system.  
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Figure 7. Storage modulus as a function of time at 37 °C for P30 in pH 6 phosphate buffer with 
gluteraldehyde (0.5 molar equivalent) and without. All samples were measured at a 
concentration of 1.6 mg/mL.  
In conclusion to understand what exactly happened to the architecture of the bundles 
during crosslinking it would be advisable to compare the two samples either by AFM or 
multi angle light scattering. 
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Dithio bridges: 
The advantage of utilizing dithio bridges as a dynamic covalent crosslinking strategy is 
that although the bonds are strong, the system is still tailorable through external stimuli. It 
is therefore possible to cleave dithio bridges with light, heat or mechanical force and to 
exchange them with other thiols dependent on external stimuli such as the pH, temperature 
and redox potential [22]. Palumbo et al. showed that for hyaluronic acids hydrogels that the 
formation of dithio bridges through oxidative crosslinking was an effective biocompatible 
crosslinking strategy [16]. The formation of di-thiol bridges were investigated through two 
different strategies. The first was by decorating acetylene polyisocyandes with thiols 
through the Huisgen cycloaddition to a short azide functional thiol. The second by the 
decoration of amine functional polyisocyanides with N-succinimidyl S-acetylthioacetate 
(SATA) is subsequently converted to a free thiol when required [23]. The formation of the 
dithio bridge can be obtained by air oxidation or induced by the addition of either hydrogen 
peroxide or a molar equivalent of DMSO.  
1.1. C. Free thiols 
Acetylene functional polyisocyanide (P46; m/n of 1:128; tetraethylene glycol based; 
169 kg/mol) was decorated with thiols through the copper catalyzed click reaction with 3-
azidopropane-1-thiol (Figure 8). The molecular weight as determined via the viscometery 
technique was unchanged after the introduction of thiols giving polymer 5 (169 kg/mol vs. 
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160 kg/mol), however after the formation of the disulphide bridges the molecular weight 
increased substantially for polymer 6 (169 kg/mol vs. 197 kg/mol).  
 
Figure 8. Reaction scheme of the formation dithio-crosslinked PIC, i) CuBr, TBTA under argon 
atmosphere, stirring 72 h, 60 % yield, ii) DMSO, DCM stirring at room temperature for 5 h, 90 % 
yield. 
The crosslinking samples were prepared by first dissolving the polymer in PBS at 1 
mg/mL and standard rheological experiments were performed (temperature ramp, 
frequency sweep, logarithmic amplitude sweep, linear amplitude sweep) upon warming. 
The sol-gel transition observed in the temperature ramp experiment of the acetylene tetra 
ethylene based polyisocyanide P46 and its relating dithio-crosslinked polymer 6 was 
essentially unchanged showing the characteristic sol-gel transition temperature of 42 °C 
(Figure 9).  
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Figure 9. Storage modulus as a function of temperature, before and after crosslinking , for P46 
via dithio bridge formation. 
It is only in the linear amplitude sweep that 6 appeared to be stiffer initially and able to 
resist breaking for longer than the blanco (Figure 10). 
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Figure 10. Storage modulus as a function of strain (linear amplitude sweep of 0.001-1 strain at 
increments 0.1 at 10 rad/s) of dithiobridge crosslinked polymer. 
This interesting increase in ultimate fail strength indicates that the complexity of the 
system has changed through the addition of crosslinks, but that ultimately the stiffness was 
unaffected.  
1.2. D. Protected thiols 
The idea behind using a protected thiol was that crosslinking could be induced at a 
defined time point. As seen in Figure 11, the protection group was introduced by 
conjugating N-succinimidyl S-acetylthioacetate (SATA) to amine appended polyisocyanide 
1. To determine the conversion of amine to thiol a small sample of 7 was deprotected with 
the deacetylation buffer and quantified via an Ellmans test. The conversion was assumed to 
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be complete as m/n from the Ellmans test was 1:330 thiols (twice the initial concentration 
of amines). The deprotected solution was oxidized to obtain the dithio hydrogel by the 
addition of a small percentage of hydrogen peroxide and allowed to react at room 
temperature for one week. 
 
Figure 11. Reaction steps required to convert PIC-NH2 to dithio crosslinked hydrogel i)SATA-
NHS, DMF, 7 days; ii) deacetylation buffer 2 h, 100 % conversion; iii) 10% H2O2, rt, 1 week. 
The samples were loaded onto the rheometer and heated to 37 °C. A standard 
frequency sweep, amplitude sweep and finally time sweep was performed at 37 °C. Figure 
12 shows the time sweep rheology overlay of crosslinked PIC 9, SATA protected PIC 7 and 
deprotected free thiol PIC 8. It is clear that 9 had a higher storage modulus than 8 and 7 (18 
vs. 11 Pa) respectively.  
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Figure 12. Storage modulus as a function of time of dithio crosslinked polymer before and after 
crosslinking (7-9) at 37 °C in a concentration of 6.75 mg/mL in PBS.   
The route of dithio bridge formation is therefore promising as crosslinking strategy. An 
optimum loading of thiols per PIC still needs to be obtained as a m/n of 1 in 1000 of 6 
seemed too few and even though a much clearer increase in bulk stiffness was observed 
with the higher ratio of m/n of 1 in 625 of 9, it still did not result in significant increases of 
the bulk stiffness.  
E. Strain promoted acetylene azide click chemistry (SPAAC) 
The strain promoted acetylene azide click reaction is known to be biocompatible, 
highly reactive, non toxic and a relatively simple way of introducing complexity to 
biological molecules [24-25]. The SPAAC reaction has been used successfully to introduce 
crosslinks into PEG hydrogels [17]. It was postulated that this method would also be 
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translatable into the PIC system as the use of bisfunctional PEG bicyclononyne crosslinker 
could be used to crosslinking of azide functional polyisocyanides. The linker opted for was 
a bisfunctional polyethylene glycol (10,000 g/mol, ca. 135 nm) which would be water 
soluble and long enough to cross the PIC pore size of ca. 100 nm. In Figure 13 the SPAAC 
crosslinking reaction, which is biologically inert, high yielding and rapid under 
physiological reaction conditions [26] is depicted.  
 
Figure 13. Schematic representation of crosslinking PIC with bis functional PEG i) PBS at 37 °C 
for 1 h. 
The functionalization of bis-functional PEG-amine with BCN-NHS to result in 10 was 
successful as the molecular weight increased on average with the mass of two BCN-units as 
seen in the MALDI-ToF spectrum (Figure 14, Experimental section).  
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Figure 14. MALDI-ToF of starting PEG-bis-amine versus PEG-bis-BCN. 
The effect of crosslinking via the SPAAC reaction between a bis-BCN-PEG (10) to the 
azide PIC (P30; m/n of 1:128; triethylene glycol based; 361 kg/mol) on the bulk stiffness 
was investigated. A time sweep rheology experiment at 37 °C showed no noticeable change 
in storage modulus occurred (Figure 15). The overall stiffness has decreased as was 
observed in the blanco experiment with non-functional PEG, but no other effects were 
visible.  
The time of the reaction (1 h) was possibly to short as the decoration of PIC with BCN-
peptides requires at least 4 h to reach full conversion. Longer experiments were not possible 
inside the rheometer as syneresis affected the sample volume and the experiment could not 
be adjusted to compensate for this. All attempts at transferring externally crosslinked gelled 
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samples onto the rheometer failed as, even when the sample was not broken, uneven sample 
surface resulted in irregular results.  Another possibility for the lack of success with this 
method could be that the PEG might be in its more disordered coiled state in solution and 
therefore much shorter than expected.  
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Figure 15. Storage modulus as a function of time at 37 °C for P30 in PBS with and without 11 at 
PIC concentration of 1.6 mg/mL.  
The solution therefore would be a longer PEG crosslinker. It is known that crosslinking 
with bisfunctional crosslinkers are kinetically slower than utilizing star morphologies [27]. 
From literature it is known that the rate and efficacy of the crosslinking hydrogel networks 
based on synthetic and hybrid materials is increased by the use of eight arm star PEG [28-
29]. 
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F. Thiolyne “click” chemistry 
Thiole(y)ne click chemistries have been used successfully by several groups to add 
permanent crosslinks and ligands to synthetic and hybrid hydrogels [10,30-31]. After 
dissolving the polymer (P58; m/n of 1:570; triethylene glycol based; 688 kg/mol) in DMF 
and adding the crosslinking reagents the samples were placed in the UV irradiation 
chamber and irradiated for 2 h. The crosslinked PIC 12 was purified via dialysis for 3 days 
(Figure 16). 
 
Figure 16. Crosslinking via thiolyne click chemistry of acetylene functional PIC (10 mg/mL) 
with pentaerythritol tetra(3-mercaptopropionate) as crosslinking agent i) Irgacure, room 
temperature, UV cure at 365 nm, 2 h 
A standard set of rheology experiments were performed on the sample before and after 
crosslinking to investigate if there was any noticeable difference between the two samples. 
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From the temperature ramp experiment it was clear that after crosslinking the stiffness and 
sol-gel transition temperature were unchanged (Figure 17).  
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Figure 17. Storage modulus as a function of temperature for P58 before and after UV induced 
thiolyne click crosslinking, in PBS at 1.6 mg/mL. 
In the linear amplitude sweep experiment as the strain increased incrementally the 
crosslinked sample exhibited a more complex response to increased strain as did not break 
at the same strain as blanco (Figure 18 red arrow indicates break point).  
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Figure 18. Storage modulus as a function of strain (Linear amplitude sweep 0.001-10 strain at 
increments 0.1 at 10 rad/s) at 37 °C before and after UV induced thiolyne click crosslinking. 
Therefore it is fair to conclude that even though the stiffness was unaffected by the 
formation of crosslinks, network complexity has increased. As to why the stiffness did not 
increase perhaps the formation of inter polymer fibre crosslinking was dominant, but as no 
loss of stiffness was observed it would be fair to assume that bundle formation as a whole 
was not adversely affected due to the presence of the crosslinks. 
2. Physical crosslinking 
2.1. Ionic crosslinking 
2.1.1. The Hofmeister effect - Salt bridges 
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In natural systems the use of a suitable counter ion has been used extensively to enable 
protein precipitation and stabilization, this is known as the Hofmeister effect [32].The 
efficiency of anions in promoting the hydrophobic interactions and thereby the self 
assembly of peptide stacking gels was shown to be consistent with the Hofmeister anion 
series affecting both the strength of gels obtained and macroscopic fibre structure [8]. In 
synthetic system of poly(N-isopropylacrylamide) this effect has also been used to 
successfully alter the lower critical solution temperature (LCST) [9]. As the PIC closely 
resembles these two systems in that it is also fibrillar in nature and thermo responsive it was 
deemed interesting to investigate the effect of the Hofmeister series on the solubility of the 
PIC fibres through complexation of the counterions with the hydrophobic core of the 
polymer (Figure 19). At the LCST, the PIC become hydrophobic and form a network of 
entangled semi-flexible bundles of polymer chains. The mechanical properties of the PIC 
hydrogels mimic those of the of biological gels, and are readily tuned by changing 
concentration, temperature and polymer length [see Chapter 3]. It was hoped that the 
addition of salt bridges would increase the overall stiffness after the sol-gel temperature.  
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Figure 19. The ethylene glycol-functionalized polyisocyanides in water and the possible effect of 
anion addition on the polymer scaffold. (A) The polyisocyanide consists of a hydrophobic core 
and hydrophilic oligoethylene glycol tail (B) Hydrogen bonds between the peptide backbone 
may be disrupted by the anion A- and the binding of the anion to the amide group of the alanine. 
The experiment of Roy et al. [8] was repeated with PIC as pseudo peptide gel in a 
sodium buffered system with variable counter anions. In Figure 20 the general order of the 
anions (Hofmeister series) the ions on the left-hand side of the series are kosmotropes, or 
well-hydrated ions. Kosmotropes decrease the solubility of proteins and decrease the LCST 
of thermo-responsive polymers [8]. The Hofmeister series was shown to directly affect the 
LCST of the PIC (P41; m/n of 1:144; triethylene glycol based; 516 kg/mol), the ions on the 
right-hand side are chaotropes, or poorly hydrated ions, which increase polymer solubility 
and raise the LCST of the PIC fibres.  
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Figure 20. Storage modulus as a function of temperature for copolymer P41 in the presence of 
various salts in a buffered PBS solution at 1.6 mg/mL.  
Not only did the stiffness at 37 °C increase when compared to PBS (Nr.4 from Figure 
20) by the addition of kosmotropes, but it also decreased the onset the sol-gel temperature, 
the inverse was observed with the addition of chaotropes. Therefore, the addition of anions 
affected the hydrophilic/hydrophobic interface on the PIC, which in turn affects the 
solubility of the polymer in solution resulting changes in the LCST and stiffness. 
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Mixed systems and pore fillers 
We postulate that by using a filler to block the pores of the matrix it would be possible 
to change the distance between crosslinks, as the closer the filler density comes to that of 
the matrix, the smaller the distance between crosslinks become (Figure 21).  
        (Eq 3) 
Where     is the length between crosslinks in PIC hydrogel dissolved in water and     
is the distance between crosslinks in PIC hydrogel mixed with filler. Fillers could be: 
particles larger than the pore size e.g. gelatine spheres; water soluble polymers e.g. PEG or 
PVA. 
 
Figure 21. Schematic representation of polymer network pores filled with A) water or B) water 
and filler. 
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2.1.2. Pore blocking via spherical particles 
Gelatine spheres (FutureChemistry) of 217 nm (PDI determined by DLS to be 0.1 and 
therefore narrowly distributed) in size were dissolved in PBS at 60 g/L were combined with 
a PIC (P41; m/n of 1:144; triethylene glycol based; 516 kg/mol) to obtain a 1.6 mg/mL 
solution containing 27 g/L gelatine spheres. A standard set of rheological experiments were 
performed (Figure 22a). From the temperature ramp it was concluded that the PIC 
containing gelatine spheres did not increase in stiffness. Interestingly, during the linear 
amplitude sweep, the PIC containing gelatine spheres still exhibited strain stiffening 
characteristics (Figure 22b).  
In conclusion, although the addition of gelatine spheres did not effectively increase the 
bulk stiffness of the hydrogel, it did not inhibit sol-gel transition. This strategy could be 
used to add complexity to the PIC system in the form of drug molecules or additional 
cellular signals (e.g. growth factors). The gelatine spheres could also act as pseudo focal 
adhesion points to induce vasculogenesis [33] or be used as a carrier for drugs or biological 
molecules [34]. 
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Figure 22. Rheology of polymer P41 with gelatine spheres (a) Storage modulus as a function of 
temperature, (b) Storage modulus as a function of strain at 37 °C (linear amplitude sweep at 
0.001-10 strain increments 0.1 at 10 rad/s) 
 
A) 
B) 
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2.1.3. Polymers as fillers 
2.1.3.1. Polyethylene glycol 
To investigate what effect the addition of polyethylene glycol (PEG) itself would have 
on the sol-gel transition of PIC, increasing weight percentages of non functional solutions 
of PEG (0.6 – 10 wt %) were added to a fixed concentration of 1.6 mg/mL PIC (P41; m/n 
of 1:144; triethylene glycol based; 516 kg/mol). In the temperature rheological experiments, 
the PIC system (sol-gel transition) seems unaffected by the addition of PEG up to 5 weight 
percent (Figure 23). 
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Figure 23. Storage modulus as a function of temperature for polymer P41 (1.6 mg/mL PBS) with 
increasing percentages of polyethylene glycol. 
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 In Figure 24 the linear amplitude sweep indicate that as the % PEG increases the 
behaviour of the PIC deters from the blanco, at 5 weight percent it even seems to be able to 
resist breaking for longer than the reference material (red arrows indicate breaking points). 
The sample containing 10 weight percent PEG has retained no PIC characteristics and upon 
increased strain breaks down completely  
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Figure 24. Storage modulus as a function of strain  (linear amplitude sweep 0.001-1 strain at 
increments 0.1 at 10 rad/s) at 37 °C of polymer P41 with increasing percentages of 
polyethylene glycol. 
To conclude, the addition of a PEG does not increase the overall stiffness, in fact a 
decrease in stiffness was observed for samples containing more than 1.9 weight % PEG. 
The sol-gel transition temperature was unaffected by the addition of PEG up to 5 weight %.  
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2.1.3.2. Polyvinylalcohol 
The maximum amount of polyvinylalcohol (PVA) added to PIC that still results in a 
convincing sol-gel transition was determined by mixing increasing amounts of PVA with 
PIC (P41; m/n of 1:144; triethylene glycol based; 516 kg/mol) and measuring the sol-gel 
transition using rheology. At a mass ratio of PVA to PIC of 1:0.6 the solution was viscous 
and gel like, but the sol-gel transition was no longer present (Figure 25, Table 8).  
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Figure 25. Storage modulus as a function of temperature for polymer P41 in the presence of 
PVA, the concentration of P41 was kept constant at 1.6 mg/mL in PBS. 
During the linear amplitude sweep it appears that the addition of PVA has positively 
affected the strain resistance properties of the mixture. This can be seen delayed break-off 
points indicated with red arrows on Figure 26. 
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Figure 26. Storage modulus as a function of strain(linear amplitude sweep 0.001-1 strain at 
increments 0.1 at 10 rad/s) at 37 °C of polymer P41 with PVA at two different mass ratio. 
In conclusion, the addition of PVA to PIC does not increase the overall stiffness or the 
sol-gel transition up to mass ratios of PVA to PIC 1:0.6. A delayed onset of break upon 
increased stain and multiple break points was observed in the mixture.  
3. Dynamic crosslinking  
3.1. Host-guest chemistry 
Host-guest chemistry has been used as a successful strategy to form hydrogels by the 
rapid crosslinking of cellulosic (naphthalene) biopolymers with polyvinyl alcohol (methyl 
viologen) in the presence of cucurbit[8]uril [12,35]. It was also shown that by choosing the 
appropriate amino acid (phenylalanine), supra-molecular hydrogels based on 
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(vinylbenzyl)trimethylammonium chloride derived polymers could be successfully 
synthesized in the presence of CB8 [36]. The addition of this dynamic crosslinking strategy 
could potentially result in a self-healing PIC hydrogel, as was the case in the system of 
Apple et al. [35,37], but with strain stiffening characteristics inherent of the PIC system. 
Two routes were employed to investigate this possible dynamic crosslinking strategy 
for PIC. The first was to decorate the PIC with phenylalanine (Phe) guest moieties and to 
use CB8 as the host to form a ternary complex filled with only Phe guest molecules. The 
second strategy was to use a flexible polyvinyl alcohol (PVA) decorated with methyl 
viologen (MV) to act as the first electron-poor guest for CB8 and add this to PIC-Phe, the 
electron-rich guest, yielding the dynamic molecular hand cuff complexes (Figure 27). The 
strength of this crosslinking could then be tuned stoichiometrically.  
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Figure 27. Proposed dynamic crosslinking strategies with cucurbit[8]uril host and A) 
phenylalanine/phenylalanine or B) phenylanaline/methylviologen guests. 
In strategy A, it was thought that the simplest way to obtain PIC-Phe 13 was to 
decorate amine functional PIC (PIC-NH2) with phenylalanine (Phe) via condensation 
reaction of the amine on PIC-NH2 and carboxylic acid groups on phenylalanine in the 
presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-
hydroxysulfosuccinimide (Sulfo-NHS) (Figure 28).    
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Figure 28. Schematic representation for the synthesis PIC-Phe  i) EDC/Sulfo-NHS, DMSO/DMF, 
14 days, ii) 16% piperidine/DMF, 9 h, room temperature 35-46 % yield.  
1H NMR was used to determine the loading of Phe onto the PIC. What appears to be a 
doublet of doublets between 8.0 – 7.5 ppm was assigned to the aromatic protons of the Phe 
and the broad multiplet between 3.75 – 3.25 ppm the CH2-CH2 protons of the PIC 
backbone. The loading of all three polymers and an example of the calculations based on 
the 1H NMR spectra of 13a can be seen in Figure 29 (Table 4). It was assumed that the 
loading of Phe for all other strategies would not be significantly different from these values 
as the same starting polymers were used. 
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 Figure 29. 1H NMR (128 scans) of polymer P38, the peaks used to determine the ratio of m/n are indicated with the coloured circles.  
Rheology measurements were performed on the 13 b-c in the presence of CB8 with a 
molar ratio of 2 Phe moieties per CB8. The stiffness decreased with the addition of CB8 
(Figure 30). This could be that even at densities as low as 1 in 280 or 625 there were still 
too many phenylalanine groups available for binding.  
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Figure 30. Storage modulus as a function of temperature for PIC-Phe at 2 mg/mL in 50 mM 
borate buffer pH 8.4 with and without CB8.  
It could also be possible that spacer flexibility and length play a role in the efficacy of 
molecular handcuff formation. Therefore a Phe with a longer more flexible spacer length 
than 13 was required.  
The synthetic strategy opted for was to synthesize a BCN functional PIC with a longer 
spacer than utilized by the synthesis of 13 (Figure 28). A condensation reaction with Fmoc-
phenylanaline and tert-butyl (3-aminopropyl)carbamate with N,N’-
dicyclohexylcarbodiimide (DCC) in the presence of catalytic amounts of 4-
dimethylaminopyridine (DMAP) resulted in 14 (Figure 31). After the successful 
deprotection, the deprotected compound 14 was then reacted under slightly basic conditions 
with the activated carboxylic acid of the bicyclononyne N-hydroxysuccinimyl (BCN-NHS) 
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to yield the Fmoc protected phenylalanine BCN linker 15. The Fmoc protection group was 
removed with the mild base piperidine in DMF. After purification, the deprotected BCN-
Phe 16 was added to PIC-N3 and allowed to conjugate for several hours to obtain 17a-c in 
good yields (Figure 31, Table 5).  
The spacer length of 13 (14.6 Å) vs. 17 (31.8 Å) was predicted by measuring the 
distance of Phe from the backbone using a modelled structure energy minimized in 
ChemDraw3D and rendered in PyMol. 
 
Figure 31. Synthetic scheme of PICR3BCN i) DCM, DCC/DMAP, room temperature16 h ii)a. 2 M 
HCl/Dioxane, 2 h, b. BCN-NHS, 50 mM Borate buffer pH 8.4 9 h iii) 5 % piperidine/DMF, 1 h, 79 
% yield iv) PIC-N3, DCM, 18 h, 82 % yield. 
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The successful synthesis of 15 was confirmed with 1H NMR, 13C NMR, NOESY, 
HSQC and LCQ-MS. The HPLC elution profile of compound 15 showed the presence of at 
least two major products, presumably some residual starting products. Since the desired 
product was present, it was decided to continue without further purification as this was still 
an intermediate product (Figure 39). 
The successful deprotection of 15 was confirmed by 1H NMR spectroscopy. The 
characteristic aromatic peaks of the Fmoc protection group disappeared and only the 
aromatic peaks of the phenyl group were present between 7.5-7.0 ppm. The singlet (1) 
assigned to the single proton on the bicyclononyne moiety was still present (Figure 47 
experimental). The HPLC elution profile of 16 showed one dominant peak at 25.6 min with 
some minor impurities (Figure 41). 
To qualitatively test if product 16 was still active, a test reaction was performed with 7-
azido-2-oxo-2H-chromene-4-carboxylic acid, which itself shows only slight fluorescence 
when excited at 432 nm, but once conjugated, it fluoresces intensely. The 7-azido-2-oxo-
2H-chromene-4-carboxylic acid was dissolved in DMSO with a concentration of 1 mg/mL . 
A small amount of 16 was dissolved in DMSO and to this an equimolar equivalent of 7-
azido-2-oxo-2H-chromene-4-carboxylic acid stock solution was added. The combined 
sample showed increased fluorescence indicating that the bicyclononyne present in 16 was 
still intact and available for conjugation (Figure 42 experimental). 
The SPAAC reaction was performed by dissolving the azide functional polymer (m/n 
of 1:67; 1: 278; 1:625) in DCM and adding a 20-fold molar excess (relative to azides 
4-41 
 
present on the PIC) of 16. The reaction was stirred at room temperature for 18 h. The 
efficacy of the conjugation was determined to be 81-92 % by the dye test (described 
previously in Chapter 2.2).  
A third BCN-Phe derivative 18 was supplied by SynAffix was also investigated. The 
distance from the PIC scaffold to the Phe (19a-c) was predicted from an energy minimized 
structure obtained from ChemDraw3D and rendered in PyMol to be 32.3 Å. The P41 was 
dissolved in ACN and a 1:1 molar equivalent of 18 was added to the PIC solution and 
stirred for 4 days at room temperature. The polymer was recovered by precipitation from 
diisopropyl ether and air dried under nitrogen flow to obtain the Fmoc protected 19 in good 
yields (Table 6). The polymer 19 was dissolved in borate buffer pH 8.4 at a concentration 
of 1.2 mg/mL and to this a solution of 5% piperidine in DMF was added. The deprotection 
was assumed to be quantitative after 16 h of stirring at room temperature (Table 7).   
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Figure 32. Schematic of the SPAAC functionalization of PIC-N3 with 18: i)ACN, 4 days 40-80 % 
yield. The m/n was varied 1:67; 1:278; 1:625. 
In strategy B to form molecular handcuffs with MV and Phe guest moieties inside a 
CB8 host, it was decided to use a flexible PVA-MV crosslinker so as to favour interbundle 
crosslinking over intrabundle crosslinking. It was established in the investigation of 
physical crosslinking that PVA could be added to the PIC system without adversely 
affecting the PIC hydrogel sol-gel transition and stiffness below mass ratios of 1:1.7. PVA 
was functionalized with MV over five steps in an overall yield of 14 %. The final step was 
performed twice resulting in 24 a-b loaded with different densities of MV relative to the 
OH groups (3 and 33 %) on the PVA backbone (Figure 33).  
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Figure 33. Synthesis of PVA-MV i) MeI, DCM, 25 °C 18 h, 80% yield ii) 2-bromoethan(1)ol, ACN, 
reflux 48 h, 54 % yield iii) NH4BF4, reflux 2 h, 55 % yield iv) 1,6-hexamethylene diisocyanate, 
dibutyltin dilaurate, ACN, room temperature 24 h, 58 % yield v) PVA, dibutyltin dilaurate, NMP, 
room temperature 18 h, quantitative. 
From the mixed system physical crosslinking investigation, the weight percent at 
which PVA adversely affects the sol-gel transition was known (Figure 25). Therefore the 
methyl viologen functional PVA-MV 24a-b (3% or 33% MV relative to -OH) was mixed 
with 19a-b in the presence of CB8 and the mass ratios of PVA to PIC were kept above 
1:0.6 (Table 9).  
For the PIC sample with the highest loading 19a Phe (1 in 67) there was no effect on 
stiffness by adding PVA at different molar concentrations, nor was there any effect on the 
stiffness due to the presence of PVA-MV in a mass ratio of 1:3 (Figure 34). 
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Figure 34. Storage modulus as a function of temperature for 19a at a concentration of 1.1 
mg/mL in 50 mM borate buffer pH 8.4 in the presence of PVA-MV and CB8 with varied molar 
ratios of MV moiety to Phe moiety and a constant mass ratio of 1:3.  
The PIC sample with a lower loading of Phe 19b (1 in 278) exhibited an increase in 
stiffness in the presence of PVA-MV and CB8. What was clear is that for a sparsely 
labelled PIC-Phe (1 in 278) at mass ratios above 1:3 an increase in stiffness was observed 
regardless of the molar ratio MV:Phe (Figure 35a). Interestingly there was a significant 
difference between the three samples during the linear amplitude sweep, the mixtures 
resistance to final rupture (as indicated by red arrows Figure 35b) was directly correlated to 
the amount of PVA-MV present and the slope of the curve is much steeper than that of the 
control experiment where the dynamic crosslinks were not present (Figure 26 ). Possibly 
this could be due to the dynamic nature of the crosslink inducing the polymer with self 
healing properties under increased strain. In both PIC (19a and 19b ) systems the sol-gel 
transition was unaffected by the reaction conditions. 
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Figure 35. Rheolgy of 19b at a concentration of 1.1 mg/mL in 50 mM borate buffer pH 8.4 in the 
presence of PVA-MV and CB8 with varied molar ratios of MV moiety a) Storage modulus as a 
function of temperature, (b) Storage modulus as a function of strain at 37 °C (0.001-10 strain 
increments 0.1 at 10 rad/s). 
  
A) 
B) 
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Conclusion/Discussion 
As a whole, crosslinking did not increase the stiffness of the PIC in gelled state as was 
expected from previous work [1] which predicts that the storage modulus should increase 
proportionally as the distance between crosslinks decreases. It was assumed that 
crosslinking in the gelled state would result in cross bundle linking and that the effect on 
bundle tightness would be negligible. If the formed crosslinks inhibit PIC fibres from 
forming tight bundles then the assumption that the persistence length of single chain applies 
to the bundle is false and as a result unpredictable effects on the storage modulus occur 
regardless of the decrease in distance between crosslinks, this proposed effect could be 
referred to as the frayed rope scenario as depicted in Figure 36.  
 
 
Figure 36. Concept illustration frayed rope, inter polymer crosslink formation results in bundle 
disruption.  
4-47 
 
 
The most promising results on increasing storage modulus of the PIC in gelled state was 
obtained by adding ionic crosslinks through the addition of kosmotropic anions that 
stabilize the polymer bundle as a whole and cause precipitation at lower temperatures.  
 
The one covalent crosslinking strategy that resulted in increased stiffness was the addition 
of dithiobridges. It is postulated that a higher ratio of dithiobridges or bulky spacers will 
result in increased overall stiffness.  
 
The addition of self healing properties into the PIC system through the formation of 
molecular handcuffs although not effective in increasing bulk stiffness did result in a PIC 
that repaired after breaking as a result of increased stress. In the future the effect of pH and 
varied concentrations of guest concentrations should be explored further.  
 
Perhaps other analytical techniques should be used to measure the effect of crosslinking on 
the polymer network, like the diffusion of nanoparticles of defined sizes to determine the 
new pore size. The stiffness could also be measured by surface indentation measurements 
[38] that would not require the excessive handling of a gelled sample. 
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Experimental: 
Procedures 
Rheology  
All crosslinking experiments were performed using the same conditions, unless stated 
otherwise. The crosslinking reagents were prepared prior to the reaction, placed in an ice 
bath and mixed cold before being rapidly transferred to a cooled plate-plate geometry. At 
this point either a temperature ramp experiment 2 °C/min 5 – 37 °C or a time experiment at 
37 °C (2 % strain) was performed followed by a frequency sweep, logarithmic amplitude 
sweep (0.1-10 %) and a linear amplitude sweep (0.001-10 strain at 10 rad/s).  
 
Synthesis 
 
1. Covalent Crosslinks 
 
A. Schiff base formation 
To quantify the amount of azides prior to the conversion to amines the Tokyo green dye test 
was performed. Briefly, a Tokyo Green stock solution was made by dissolving BCN-Tokyo 
Green (2.2 mg, 43.7 μmol) in DMSO (1 mL). The polymer to be tested was dissolved in 
ACN at a concentration around 3.0 mg/mL, with a total volume of 3 mL. The polymer 
solution was stirred for one hour at 5 °C to completely dissolve it. A volume of the Tokyo 
Green stock solution corresponding to 2 equivalent of BCN-Tokyo green per azide was 
pipetted to the polymer solution. The mixture was stirred overnight at room temperature 
and was then precipitated in diisopropyl ether (40 mL). The diisopropyl ether was decanted 
off and the remaining polymer was air dried for one hour. This precipitation process was 
repeated until the diisopropyl ether was no longer yellow. After the final precipitation the 
polymer was air dried over night under a nitrogen flow. 
 
To convert azides to amines, the azide functional PIC polymer was dissolved in acetonitrile. 
To this polymer solution triphenylphosphine (1.2 molar equivalent) and water (1.3 molar 
equivalent) were added. The mixture was allowed to react for 16 h at 40 °C and then placed 
in the cold room for 12 days. The polymer was precipitated from diisopropyl ether, the 
excess solvent decanted and polymer 1 dried under a nitrogen flow.  
 
To quantify the conversion of azides to amines the amount of amines was determined by 
performing a dye test with an amine reactive dye.  
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Table 1. Azide conversion to amine.  A summary of experimental masses, gravimetric yields and 
dye test ratio. 
 Sample PIC-
N3 
mg 
Molar Ratio 
m/n* 
mg 
Ph3P 
mg 
PIC-
NH2 
% 
Yield 
Molar Ratio 
Spacer:Amine**  
a P38 148.0 1:50 49.0 100.0 68 1:53 
b P20 37.0 / 49.0
 32.0 87 1:157 
c P36 100.0 1:360 49.0 58.0 58 1:478 
* As determined by the Tokyo green dye test. **As determined Amine-reactive dye 
 
For the crosslinking experiment the polymer (1c) stock solution in pH 6 phosphate buffer 
was made at a concentration of 3.2 mg/mL by dissolving the polymer overnight at 5 °C. 
The crosslinking experiments were performed on 1c at a concentration of 1.6 mg/mL with 
0.5 and 50.0 equivalent of crosslinker to amine.  
 
B. Schmidt Reactions 
 
The experiments were performed on P30 (m/n of 1:128; triethylene glycol based; 361 
kg/mol) at 1.6 mg/mL with 0.5 and 50.0 molar equivalent of gluteraldehyde to azide. A 
polymer stock solution in pH 6 phosphate buffer, at a concentration of 3.2 mg/mL was 
obtained by dissolving the polymer overnight at 5 °C. The gluteraldehyde was bought as a 
25% solution in MQ. From this a 0.6 mM stock solution in pH 6 phosphate buffer was 
made by pipetting 10.0 μL of the 25%-wt solution into 40 mL of pH 6 phosphate buffer. To 
1.1 mL of the P30 stock solution, 4.0μL of the 0.6 mM gluteraldehyde solution was 
pipetted. The volume of the added gluteraldehyde stock solution was assumed to be small 
enough to not change the concentrations significantly. For the control samples the same 
amount of pH 6 phosphate buffer without gluteraldehyde was added. 
 
Dithiobridge formation 
1.1.) C. Unprotected thiols 
 
To 1.0 g (9.0 mmol) of 3-chloropropane-1-thiol and 1.1 g (17.5 mmol) of NaN3, a solution 
of H2O/EtOH (10 mL, 2:1 v/v) was added. The mixture was stirred for 24 h at 100 °C. To 
the warm solution 50 mL water was added before the product was extracted with diethyl 
ether. The organic layers were washed with water (3x) and dried with Na2SO4. The solvent 
was evaporated under reduced pressure, resulting in 4 as a yellow oil, 490.0 mg, 46% yield. 
Rf  = 0.6 (MeOH/n-hexane 3:1 v/v)) 
1
H NMR (CDCl3, 300 MHz): δ = 1.88 (m, 2H, CH2-
CH2- CH2); 3.43 (m, 2H, , N3-CH2-CH2- CH2-SH), 3.72 (m, 2H, N3-CH2-CH2- CH2-SH)
13
C 
NMR (CDCl3, 75 MHz): δ = 49.70 (N3-CH2-CH2- CH2-SH), 35.27 (N3-CH2-CH2- CH2-
SH), 28.26 (N3-CH2-CH2- CH2-SH) FT-IR (cm
-1
, ATR): 2926.58 (C-H); 2094.63 (azide). 
 
To 15.0 mL of freshly distilled dichloromethane was added 3.7 mg (7 µmol) TBTA and the 
solution was degassed by freeze-pump-thaw method (x4). To this solution 1.0 mg CuBr (7 
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µmol) was added and stirred 16 h under an argon atmosphere. In a separate Schlenk finger, 
100.0 mg (0.3 mmol) P46 was dissolved in 50 mL freshly distilled DCM and the mixture 
was degassed by purging with argon. To the degassed polymer solution 6.5 mg (0.1 mmol) 
of 4 was added and the mixture was stirred for 4 h. Finally, 400 µL (0.6 µmol) of the 
catalyst solution was added to the polymer mixture and was stirred for 72 h at room 
temperature. The polymer was recovered by precipitation from diisopropyl ether (x3) to 
obtain 60.1 mg (60% yield). 
 
To a solution of 20.0 mg of polymer 5 in 4 mL dichloromethane was added 0.2 mL DMSO 
and the mixture was stirred for 5 h at room temperature. The polymer was precipitated in 
diisopropyl ether and 18.0 mg of 6 was obtained (90% yield). 
 
1.2.) D. Protected thiols 
Polymer 1c (54.5 mg, 172 µmol) was dissolved in 3 mL DMF. N-succinimidyl S-
acetylthioacetate (7.2 mg, 31.0 µmol) was added to the polymer solution, the reaction was 
allowed to react for one week. This solution was diluted with 1.0 mL MQ. The solution was 
dialysed against water and finally against PBS to obtain 4 mL of 7 a SATA-decorated 
polymer (13.5 mg/mL).  
The deacetylation buffer was prepared separately by adding 40 mL 50 mM phosphate 
buffer pH 7.2 to 3.8 mL of 200 mM EDTA solution and diluting it with 6.3 mL MQ.  
To determine the conversion success a test deprotection reaction was performed on 0.5 mL 
of the reaction mixture by adding to this 4.5 mL deacetylation solution allow to stir at room 
temperature for 2 h. An Ellmans test was performed on the deprotected solution to 
determine the concentration of thiols in solution. The reaction buffer for this was prepared 
by combining 8.0 mL 250 mM phosphate buffer pH 8.0, 0.1 mL 200 mM EDTA and 11.9 
mL MQ. The Ellmans reagent solution was prepared by dissolving 4.0 mg dithiobis(2-
nitrobenzoic acid) in 1 mL reaction buffer. The UV analysis test itself was performed on a 
dilute stock sample which was prepared by combining 50 µL of the deprotected solution 
with 950 uL of the reaction buffer. From this dilute stock solution a dilution series was 
prepared and the UV absorption at 412 nm used (Ɛ=14,150 M-1 cm-1) to calculate the thiol 
concentration.  
 
An amount of 500.0 µL of 7 (13.5 mg/mL) was treated with 500.0 µL deacetylation buffer 
at room temperature for 1 week to obtain the deprotected thiol 8 (6.8 mg/mL). 
Simultaneously another sample of 7 was treated with 400.0 µL deacetylation buffer and 
100.0 µL 30 % hydroxide solution at room temperature for 1 week to obtain  a crosslinked 
dithio PIC 9 (6.8 mg/mL) these solutions were analyzed by rheology.  
 
E. SPAAC crosslinking of PIC-N3 with flexible bifunctional linker 
 
 
The bis-amine PEG (10 kDa) (450.0 mg, 45.0 µmol) was dissolved in 1 mL ACN. To the 
PEG solution BCN-NHS (27.5 mg, 94.5 µmol) was added and allowed to conjugate for 4 
4-51 
 
days at 4 °C on the roller/shaker. The product 10 was precipitated in ice cold diethyl ether 
and the precipitate dried under nitrogen flow. MaldiToF 11638 g/mol 
 
SPAAC crosslinking 
The experiments were performed on P30 at 1.6 mg/mL with 0.5, 5.0 and 50.0 molar 
equivalent of 10 to azides on the polymer backbone. A polymer stock solution P30 in PBS 
(3.2 mg/mL) was made. A stock solution of 10 dissolved in MQ at a concentration of 0.5 
g/mL was prepared. For the 0.5 equivalent crosslinking, 10 μL stock solution of 10 was 
diluted with 8 mL of MQ to obtain a diluted stock solution of 10 with a concentration of 56 
μM. Four samples containing the bis-BCN crosslinker were made by mixing the polymer 
stock solution (0.6 mL) with the bis-BCN stock solution (0.6 mL). For the control samples 
the polymer stock solution (0.6 mL) was mixed with MQ (0.6 mL). The experiments with 1 
and 50 equivalents of crosslinker were carried out in the same way, but with pipetting 
respectively 20 μL and 100 μL of the 0.5 g/mL bis-BCN solution into 8 mL MQ. 
 
Rheology experiments of PIC in the presence of PEG 
A stock solution of PEG 6.0 kDa was prepared by dissolving 40.0 mg in 100 µL of PBS to 
obtain a 40 wt% solution. Different amounts of this PEG solution were added to PIC 3.4 
mg/mL and diluted with PBS to obtain a final concentration 1.6 mg/mL of PIC (Table 2).  
 
Table 2. Rheology experiment of PIC with increasing amount of PEG 
wt% vol PEG 
µL 
µmol 
PEG 
vol PBS 
µL  
vol 
PIC 
µmol 
PIC 
c PIC (mg/mL) 
PE 0 0.0 0.0 210.0 190.0 2.0 1.6 
PE 0.6 6.0 0.4 204.0 190.0 2.0 1.6 
PE 1.9 18.8 1.3 191.0 190.0 2.0 1.6 
PE 5 50.0 3.3 160.0 190.0 2.0 1.6 
PE 10 100.0 6.6 110.0 190.0 2.0 1.6 
 
F. UV induced thiolyne click chemistry  
Dissolve 94.3 mg of the acetylene (1:570) functional polymer P58 in 10 mL of DMF. A 2.0 
mL (17.7 mg, 1.0 pmol acetylene) portion of the stock solution was removed and placed in 
a glass vial. To the polymer solution 21.3 µL (55.6 µmol) of pentaerythritol tetra(3-
mercaptopropionate) (PETMP) and 26.9 µL (1.2 µmol) of an Irgacure solution of 10.0 
mg/mL in DMF was added. The sample was placed in the UV irradiation box and isolated 
with aluminium foil. A custom setup was build with a hand held 365 nm UV Tube Hg 
source, 4 Watt output (BLE-220B) with 15.9 x 5.1 x 2.5 cm dimensions.  Samples were at a 
fixed distance of 3.0 cm from the source resulting in a radiation of 84.0 mW/cm2. The light 
source was turned on and the reaction left for 2 h. The polymer 12 was purified by dialysis 
using a membrane (snakeskin) with a 1000 g/mol cut off and dialysing against 50:50 
DMF:MQ, then plain MQ for 48 h at 37 °C. It is assumed that the polymer concentration 
does not decrease during the dialysis process as dialysis was performed in the gelled state.  
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2. Physical crosslinking  
 
2.1.  Ionic Crosslinking 
 
2.1.1. Hofmeister Effect 
Polymer P41 was dissolved in 100 mM pH 7.4 PBS to obtain a stock solution of 3.4 
mg/mL. The sodium salt solution of all the counter ions depicted in Figure 21 was prepared 
by dissolving the respective salts in 100 mM pH 7.4 PBS to obtain a 200 mM stock 
solution. To obtain the working solution, 210 µL of the salt solution was dissolved in 190 
µL of polymer stock solution to obtain a 100 mM pH neutral salt solution with a polymer 
concentration of 1.6 mg/mL.    
 
2.2. Physical crosslinking 
 
2.2.1. Gelatin Spheres 
The gelatine particles were dissolved by adding 61.0 mg in 1 mL of 100 mM pH 7.4 PBS 
by sonicating the mixture for 30 min at 24 °C.  The PIC polymer P41 was dissolved in PBS 
to obtain a stock solution of 3.4 mg/mL. Prior to the rheological experiment the two 
solutions were cooled on ice and 59 µL of the gelatine stock solution was combined with 72 
µL of the PIC solution. The mixture was aspirated several times to obtain a homogeneous 
solution before being placed on a 5 °C rheometer for analysis.  
 
3. Dynamic crosslinking  
 
3.1. Host Guest Crosslinking 
 
3.1.1. Synthesis of PIC-Phe (13) 
The amine functional polymer was swollen overnight in 1.0 mL DMF. In a separate round 
bottom flask (((9H-fluoren-9-yl)methoxy)carbonyl)-L-phenylalanine (Fmoc Phe) (110 mg, 
0.03 µmol) and EDC (0.1 mg, 0.1 µmol) were dissolved in 2 mL DMSO and 2 mL DMF. 
To this mixture (130.0 mg, 0.1 µmol) Sulfo-NHS dissolved in 2 mL DMSO was added. 
Then 2 mL of this mixture was added to each polymer solution and the reaction allowed 14 
days to reach completion. Deprotection with 16 % piperidine in DMF was performed on the 
reaction mixture, stirring for 9 h at room temperature. At this time the solution was dialysed 
against water for 3 days. The water was removed by co-evaporation with iso-propanol 
under reduced pressure. The resulting solid was dissolved in DCM and precipitated from 
diisopropyl ether.  The excess solvent was decanted and the polymer 13a-c was dried under 
nitrogen flow.  
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Table 3. PheFmoc conversion to Phe and ratio as determined by 1H NMR. 
Compound mg PIC mg 
PheFmoc 
mg deprotected 
PIC 
Ratio m:n % Yield 
P38 29.9 36.7 10.6 1:67 35 
P20 17.1 30.6
 7.9 1:278 46 
P36 28.8 36.7 10.0 1:625 35 
 
Table 4. Masses used for the rheology dynamic crosslinking experiment Strategy A. 
Compound Mol 
ratio 
mg 
PIC 
pmol 
Phe 
mg CB8 pmol 
CB8 
concentration 
PIC (mg/mL) 
P38 0 2.0 147.0 0.0 0.0 2.0 
P38 2:1 2.0 147.0 0.1 71.0 2.0 
P38 1:1 2.0 147.0 0.2 146.0 2.0 
P20 0 2.0 15.8 0.0 0.0 2.0 
P20 0.5:1 2.0 15.8 0.04 29.0 2.0 
 
3.1.2. Synthesis of PIC-Phe (17) 
 
Tert-butyl (3-aminopropyl)carbamate (0.2 g, 0.9 mmol) was dissolved in 50 mL DCM. To 
this solution Fmoc-Phe (0.3 g, 0.9 mmol), DCC (0.2 g, 1.1 mmol) and a spatula tip of 
DMAP were added together and allowed to stir at room temperature overnight. The mixture 
was diluted with 100 mL chloroform and extracted three times with 10 % citric acid 
solution. The organic layer was concentrated to result in compound 14 as a white powder. 
Rf = 0.5 (DCM)  
1
H-NMR (400 MHz, CDCl3) δ 7.75 (d, J= 7.4 Hz, 2H, Ha), 7.55 (t, J=7.6 
Hz, 2H, Hd), 7.40 (t, J=7.2 Hz, 2H, Hh), 7.35-7.15 (m , 9H, Hb,c), 6.40 (s, 1H, Hq), 5.42 (s, 
1H, Hk), 4.77 (s, 1H, Hs), 4.47-4.27 (m, 3H, He,f), 4.19 (m, 1H, Hr), 3.30-2.85 (m, 6H, 
Hl,m,n), 1.26 (s, 9H, Hp) 
13
C NMR (CDCl3, 75 MHz) δ 171.25 (C=O), 144.17(C), 
141.70(C), 136.89 (CAr), 129.73, 129.11, 127.46, 125.45 (CHc), 120.39 (CHd), 
67.43(CH2CHe), 49.58 (CHr), 47.57 (CHe), 39.29 (CH2-CAr), 36.32 (CH2), 34.38, 30.36, 
28.78 (3-CH3), 26.04, 25.35 MS (ESI): m/z ([M]
+: C32H37N3O5Na), calcd 566.7; found 
566.1 
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Product 14 (0.1 g, 0.1 mmol) was dissolved in 3 mL DCM. To this mixture 3 mL 4.0 M 
HCl in dioxane was added. The product formation was traced by TLC and deprotection was 
deemed complete when only Rf  = 0.88 (DCM) was observed and no peaks corresponding 
to tert-butyloxycarbonyl (BOC) protons were present in the 1H NMR anymore. Excess acid 
was removed by removing excess solvent under reduced pressure. To the resulting paste 
(0.1 g, 0.1 mmol) 10 mL DCM was added and removed under reduced pressure another two 
times to ensure all acid was removed. The deprotected intermediate was dissolved in 10 mL 
50 mM pH 8.4 borate buffer. To this BCN-NHS (0.1 g, 0.1 mmol) in 2 mL DMSO was 
added. The reaction was allowed to stir at room temperature for 9 h. The solvent was 
removed by freeze drying to obtain 15 a white powder (0.2 g, 0.2 mmol). 1H-NMR (400 
MHz, MeOD) δ 7.82 (d, J = 7.6 Hz, 2H, H19), 7.69 – 7.50 (m, 2H, H17), 7.42 (t, J = 7.5 Hz, 
2H, H19), 7.27 (dd, J = 27.8, 11.4 Hz, 5H, H19/17), 4.35 (d, J = 7.0 Hz, 1H, H18), 4.28 (s, 1H, 
H15), 4.23 – 4.08 (m, 2H, H2), 3.68 – 3.47 (m, 6H), 3.18 (dd, J = 21.5, 14.7 Hz, 3H), 2.91 
(s, 1H), 2.65 (s, 4H), 2.25 (s, 6H), 1.99 – 1.83 (m, 3H), 1.72 (s, 1H), 1.68 – 1.51 (m, 3H), 
1.37 (s, 2H), 1.18 (s, 2H), 0.94 (dd, J = 17.8, 8.5 Hz, 1H1) 
13
C NMR (CDCl3, 75 MHz) δ 
172.79 (C=O), 171.90 (C=O), 155.78 (C=O), 143.76 (C=O), 140.67 (Cfmoc), 138.16 (Cfmoc), 
129.22 (2CH), 128.06 (2CH), 127.65(2CH), 127.05(2CH), 125.30 (CH), 120.09 (2CH), 
99.02 (2CBCN), 69.54 (C20), 69.15 (C2), 65.67 (CH18), 46.59 (CH15), 36.15, 34.74, 33.38, 
30.72, 29.21, 28.62, 25.26 (2CH2), 24.49, 20.88 (C1), 19.58, 17.68 MS (ESI): m/z ([M]
+: 
C49H61N5O9Na), calc 887.04; found 887.5 
 
To assign the protons with more certainty, 2D NMR strategies such as NOESY and HSQC 
were used, see Figure 45-46. In NOESY spectra long distance coupling between protons 
was used to clearly assign protons and with the HSQC it was possible to distinguish peaks 
that originated from carbon-proton interactions which resulted in the peaks of CH3 and CH2 
protons appearing inverted with regards to CH proton peaks. 
4-55 
 
Figure 37. NOESY 2D NMR of FMOC-Phe-BCN 
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Figure 38. HSQC 2D NMR of FMOC-Phe-BCN 
4-57 
 
 
Figure 39. HPLC chromatogram of FMOC-Phe-BCN (15), analyzed with UV detector at λ = 214 
nm 
1 mL 5% piperidine/DMF and Fmoc-Phe R3 BCN 15 (0.2 g, 0.2 mmol) was combined and 
stirred at room temperature for 1 h. Once dissolved 10 mL of MQ was added. A white 
precipitate formed and was filtered off. The water layer was freeze dried to obtain 16, 
colourless oil (0.1 g, 0.1 mmol) in a 79% yield. 1H-NMR (500 MHz, MeOD) δ 7.34 – 7.18 
(m, 5H, H17), 4.13 (d, J = 8.1 Hz, 2H, H2), 3.68 – 3.43 (m, 10H), 3.35 (t, J = 5.5 Hz, 2H), 
3.21 (s, 1H), 3.16 – 3.03 (m, 12H), 2.72 (dd, J = 17.5, 7.2 Hz, 1H), 2.46 – 2.34 (m, 2H), 
2.24 (m, 5H), 1.87 (m, 2H), 1.77 (m, 21H), 1.72 – 1.61 (m, 3H), 1.56 (m, 3H), 1.36 (m, 
1H), 0.93 (m, 1H, H1) 
13
C NMR (126 MHz, MeOD) δ 182.03 (C=O), 178.14 (C=O), 
177.34 (C=O), 138.33 (Ca), 130.02 (Cc), 129.19 (Cb), 127.43 (Cd), 111.95, 99.24 (Ce), 
70.87(C16), 70.18 (C2), 57.57, 45.33, 43.54, 41.88, 40.02, 37.83, 35.86, 33.04, 29.80, 28.55, 
27.21, 26.37, 25.11, 23.56, 22.82, 22.43, 21.53, 20.98 (C1) MS (ESI): m/z ([M]
+: 
C34H52N5O7), calcd 641.4; found 642.4 
To assign the protons with more certainty 2D NMR strategies such as NOESY was used see 
Figure 40. In NOESY spectra long distance coupling, between protons were used to clearly 
assign protons. 
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Figure 40. NOESY 2D 1H NMR of 16 
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Figure 41. HPLC chromatogram of Phe-BCN (16) analyzed with UV detector 214 nm 
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Figure 42. Fluorescence emission of 7-azido-2-oxo-2H-chromene-4-carboxylic acid with and 
without BCN-Phe (16). 
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The polymer (see Table 5 for details) was dissolved in DCM, to this 20-fold molar 
equivalent of 16 was added. The mixture was stirred for 18 h at room temperature. The 
polymer was obtained by precipitation from diisopropyl ether. The excess solvent was 
decanted and the polymer dried under reduced pressure to obtain 17a-c. The remaining 
azides were measured by dying with BCN-Tokyo green as described previously in Chapter 
3 section 1.2.2, if 1:315 azides remained in the PIC with an initial density of 1:67 azides 
then 79% of the azides were converted to phenylalanine. 
 
Table 5. Experimental masses used for the synthesis of PIC-Phe (17). 
 Sample mg PIC µmol N3 mg PIC-Phe Conversion % Yield % 
a P38 34.0 4.3 28.0 79 82 
b P20 35.0 0.3 34.6 87 97 
c P36 40.0 0.1 36.8 81 93 
 
3.1.3. Synthesis of PIC-Phe (19) 
PIC-N3 (Table 8) was dissolved in ACN, to this an aliquot from a stock solution of 10 
mg/mL 18 was added and allowed to react for 4 days at room temperature. The polymer 
was precipitated from diisopropyl ether. The excess solvent was decanted and dried under 
nitrogen flow. Samples of Fmoc protected 19a-c were sent to Cambridge for analysis and 
rheology experiments.  
 
Table 6. Experimental masses and volumes used for the synthesis of PIC-Phe 19. 
 Compound mg µmol 
N3 
BCN-Phe-
Fmoc µL 
µmol BCN-
Phe-Fmoc 
% Yield 
a P38 23.0 1.7 200.0 2.9 65 
b P20 15.0 0.1 70.0
 1.0 40 
c P36 10.0 0.1 70.0 1.0 80 
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The polymer PIC-N3 (Table 7) was dissolved in 50 mM borate buffer pH 8.4 to obtain a 
stock concentration of 4.0 mg/mL. To this a stock solution of 1.1 mg/mL 18 in DMSO was 
added. The reaction mixture was placed in the heated shaker and allowed to react at 10 °C 
shaking at 350 rpm overnight. A portion of the reaction mixture was removed for analysis 
of the intermediate step by rheology. The remaining portion was treated with 5% 
pipiridine/DMF at 22 °C shaking at 350 rpm for 16 h. The solution was dialysed against 
MQ and refreshed twice and finally dialysed against 50 mM borate buffer pH 8.4 to obtain 
a stock concentration of 1.2 mg/mL PIC-Phe 19 in borate buffer.  
 
Table 7. Data summary of PIC-N3 functionalization and Fmoc deprotection used to synthesize 
PIC-Phe 19. 
Compound mg µmol 
N3 
BCN-Phe-
Fmoc µL 
µmol 18 µL 
pipiredine/DMF 
P38 4.0 0.3 160.0 0.3  
P20 4.0 0.03 80.0
 0.1  
P36 2.0 0.01 40.0 0.1  
P38-PheFmoc 3.0 0.2   750.0 
P20-PheFmoc 3.0 0.02   750.0 
P36-PheFmoc 1.0 0.01   250.0 
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Figure 43. Storage modulus as a function of temperature for Fmoc 19a-c at 1.2 mg/mL in 50 mM 
borate buffer pH 8.4 . 
3.1.4. Synthesis of PVA-MV 24 
 
 
4,4’-Bipyridine (2.50 g, 16.1 mmol) was dissolved in DCM (25 mL). MeI (2.85 g, 20.1 
mmol) in DCM (13 mL) was added and the mixture was stirred at 25 °C for 18 h. The 
resulting yellow precipitate was isolated by vacuum filtration, washed with DCM and dried 
in vacuo to yield 1-methyl-[4,4’-bipyrindin]-1-ium iodide (3.82 g, 12.8 mmol, 80 %)  20 as 
a yellow solid [35]. 
1
H-NMR (400 MHz, D2O) δ 8.93 (d, J = 6.3 Hz, 2H, Hd), 8.79 (d, J = 4.9 Hz, 2H, Hc), 
8.41 (d, J = 6.3 Hz, 2H, Hb), 7.93 (d, J = 4.9 Hz, 2H, Ha), 4.47 (s, CH3). 
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1-methyl-[4,4’-bipyrindin]-1-ium iodide 20 (3.00 g, 10.1 mmol) in acetonitrile (125 mL) 
was refluxed until a homogenous solution formed. Bromo ethanol (1.8 mL, 25.2 mmol) was 
added and the mixture was refluxed for 48 h. The resulting precipitate was isolated by 
vacuum filtration, washed with acetonitrile and dried in vacuo to yield 1-(2-hydroxyethyl)-
1’-methyl-[4,4’-bipyridine]-1,1’-diium bromide iodide 21 (2.30 g, 5.44 mmol, 54 %) as a 
yellow solid [35]. 
1
H-NMR (400 MHz, D2O) δ 9.16 (d, J = 6.8, 2H, Ha), 9.09 (d, J = 6.7, 2H, Hd), 8.61 (d, J 
= 6.6, 2H, Hb), 8.57 (d, J = 6.5, 2H, Hc), 4.89 (m, 2H, He), 4.54 (s, CH3), 4.18 (m, 2H, Hf). 
 
 
1-(2-hydroxyethyl)-1’-methyl-[4,4’-bipyridine]-1,1’-diium bromide iodide 21 (2.00 g, 4.73 
mmol) and NH4BF4 (0.99 g, 9.46 mmol) in acetonitrile (50 mL) were refluxed for 2 h. The 
colourless salt was separated from the brown solution by filtrations. The solvent was 
removed under reduced pressure to yield 1-(2-hydroxyethyl)-1’-methyl-[4,4’-bipyridine]-
1,1’-diium tetrafluoroborate 22 (1.01 g, 2.59 mmol, 55 %) as an orange solid [35]. 
1
H-NMR (400 MHz, D2O) δ 9.16 (d, J = 6.6, 2H, Ha), 9.09 (d, J = 6.6, 2H, Hd), 8.61 (d, J 
= 6.4, 2H, Hb), 8.57 (d, J = 6.4, 2H, Hc), 4.89 (m, 2H, He), 4.54 (s, CH3), 4.17 (m, 2H, Hf). 
 
 
The product 22 (900 mg, 2.31 mmol) was dissolved in dry acetonitrile (250 mL) and 1,6-
hexamethylene diisocyanate (3.7 mL, 23.1 mmol) and dibutyltin dilaurate (1 drop) were 
added. The reaction was stirred for 24 h at room temperature. The solvent was evaporated 
under reduced pressure to ± 10 mL and 200 mL anhydrous Et2O was added. This mixture 
was put to stand in the freezer for 2 h after which the solvent was decanted. The residue 
was dried in vacuo to yield 23 (751 mg, 1.35 mmol, 58 %) as a dark orange solid [35]. 
1
H-NMR (400 MHz, D2O) δ 9.20 (m, 2H, Ha), 9.11 (d, J = 4.7, 2H, Hd), 8.62 (d, J = 4.8, 
2H, Hb), 8.58 (d, J = 4.8, 2H, Hc), 5.05 (m, 2H, Hf), 4.67 (m, 2H, He), 4.55 (s, CH3), 3.04 
(m, 4H, Hh;g), 1.49 (m, 8H, Hl-i). 
 
 
4-64 
 
 
PVA was dried in a vacuum oven at 60 °C for 24 h. Then, PVA (100 mg, 2.44 mmol -OH) 
was dissolved in dry NMP (6 mL). To this mixture 23 (150 mg, 0.268 mmol) and dibutyltin 
dilaurate (1 drop) were added and stirred over night at room temperature. The product was 
purified by precipitation of the reaction mixture into ethyl acetate, filtration and then 
lyophilized to yield 24 (244 mg, MV:OH = 1:27) as a white solid [35]. 
1
H-NMR (500 MHz, D2O) δ 9.08 (4H, Hh), 8.57 (4H, Hi), 4.86 (2H, Hf part of H2O peak), 
4.52 (3H, Hj), 4.05 (28H, Hb), 3.87 (2H, Hg), 3.03 (4H, Hc), 1.67 (60H, Ha;d), 1.23 (4H, He). 
 
3.1.5. Synthesis PIC-methyl viologen 26 
 
PIC-N3 P38 (100 mg, 7.3 µmol –N3) was dissolved in a mixture of DMSO (3 mL) and 
ACN (5 mL) after which compound 25 (4.0 mg, 7.3 µmol) was added. This viscous 
solution was degassed for 2 h. CuPF6(CH3CN)4 (2.7 mg, 7.3 µmol) was degassed by 
consecutive flushing with nitrogen gas and a vacuum. Then the solution was added to the 
copper complex and the mixture was stirred for 4 days between 0 °C and room temperature. 
The product was purified by dialysis against MQ for 2 days and then isolated by 
lyophilisation. The polymer was isolated as a white solid 26 (29 mg, 29 %). 
1
H-NMR (500 MHz, CD3CN) δ 9.01 (MV), 8.50 (MV), 3.55 (backbone). IR (neat) ν 3268, 
2886, 1740, 1657, 1533, 1206, 1106, 955, 862, 755, 695 cm-1. UV-vis λmax=244 nm. Degree 
of functionalisation has to be determined using displacement studies with acridine orange 
as described by Urbach [3539] as conventional 1H-NMR ratio determination was not 
possible. 
 
3.1.6. Synthesis of PVA-phenylalanine 29 
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PVA (200.0 mg, 4.9 mmol –OH) was dissolved in DMSO (4 mL) and pyridine was added 
(0.5 mL). The solution was cooled down to 0 °C and TsCl dissolved in DMSO (2 mL) was 
added dropwise. The mixture was stirred over night at room temperature. The product was 
purified by precipitation into ethyl acetate and filtration. The product was dissolved in 
DMSO and then dialysed against MQ after which it was lyophilized to yield 27 (185.0 mg, 
OTs:OH = 1:4.5) as a white solid [40]. 
1
H-NMR (400 MHz, D2O) δ 7.70 (d, J = 8.4, 2H, Hd), 7.38 (d, J = 8.4, 2H, He), 5.08 (s, 
0.5H, Hc), 4.02 (s, 4H, Ha), 2.40 (s, 3H, Hf), 1.64 (m, 9H, Hb). 
 
 
PVA-OTs 27 (100.0 mg, 0.3 mmol –OTs) was dissolved in DMF and NaN3 (38.0 mg, 0.6 
mmol) was added. The resulting solution was allowed to stir at 65 °C for 2 days and 
precipitated into Et2O followed by lyophilisation to yield 28 (84.0 mg, N3:OH = 1:5.6) as a 
white solid [41]. 
1
H-NMR (400 MHz, D2O) δ 7.70 (d, J = 8.4, 0.6H), 7.38 (d, J = 8.4, 0.6H), 5.07 (s, 0.3H), 
4.02 (s, 5.4H), 2.41 (s, 0.9H), 1.68 (m, 11.4H). IR (neat) ν 3383, 2940, 2128, 2040, 1657, 
1425, 1174, 1094, 1012, 817, 693 cm-1. 
 
 
PVA-N3 28 (4.2 mg, 14.3 µmol –N3) was dissolved in DMSO (2.1 mL) after which 
compound 18 (5.0 mg, 7.2 µmol) in DCM (0.5 mL) was added. The solution was stirred at 
room temperature for 4 days after which it was dialysed to remove the DMSO followed by 
lyophilisation to yield a white solid. The white solid was dissolved in DMF (2 mL) and 
piperidine (1 mL) was added for the deprotection. This mixture was stirred over night at 
room temperature. The product PVA-Phe 29 was purified by dialysis and isolated by 
lyophilisation to yield a white solid. 
 
4-66 
 
3.1.7. Alternative route to synthesize PVA decorated with phenylalanine 31 
 
1,6-hexamethylene diisocyanate (2.0 mL, 12.4 mmol) was dissolved in dry toluene (50.0 
mL). Fmoc-Phe (1.0 g, 2.6 mmol) was slowly added after which the mixture was heated to 
100 °C and stirred over night. Then the solution was allowed to cool down and the solvent 
was removed in vacuo. The resulting mixture was triturated several times with cold, dry 
diethyl ether to crystallize the product. The Fmoc-Phe-NCO was then washed with diethyl 
ether on a filter and dried under reduced pressure at 60 °C to yield 30 as a white solid 
(918.0 mg, 1.7 mmol, 66%, 0.1 equivalents diisocyanate). 
 
 
PVA (300.0 mg, 7.3 mmol –OH) was dissolved in dry NMP (15 mL) by heating to 125 °C 
for 1.5 h. This solution was allowed to cool down after which dibutyltin dilaurate (3 drops) 
was added. Then 30 (394.0 mg, 0.7 mmol) in dry NMP (2 mL) was added followed by 
stirring at room temperature for 24 h. Next, piperidine (3 mL) was added and the solution 
was stirred for another 24 h. The resulting mixture was very viscous and placed in acetone 
to precipitate the polymers out. The precipitation was stirred for 24 h after which the 
product was isolated as a white solid by centrifugation. It was not possible to analyze 
polymer 31 as it was crosslinked most likely due to residual diisocyanate. 
 
Test rheology experiments PIC in presence of PVA 
 
The two polymers were dissolved in 50 mM pH 8.4 borate buffer to obtain their respective 
stock solutions of 3.2 mg/mL PIC-N3 P41 and 44.0 mg/mL PVA. The two solutions were 
placed on ice prior to the rheology experiment to enable efficient mixing. 
 
Table 8. Rheological crowding experiment of increasing weight ratio PVA in PIC (P41).  
mg PVA mg PIC w/w PVA:PIC Concentration PIC 
(mg/mL) 
0 0.4 0 0 1.6 
0.24 0.4 0.6 1:1.7 1.6 
0.72 0.4 1.8 1:0.6 1.6 
 
Crosslinking experiments of 19 with flexible linker 
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Table 9. Ratios used in the rheological mixing experiments of PVA-MV and PIC-Phe (P38 1:67; 
P20 1:625) in the presence of CB8. 
Compound PVA:
PIC 
Mol 
ratio 
mg 
PIC 
pmol 
Phe 
mg 
PVA-
MV 
pmol MV pmol 
CB8 
P38 0 0 0.6 44.1 0.0 0 0.0 
P38 1:3 1:3675 0.6 44.1 0.2* 0.01 44.1 
P38 1:3 1:300 0.6 44.1 0.2 1.5 44.1 
P20 0 0 0.6 4.7 0.0 0.0 0.0 
P20 1:3 1:3 0.6 4.7 0.2 1.6 4.7 
P20 1:30 1:340 0.3 2.4 0.01* 7.1x10
-3 2.4 
P20 1:2 1:3 0.3 2.4 0.2* 0.7 2.4 
* 3 % PVA-MV 
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Chapter 5 : Potential therapeutic properties of 
Poly(isocyanopeptides) as synthetic Dendritic Cells 
Abstract 
In this chapter the use of PIC-based potential therapeutic agents was investigated. A new 
class of antibody-functionalized, semi-flexible and filamentous polymer (diameter 5-10 nm, 
length ~200nm) with a controlled persistence length, a high degree of stereoregularity and 
the potential for multiple simultaneous receptor interactions was developed. These highly 
controlled, semi-stiff polymers were decorated with T cell activating anti-CD3 antibodies 
and were analyzed for application as potential synthetic dendritic cells (sDCs). The sDCs 
do not only activate T cells at significantly lower concentrations than free antibodies or 
rigid sphere-like counterparts (PLGA particles) but also induce a more robust T-cell 
response. These novel sDCs are further biocompatible and non-toxic. The observed 
increased efficacy highlights the importance of architectural flexibility and multivalency to 
modulate T cell response and cellular function in general. 
 
Introduction 
The innate immune system is the body’s first line of defense against invaders like 
pathogens and cancerous cells. Among the various cell types of the innate immune system, 
dendritic cells (DCs), also known as “professional” antigen-presenting cells (APCs) are of 
prime importance[1]. The knowledge about dendritic cells (DCs) has increased 
tremendously in the last 30 years[2] and their applicability for cancer immunotherapy has 
been investigated. Ex-vivo generated DCs, when loaded with tumor lysates, tumor antigen-
derived peptides or whole tumor proteins, have demonstrated enhanced anti-cancer immune 
responses[3]. Clinical studies have shown the potential of DCs as an autologous vaccine for 
cancer therapy[4-5]. In spite of their potency, the application of ex-vivo DCs is so far 
limited by their availability. Growth of ex-vivo DCs is both labor and resource intensive. 
The requirement to generate a tailor made vaccine for every patient[6-7] means that ex-vivo 
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DCs are not economically sustainable. The aforementioned inefficiencies in production of 
ex-vivo DCs have inspired investigators to design artificial antigen-presenting cells (aAPC) 
as alternatives. 
Extensive studies on DC/T cell interactions in vitro have shown that the activation of T 
cells proceeds via a pre-clustering of MHC-peptide complexes. The formed micro-domains 
subsequently cluster into the so-called ‘immune synapse’ (IS)[8-9]. Similar to many 
extracellular biological recognition processes, T cell activation consequently requires the 
simultaneous multivalent interaction of a number of receptors to initiate clustering. 
Molecular constructs that are able to mimic this simultaneous multivalent binding have a 
higher efficacy by increasing the avidity[10]. Further, activation does not only involve one 
type of receptor but instead multiple receptors that interact with different activation-
inducing molecules (i.e. MHC/peptides, co-stimulatory adhesion molecules, etc.). 
The first generation of aAPCs, microbead-based DCs, have shown a marked advantage 
in expanding specific T cells under laboratory conditions compared to free MHC peptide 
complexes. Their efficacy for long-term T cell expansion has been limited, however[11]. 
Unlike aAPCs, natural APCs have the ability to conform to the cell surface topography and 
allow the dynamic movement of receptor-ligand complexes to form the IS site that 
ultimately causes T cell activation. Most likely the rigid sphere morphology of these first 
generation aAPCs hinders the efficient formation of multivalent interactions with the T 
cells[12-13]. The aAPCs lack the plasma membrane fluidity of natural DCs that allows for 
the dynamic movement of these complexes to the IS site[14]. Soft spherical aAPCs such as 
liposomes[15], have overcome the membrane fluidity constraint enhancing activation of T 
T cell
Spherical
synthetic DC 
FilomicelleDendritic cell
Soluble
antibody 
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cells over and above that observed for the rigid sphere models, suggesting that the IS can 
form more efficiently if a dynamic movement of both binding partners can take place 
(Figure 1). 
 
Figure 1. Schematic diagram illustrating different systems available for T cell activation. 
Besides an efficient formation of the IS, also the number of receptor-ligand interactions 
involved in IS formation is thought to play an important role in T cell activation. The 
number of interactions is dictated by the size and the morphology of the particle. In general, 
for rigid spherical particles the number of ligands available to participate in the required 
simultaneous interaction is limited by its topology [15-17]. Second generation 
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immunotherapeutic delivery vehicles have, therefore, explored extended aspect ratio 
topologies such as filamentous or rod-like particles. These extended aspect ratio structures 
have utilized either copolymer filomicelles[18] or decorated carbon nanotubes (CNTs)[19]. 
Filomicelles have demonstrated a higher anti-tumor activity compared to their spherical 
counterparts[19-20]. This marked increase in efficacy is most likely a result of the larger 
surface-to-volume ratio that allows a more effective loading. If the micelle area is held 
constant for a given mass of copolymer, their effective loading is increased by 50% 
compared to the corresponding sphere[18]. Besides the increased effective loading that may 
aid in enhancing multivalent binding, filamentous or rod-like particles also show longer 
circulation times that might play an additional advantageous role in T cell activation[18].  
The design criteria for an ideal synthetic dendritic cell (sDC) should incorporate the 
described knowledge gained from aAPCs and commonly used therapeutic delivery 
vehicles. It should combine the above characteristics of high aspect ratio, flexible 
architecture and multiple interactions to achieve highly efficient T cell activation. The sDCs 
should further possess an extended half-life and a low systemic toxicity[21-23]. 
Here, we propose a fundamentally new design of sDCs that have the potential to fulfill 
all of the above criteria. Our strategy to building these novel delivery vehicles is based on a 
new class of rod-like, semi-stiff and water-soluble polymers derived from oligoethylene 
glycol substituted poly(isocyanopeptides). Poly(isocyanopeptides) consist of a helical 
polyisocyanide backbone carrying peptide functionalized side chains attached to every 
carbon that stabilize the helix through hydrogen bonding[24-26]. These polymers can be up 
to 2 µm long and exhibit a well-defined stereoregularity[27] as well as a controlled stiffness 
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that can be tuned between persistence lengths (lp) of 5 nm to 200 nm. Since in principle 
every individual monomer can be substituted with a functional unit, a versatile synthon for 
the design of multivalent filamentous sDCs is easily obtained (Figure 2). Our hypothesis is 
that such a semi-stiff poly(isocyanopeptide) decorated with effector molecules rapidly 
docks on T cells (Figure 2a/b). Subsequently, in contrast to a spherical bead or a random-
coil polymer, the semi-stiffness of the poly(isocyanopeptide) will allow it to bind to 
neighboring receptors on the same cell (Figure 2c). Further, these receptor sites will be able 
to cluster with a concomitant contraction of the polymer backbone to form the IS while 
retaining the activated state (Figure 2d). To test our design strategy, we functionalized these 
sDCs with anti-CD3 antibodies (αCD3-sDC) that are known to cause T cell activation and 
compared their efficacy with free αCD3 antibodies. 
 
Figure 2. Stages of sDC binding and T cell activation. (a) the mobility of the sDC helps to locate 
the T cell, (b) sDC docks onto the T cell, (c) attachment to multiple recognition sites, (d) sDC 
contracting/clustering at the recognition sites, IS formation. 
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Results and Discussion 
1.1. Synthesis and Characterization of the αCD3-sDCs 
 
Scheme 1. Synthetic scheme to obtain Streptavidin (SAv) functionalized poly(isocyanopeptides). 
(a) random co-polymerization of the azide (1) and the methoxy (2) monomers to obtain the 
azide-functionalized polymer (3), i) Ni(Cl2O4)2 • 6 H2O, toluene, (b) coupling of BCN-NHS (4) to 
SAv, ii) 4 days at 4 ˚C in 10 mM borate buffer pH 8.5, (c) synthesis of the SAv-polymer 
bioconjugate (6), iii) 4 days at 4 °C in 10 mM borate buffer pH 8.5. 
Synthetic dendritic cells (sDCs) carrying T cell stimulating αCD3 antibodies have 
been synthesized from semi-stiff poly(isocyanopeptides). To obtain these sDCs, an azide 
containing poly(isocyanopeptide) was synthesized in the first step. This was achieved by 
copolymerizing a mixture of an azide-functionalized monomer and a methoxy-
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functionalized monomer using a 1:100 molar ratio resulting in a random copolymer 
(Scheme 1). The obtained polymers have a degree of polymerization DP = 1633 and a 
length between 150 nm and 200 nm (Table 1 experimental). The average spacing between 
azide groups is 10 nm. These azide groups were subsequently used to couple BCN-
functionalized streptavidin (SAv) to the polymer backbone using a strain-promoted azide 
alkyne click (SPAAC) reaction[28]. 
The obtained SAv-functionalized polymer contains on average one SAv molecule 
every 50 nm (Figure 3), as determined with AFM. sDCs were obtained by adding 
biotinylated αCD3 antibodies yielding αCD3-sDC. When preparing the αCD3-sDC, the 
ratio of αCD3 to SAv on the polymer was adjusted such that on average every SAv was 
bound to one αCD3 antibody (Figure 14). Consequently, an average polymer contains 
between 3 and 5 αCD3 antibodies. 
 
 
Figure 3. AFM analysis of polymer 6. (a) representative AFM image clearly showing the SAv 
molecules (bright dots) attached to the polymer, (b) number of SAv molecules per polymer. 
1.2. Cell viability measurements 
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Before testing the efficacy of these novel sDCs on peripheral blood lymphocytes 
(PBLs), cell viability studies were carried out to study their biocompatibility. PBLs exposed 
to αCD3-sDC or free αCD3 at different concentrations exhibited no significant decrease in 
cell viability (MTT assay; Figure 4a). At higher αCD3 concentrations even an increase in 
the number of cells was observed, which could be explained by induction of T cell 
proliferation by the αCD3 antibodies (vide infra). Even after prolonged incubation times, 
cell viability remained constant between 90 – 100 % even up to 72 hours (Trypan Blue 
assay; Figure 4b). 
 
Figure 4. Viability of PBL cells exposed to αCD3-sDC. (a) MTT assay showing cell viability as a 
function of αCD3 concentration (incubation time 24 h), (b) Trypan Blue assay showing cell 
viability as a function of incubation time (αCD3 concentration of 200 ng/mL for both αCD3-sDC 
and free αCD3). The results represent the mean ± s.e.m. (n = 3). 
1.3. T cell activation 
In subsequent experiments, the capacity of αCD3-sDC to activate T cells was 
determined, in comparison to free αCD3. After clustering of CD3 on the T cells, 
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intracellular signaling results in direct activation as demonstrated by expression of the early 
T cell activation marker CD69[29]. Activated T cells further show enhanced secretion of 
IFNγ as a late activation event[30] and eventual T cell proliferation is observed[31]. At 
saturating conditions (> 50 ng/mL) CD69 expression was maximum, for both the αCD3-
sDC and the free αCD3 treatment (Figure 5a). At low concentrations (1 - 20 ng/mL), 
however, the αCD3-sDCs were ~2.5 fold more effective in inducing T cell activation when 
compared to free αCD3 treatment. Similarly, the αCD3-sDC activated T cells released 2-3 
fold higher amounts of IFNγ (Figure 5b). This indicates a more robust T cell activation in 
comparison to T cells exposed to free αCD3. 
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Figure 5. T cell activation upon treatment at different concentrations. (a) percentage of T cells 
showing CD69 expression and (b) IFNγ release at different αCD3 concentrations (incubation 
time 24 h), (c) percentage of T cells showing CD69 expression after different incubation times 
(αCD3 concentration 5 ng/mL), (d) T-cell proliferation measured with an CFSE assay (αCD3 
concentrations 50 ng/mL). In (a) the values were normalized against the untreated control and 
represent the mean ± s.e.m. (n = 4). The asterisks (*) indicate the statistical significance (*, **, 
*** p≤ 0.05, 0.01, 0.001) of αCD3-sDC compared to αCD3. 
To substantiate the above findings, T cell activation was followed over time at a low 
effective treatment concentration (5 ng/mL αCD3 for both αCD3-sDC and free αCD3). The 
5-11 
 
αCD3-sDC treated T cells were activated at significantly earlier time points (Figure 5c). 
Over prolonged exposure, T cell activation increased up to ~35%. In comparison, T cell 
activation following treatment with free αCD3 shows a delay in T cell activation (10 hours 
vs. 7 hours for αCD3-sDC) and a lower percentage of activated T cells (only ~10-15%). 
Finally, the ability of αCD3-sDC to induce T cell proliferation was tested (50 ng/mL αCD3 
for both αCD3-sDC and free αCD3). In line with the above results, a 2-3 fold higher 
number of proliferated T cells was detected when the T cells were treated with αCD3-sDC 
(Figure 5d). Treatment with αCD3-sDC leads to a constant increase in the proliferation rate 
until 72 h of treatment. The observed decrease in the number of T cells at 96 h is likely 
resulting from nutrient depletion in the growth medium at high cell concentration. 
To investigate the importance of the structural architecture of our novel sDCs, 
their efficacy was compared to that of spherical αCD3-PLGA particles (1.8 µm diameter, 
see experimental section 2.1-2.3). The worm-like αCD3-sDCs were ~7 fold more efficient 
in stimulating T cell activation (CD69 expression) when compared to αCD3-PLGA spheres, 
even at concentrations as low as 1 ng/mL (Figure 6a). Also the production of IFNγ was ~3 
fold higher when compared to αCD3-PLGA spheres (Figure 6b). Together these 
observations indicate that our αCD3-sDCs do not only activate T cells significantly better at 
lower concentrations. They also induce the highest IFNγ production when compared with 
solid particle based DCs. 
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Figure 6. Comparison of αCD3-sDC with spherical αCD3-PLGA. (a) percentage of T cells showing 
CD69 expression and (b) IFNγ release at different αCD3 concentrations (incubation time 24 h); 
The results represent the mean ± s.e.m. (n = 3). The asterisks (*, **, *** p= < 0.05, 0.01, 0.001) 
indicate the statistical significance of αCD3-sDC compared to αCD3. 
This difference cannot be explained with the number of receptor-ligand interactions 
established between the αCD3-sDCs (max. 3-5 interactions) or the αCD3-PLGA spheres 
(approximately 150 interactions; see Materials and Methods). The comparison of αCD3-
sDC with the hard-sphere PLGA particles clearly suggests that it is not only the density of 
αCD3 but more importantly the ability to flexibly adjust to the spacing of receptors and to 
dynamically form the immune synapse that leads to the superior activity of our sDCs. In 
other words, multiple static interactions are not sufficient. We postulate that a more 
dynamic anisotropic interaction between the binding partners is required to induce and 
enhance T cell activation[32-33]. Unlike the static shape of the hard sphere model, the 
controlled stiffness of the αCD3-sDC filament has the capacity to ‘concertina’ in response 
to the receptor clustering events associated with the formation of the immune synapse. 
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1.4. Localization of αCD3-sDC on the cell surface 
To investigate the molecular process in more detail and to understand how the sDCs 
interact with T cells, binding studies were performed with fluorescently labeled αCD3-
sDCs. The PBLs were incubated with different concentrations of either fluorescein labeled 
αCD3-sDCs (FαCD3-sDC) or with free αCD3 (FαCD3) for 24 hours. Subsequently, the 
number of fluorescent cells was determined using a laser scanning confocal microscope 
(Figure 7).  
 
Figure 7. Overview images illustrating co-localization (yellow) of (a) Fluorescein-labelled 
FαCD3-sDCs and (b) FαCD3 on the PBL membrane (stained with the membrane specific dye 
PKH26, red) 
At high concentrations (50 and 100 ng/mL) the relative number of T cells that show 
binding of FαCD3-sDC on their surface was comparable to the percentage of cells that have 
bound free FαCD3. In the low concentration range (≤ 20 ng/mL), however, a higher 
fraction of PBLs carrying FαCD3-sDC was observed when compared to the cells treated 
with free FαCD3. This result clearly explains the higher efficacy of the αCD3-sDCs in the 
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low concentration range (Figure 8a). Besides more efficient binding, 3D images taken after 
24 hours further reveal that FαCD3-sDC remained co-localized on the membrane indicating 
that no receptor internalization has been taking place (Figure 8b). 
 
Figure 8. αCD3-sDC binding and location on the cell. (a) percentage of PBLs showing bound 
FαCD3 or FαCD3-sDC after 24 hours of treatment. The result shows the mean ± s.e.m. (n = 3). 
The significance of αCD3-sDC compared to αCD3 is indicated by the asterisks (*** p≤ 0.001). b) 
Orthographic projection of one PBL illustrating αCD3-sDC clustering/binding (yellow; co-
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localization of red and green fluorescence). The fluorescence image is merged with a DIC image. 
The series represent images with varying y-coordinate (x- and z-coordinate constant) over an 
entire cell showing the αCD3-sDC distribution in the optical plane. 
Summarizing the above results, this new class of semi-stiff and filamentous 
polymers serves as an ideal scaffold for functionalization with antibodies to allow for 
multiple, simultaneous receptor interactions. These novel sDCs do not only activate T cells 
at significantly lower concentrations than free antibodies and their rigid sphere-like PLGA 
counterparts but also induce a faster T cell response. Docking of the first antibody to the T 
cell increases the effective molarity of αCD3 at the cell surface thereby increasing the 
probability for the remaining antibodies to bind (Figure 2b). It is known that T cell 
stimulation by αCD3 in solution causes internalization of the CD3 and prevents a further T 
cell response[34]. The experiments with fluorescently labeled αCD3-sDC have indicated 
that αCD3-sDC remains bound on the T cell surface even for 24 h after treatment. The 
semi-stiff, filamentous morphology of the αCD3-sDCs consequently does not only lead to a 
significantly higher and earlier (CD69 expression) but also to a more sustained T cell 
response compared to the free antibody and the spherical geometry. This result is supported 
by the expression of the late stage activation marker INF and the associated higher T cell 
proliferation rates. 
Despite their clearly proven potential, a number of open questions remain. 
Compared to the structural perfection of biomacromolecules, our sDCs show a relatively 
high polydispersity. Further, the loading with effector molecules is rather low compared to 
hard spheres. Still, a plurality of valences per molecule is clearly present and exhibits a 
dramatic effect at extremely low concentrations of αCD3-sDC in inducing T cell activation. 
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Experiments are currently underway to investigate the role of the polymer length, the 
polymer stiffness and the effector molecule loading on T cell activation. 
Conclusions 
In this chapter we demonstrate that multivalency in combination with a controlled 
semi-stiffness are key parameters for designing potentially therapeutically active vehicles 
that closely mimic natural DCs. Using the novel sDC design, a more efficient as well as 
more sustained T cell response is observed. This enhanced activity clearly validates the 
final stage of the proposed binding mechanism (Figure 2d) that requires the sDC to react to 
the processes occurring on the T cell surface during formation of the immune synapse. 
Having shown the potential of this sDCs, the next steps are a more detailed investigation of 
the activation mechanism allowing for increasing their efficacy even further. Instead of 
αCD3, MHC-peptide complexes will be coupled to the polymer backbone and co-
stimulatory molecules, necessary for efficient T cell activation, as well as cytokines will be 
added to further shape the T cell response. Ultimately, after characterization of their in vivo 
behavior, our sDCs have the potential to become highly efficient and cost-effective sDCs 
for cancer immunotherapy. 
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1. Materials and Methods 
1.1. Materials 
Unless otherwise stated, all chemicals were obtained from Sigma Aldrich  and used without 
further purification. Toluene was distilled over sodium. Dichloromethane was distilled over 
phosphorous pentoxide. Column chromatography was performed using silica gel (0.060 - 
0.200 mm) provided by Baker. Thin layer chromatography (TLC) analyses were carried out 
on silica 60 F254 coated glass obtained from Merck Millipore. The compounds were 
visualized using ninhydrin or basic aqueous KMnO4 solutions. All glassware was soaked in 
0.5 M NaOH for 3 hours before use. 
 
Peripheral Blood Lymphocytes (PBLs) were isolated from the buffy-coat obtained from a 
healthy volunteer via Ficoll density gradient centrifugation (Lucron Bioproducts). The 
PBLs and OKT3 hybridoma were always maintained in RPMI-1640 medium (Life 
Technologies) containing 10% Fetal Bovine Serum (FBS) (Greiner Bio-One B.V.), 1% 
glutamine (Lonza) and 1x Antibiotic-Antimycotic (Life Technologies). For the αCD3 
production, OKT3 hybridoma cells (at confluence) were transferred into Protein Free 
Hybridoma Medium (PFHM-II, Life Technologies). These cells were cultured for 3-4 days 
in PFHM-II before purifying the αCD3 monoclonal antibodies using HiTrap™ Protein G 
HP Columns (GE healthcare). 
 
1.2. Polymer synthesis 
 
Azide monomers (compound M1; Scheme 1a) and methoxy monomers (compound M4; 
Scheme 1a) were synthesized as described previously [35]. 1H NMR and 13C NMR spectra 
were recorded on a Bruker AC-300 MHz instrument operating at 300 MHz and 75 MHz, 
respectively. FT-infrared spectra of the compounds were recorded using a Thermo Nicolet 
IR300 FT-IR spectrometer (Thermo Fisher Scientific) equipped with a Harrick ATR unit. 
UV measurements were done using a Varian Cary 50 spectrometer (Agilent Technologies). 
For mass spectrometry a LCQ Advantage MAX instrument (Thermo Fisher Scientific) was 
used. 
 
Compound M1 (3.1 mg, 8.3  10-3 mmol) and compound M4 (300 mg, 8.3  10-1 mmol) 
were dissolved in 30 mL of distilled toluene yielding a ratio of azide-functionalized 
monomers to methoxy-functionalized monomers of 1:100. The catalyst stock solution was 
prepared separately by dissolving Ni(Cl2O4)2 • 6 H2O (30.7 mg, 8.4  10
-2 mmol) in 10 mL 
of absolute ethanol and 90 mL of toluene. From the catalyst stock solution 83 µL (8.3  10-5 
mmol) was added to the reaction mixture. The mixture was stirred for 3 days at room 
temperature (RT) and followed by IR until all isocyanide was consumed. The polymer 
(compound 3) was isolated via precipitation into diisopropylether. This precipitation cycle 
was repeated thrice to obtain 299.6 mg, 78 % yield. 
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1.3. Viscosity measurements 
 
To obtain the intrinsic viscosity of polymer 3, an Ubbelohde viscometer (Schott 
Instruments) was used. A stock solution (4 mg/mL) of polymer 3 was prepared in 
acetonitrile. From this stock solution, 4 mL of the following concentrations were prepared: 
0.6; 0.5; 0.4; 0.3; 0.2 and 0.1 mg/mL. The solutions were loaded into a viscometry tube (nr. 
1053431; Schott Instruments). The tube was placed into the water bath (25 ˚C) and allowed 
to equilibrate for 15 min before the measurement was started. The flow speed for each 
sample was measured four times and used to determine the kinematic viscosity . From this 
data, the reduced viscosity red and the inherent viscosity inh were calculated[36] and 
plotted against the polymer concentration. The intrinsic viscosity [] represents the limiting 
value of red or inh at infinite dilution of the polymer, i.e.              . From 
extrapolation of red to c = 0, [] = 9.64 dL  g
-1 was obtained (Figure 9). Based on [], a 
molecular weight of 421 kg/mol was determined using the Mark-Houwink equation 
        
 . The constants K = 1.4  10-9 dL  mola  g-(1+a) and a = 1.75 for a rigid 
polyisocyanide have been reported previously[37]. The average polymer length was 
calculated to be 123 nm (Table 1). 
 
 
Figure 9. Ostwald viscosity measurement. The intrinsic viscosity was determined 
experimentally from both the reduced viscosity and the inherent viscosity for different 
concentrations of the polymer in acetonitrile. The value for the intrinsic viscosity was obtained 
from extrapolation to c = 0 g/dL. The molecular weight       was calculated to be 421 kg/mol 
using the Mark-Houwink equation (with K=1.4x10-9 dL mola g-(1+a) and a=1.75). 
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Table 1. Summary of molecular weight and polymer length 
 molecular weight Mw 
(kg/mol) 
apparent polymer length l 
(nm) 
       viscosity 421 123
a 
Mw SEC 588 172
a 
AFM 677b 197 
aThe apparent polymer length l was calculated from the measured molecular weight: 
     
 
 
 
 
         
        
bThe molecular weight Mw was calculated from the experimentally determined polymer 
length:                 
 
       
 
 
 
1.4. Size exclusion chromatography 
Polymer 3 was further analyzed by size exclusion chromatography (SEC) to determine its 
hydrodynamic radius. The SEC system was equipped with a Waters 1515 Isocratic HPLC 
pump, a Waters 2414 refractive index detector, a Waters 2707 autosampler, a PSS PFG 
guard column followed by 2 PFG-linear-XL (7 µm, 8*300 mm) columns in series. The 
system was run at 40 °C. Hexafluoroisopropanol (HFIP, Biosolve) with potassium trifluoro 
acetate (3 g/L) was used as eluent at a flow rate of 0.8 mL/min. The molecular weights 
were calculated against poly(methyl methacrylate) standards (Mp = 580 g/mol up to 
Mp = 7100  kg/mol; Agilent). The measurement yielded a molecular weight of 588 kg/mol 
and the average polymer length was calculated to be 172 nm (Figure 10 and Table 1). 
 
  
Figure 10. Size exclusion chromatography. a) Compound 3 eluted at 18.5 min. b) This 
corresponds to a weight average molecular weight Mw of 588 kg/mol (PMMA standards) and a 
Đ of 2.6. 
 
 
 
5-20 
 
 
1.5. AFM measurements 
The polymer sample was diluted in 1 mM sodium acetate buffer pH 4.5 to obtain a 
concentration between 0.5 µg/mL and 5 µg/mL. The samples were drop casted onto freshly 
cleaved and polylysine coated mica and incubated for 10 minutes. The remaining liquid 
was then removed and the sample was dried in a stream of N2. AFM images were recorded 
in tapping mode in air using a Nanoscope IV instrument (Bruker) and NSG-10 tapping 
mode tips (NT-MDT, Limerick). The polymer length was determined by hand using the 
program ImageJ[38] (Figure 11 and Table 1). 
 
 
Figure 11. Measurement of the polymer length with AFM. The mean value obtained from n = 
198 polymers is 197 nm. 
 
1.6. Functionalization of Streptavidin with BCN-NHS 
Streptavidin (SAv) was obtained from Thermo Fisher Scientific  and bicyclo[6.1.0]nonyne -
POE3-NH-C(O)CH2CH2CH2C(O)OSu (BCN-NHS; compound 4) was obtained from 
Synaffix. SAv (34.5 mg, 5.2  10-4 mmol) was dissolved in 7 mL borate buffer (10 mM, pH 
8.5). BCN-NHS (1.7 mg, 3.1  10-3 mmol) was added to the SAv solution to yield BCN-
NHS:SAv = 5:1. The mixture was kept at 4 ˚C for four days. BCN-functionalized SAv 
(compound 5) was purified by gel filtration (PD 10 column, GE Healthcare). The eluent 
was further purified by ultrafiltration (Amicon Ultra-4, 10 kDA; Merck Millipore). The 
final yield of 5 was determined by measuring absorption at 280 nm. Using an extinction 
coefficient of Ɛ = 167280 mol-1 cm-1, the final yield was determined to be 26.1 mg, 76 %. 
The conjugate was further characterized using MALDI-ToF to obtain the labeling ratio. 
MALDI-ToF was performed using a Bruker Biflex III MALDI-ToF spectrometer. SAv and 
SAv-BCN samples were prepared using α-cyano-4-hydroxycinnamic acid as the matrix. 
The mass obtained for SAv (monomer) was determined to be 13280 Da [M+ H+]. This 
served as a reference for 5. Compound 5 shows both the peak of the non-functionalized 
monomer 13280 Da [M + H+] as well as the mass of 5 carrying one BCN-group coupled to 
the SAv monomer: 13783 Da [M + 2K+] (Figure 12). No peak corresponding to a doubly 
labeled monomer was visible. Consequently, the degree of functionalization is between 0 
and 4 BCN-groups for the SAv tetramer. 
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Figure 12. MALDI-ToF analysis. a) SAv before addition of BCN-NHS; b) BCN-functionalized SAv. 
 
1.7. Synthesis and characterization of the SAv-polymer bioconjugate (6) 
Polymer 3 in 10 mL 10 mM borate buffer (10 mg, 2.7 x 10-5 mmol) was mixed with SAv-
BCN (26 mg, 3.9 x 10-7 mmol) in 4 mL 10 mM borate buffer. The mixture was incubated at 
4 ˚C for four days. Polymer 6 was purified by dialysis against water at 4 °C for 2 days with 
a membrane with cut-off of 100 kDa. 
 
To ensure that the bioconjugation does not affect the structure of the poly(isocyanopeptide) 
polymer, circular dichroism spectra were recorded for both polymer 3 and polymer 6. The 
measurements were performed at 20 °C at a concentration of 1 mg/mL in 50 mM borate 
buffer pH 8.5 using a Jasco J-810 CD spectrometer. Both polymers showed identical 
spectra (Figure 13) clearly indicating that the coupling of SAv does not influence the 
secondary structure of the SAv-polymer conjugate. The SAv loading of 6 was determined 
with AFM using the same procedure as for polymer 3. 
 
 
Figure 13. Circular dichroism spectra. a) polymer 3; b) SAv-polymer conjugate 6. Both 
measurements were done at a concentration of 1 mg/mL in 10 mM borate buffer pH 8.5 at 20 
°C. 
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1.8. Synthesis and characterization of αCD3-sDCs 
To obtain the aCD3-sDCs, the aCD3 antibodies were first biotinylated with EZ-Link Sulfo-
NHS-LB-Biotin (Thermo Fisher Scientific) to allow for binding to SAv on polymer 6. 
Before preparing the aCD3-sDCs, the molecular ratio of aCD3:SAv was optimized using a 
biotinylated AlexaFluor488-labelled aCD3 antibody. Using the fluorescently labeled 
antibody, it was possible to determine the aCD3 concentration while measuring the total 
protein concentration in the same sample. 
 
First the SAv concentration on polymer 6 was determined using a BCA micro assay 
(Thermo Fisher Scientific). Then polymer 6 was mixed with the AlexaFluor488-labeled and 
biotinylated αCD3 antibody using 4:1, 6:1 and 8:1 molar ratios of αCD3:SAv. The mixture 
was left at 4 °C for 24 h. After removing the free αCD3 by ultrafiltration (Nanosep Omega, 
cut-off of 300 kDa, PALL Life Sciences) the total protein concentration was again 
determined using the BCA assay. In addition, the fluorescence originating from the 
AlexaFluor488-labeled antibody was determined from a fluorescence measurement in a 
microplate reader (Cytofluor II, PerSeptive Biosystems). The aCD3 concentration was 
calculated using a standard curve of AlexaFluor488-labeled aCD3. Subtracting the 
Alexa488-αCD3 concentration from the total protein concentration allowed for calculating 
the SAv concentration as well as the αCD3:SAv ratio. For a 4:1 ratio of αCD3:SAv 
approximately one αCD antibody was bound per SAv molecule (Figure 14). 
 
 
Figure 14. Loading of polymer 6 with αCD3 antibodies. Different ratios of biotinylated, Atto488-
labeled αCD3 were added to polymer 6 (αCD3:SAv ratio = 4:1, 6:1 and 8:1). For a ratio of 4:1, an 
average number of 0.93 αCD3 molecules were obtained per SAv molecule. For 6:1 and 8:1, a 
final ratio of 2.69 and 3.37 αCD molecules were bound per SAv molecule, respectively. A ratio of 
4:1 was used for the T cell experiments. 
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To prepare the sDCs for the T cell experiments, a 4:1 ratio was used following exactly the 
same protocol as used in the preliminary experiment. Assuming that the ratio of bound 
αCD3:SAv will be identical, the concentration of αCD3 could now be determined from the 
total protein concentration without the need for fluorescently labeling the αCD3 antibody. 
For the T cell experiments, all the treatment concentrations were based on the concentration 
of αCD3 present on the sDC backbone, on the micro-bead system or as free αCD3. 
 
1.9. MTT assay 
The cytotoxic effect of the αCD3-sDCs was determined using a standard MTT assay[39]. 
PBLs (105 cells/well) were treated with αCD3-sDC, αCD3 or left untreated (control) for 24 
h using different concentrations (5, 50, 500 ng/mL) of the respective molecules. After 
washing twice, the cells were incubated with MTT (5 mg/mL; Sigma Aldrich) for 2 h. The 
medium was then replaced with 100 µl of DMSO. After solubilization, the microplates 
were read at 550 nm using a microplate reader (iMark, Bio-Rad). The results were derived 
from three independent experiments (with three replicates per experiment). 
 
1.10. Trypan Blue assay 
In addition, the cell viability was estimated over time. Viable and non-viable cells were 
counted after αCD3-sDC treatment using the hemacytometer method by means of a Trypan 
Blue assay[40]. The percentage of viable cells was determined upon exposure to αCD3-
sDC, αCD3, and untreated (control) in a concentration of 200 ng/mL and incubation times 
of 0, 24 and 72 h. The percentage was calculated according to the formula: 100 × (number 
of viable cells in treated samples/total number of cell counted). The results were obtained 
from three independent experiments (with three replicates per experiment). 
 
1.11. Flow cytometry (CD69 expression) 
The estimation of activated T cells (CD69+ T cells) upon αCD3-sDC treatment was 
determined using Fluorescence Activated Cell Scanning (FACS). FACS analysis was 
performed for cells treated with αCD3-sDC and for the following controls: αCD3, αCD3-
PLGA (Figure 16), polymer 3, mIgG2a-sDC and untreated. Briefly, PBLs (105/well) were 
treated with the respective molecules for 24 h at different concentrations (0.005, 0.01, 1, 5, 
10, 50, 100 ng/mL). In addition to these concentration dependent experiments also time 
dependent T cell activation studies were performed. The T cells were treated with αCD3-
sDC and αCD3 using a concentration of 5 ng/mL and incubation times of 2, 4, 6, 8, 10, 24, 
28 and 30 h. The treated cells were washed with PBS containing 10% BSA (PBA; Sigma 
Aldrich). Subsequently, the cells were incubated with fluorescein-labeled mouse anti-
human CD69 mAb (activated T cell marker, BD Biosciences) and APC-labeled mouse anti-
human CD4/8 mAb (T cell marker, BD Biosciences). After washing twice with PBA, 
FACS analysis was performed using a CyAn™ ADP Analyzer instrument (Beckman 
Coulter). The results were analyzed using Flow-Jo ver. 9.2 software (Tree Star Inc.). The 
above experiment was repeated four independent times (with three replicates per 
experiment). 
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1.12. Enzyme-linked immunosorbent assay (ELISA; IFNg secretion) 
The level of secreted IFNγ was determined in the culture supernatants using a standard 
sandwich ELISA method. After coating overnight at 4°C with mouse anti-human IFNγ 
antibody (Thermo Fisher Scientific), the 96-well microplates (Nunc Immunomodules; 
Thermo Fisher Scientific) were washed with PBS/Tween (0.05%) and blocked with PBS-
1% BSA. Subsequently, the IFNγ standards (Thermo Fisher Scientific) and the supernatants 
were added into the wells and incubated for 1 hour at room temperature. Following washing 
with PBA for three times, the presence of IFNγ was detected using a biotinylated mouse 
anti-human IFNγ antibody (Thermo Fisher Scientific) and a streptavidin-horseradish 
peroxidase (HRP) conjugate (Life Technologies). HRP activity was detected using 
tetramethyl benzidine (TMB; Sigma Aldrich). The absorption was measured at 450 nm 
using an iMark Microplate Reader (Bio-Rad). The experiments were conducted for four 
independent times. 
 
1.13. CFSE assay 
T cell proliferation induced by αCD3-sDC was assessed using a CFSE assay[41]. PBLs 
(105) were pre-labeled with 5 µM CFSE (Life Technologies). Free CFSE was quenched 
with FBS. αCD3-sDC and αCD3 was added to the CFSE-labeled PBLs (105/well) at a 
concentration of 5 ng/mL. Treated cells were incubated overnight along with untreated 
control cells. After incubation times of 0, 24, 48, 72 and 96 h, the treated cells were used 
for FACS analysis. T cells were identified based on labeling with a mouse APC-labeled 
anti-human CD4/8 antibody. T cell proliferation was assessed from determining the CFSE 
staining intensity. The results were interpreted by considering the % decrease in 
fluorescence intensity as a corresponding % increase in T cell proliferation. The % 
difference in T cell proliferation (%∆PF) was determined by normalizing the treated value 
against the untreated (control) value. Cyton software was utilized to analyze the number of 
cells proliferated per generation[42] (Figure 15). The results were derived from four 
independent experiments (with three replicates per experiment). 
 
Figure 15. T cell proliferation determined with a CFSE assay. Shown is the increase in the 
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number of T cells per generation after treatment with αCD3-sDC and soluble αCD3, respectively. 
In the case of the αCD3-sDC treatment, the cell proliferation rate increases to a maximum in the 
first generation. This proliferation rate was maintained over the following generations (for the 
complete time period analyzed). When treating the T cells with soluble αCD3, the cell number 
only gradually increases per generation. 
 
1.14. Confocal imaging 
The binding of αCD3-sDC on the T cell surface was analyzed by confocal imaging using 
sDCs carrying a fluorescein-labeled αCD3 antibody (FαCD3-sDC). PBLs (105/well) were 
treated for 24 h with FαCD3-sDC and FαCD3 (F-Fluorescein, λex = 488 nm, λem = 520 nm) 
at different concentrations (5, 10, 20, 30, 50, 200 ng/mL). Further, these cells were labeled 
with the membrane dye PKH26 (λex = 551 nm, λem = 567 nm; Sigma Aldrich) following the 
manufacturer’s protocol. These labeled PBLs were fixed in 4% paraformaldehyde. The 
fixed cells were quenched with glycine (0.1 mM) in PBS. The cover slips were mounted 
onto microscope slides (Thermo Fisher Scientific) using MOWIOL (Merck Millipore). The 
slides were imaged using a Confocal Laser Scanning Microscope (Olympus FV1000) 
equipped with a 63x oil immersion objective. The cells that show bound FαCD3-sDC were 
counted manually and compared to the number of FαCD3-sDC-free cells (Figure 16) using 
the program ImageJ[38]. All the experiments were repeated three independent times using 
PBLs from three different healthy donors. 
 
1.15. Statistical analysis 
Two-way ANOVA and Bonferroni post-tests were performed for a pair wise comparison 
between the variables using Graphpad Prism 5 software. The statistical significance is 
defined as p < 0.05. The asterisk ‘*’, ‘**’, ‘***’ represents p values <0.05, <0.01 and 
<0.001. 
 
2. Comparison of aCD3-sDC efficacy with aCD3-PLGA particles 
 
2.1. Synthesis of αCD3-PLGA particles 
A particle based DC system was prepared using PLGA particles as described 
previously[43] with the following modifications. To attach the αCD3 antibody to PLGA via 
the SAv-biotin interaction, SAv was covalently coupled to the PLGA particles (PLGA-
SAv). In brief, protected sulfhydryl groups were introduced into SAv using N-Succinimidyl 
S-Acetylthiopropionate (SATP; Thermo Scientific) and deprotected with hydroxylamine 
hydrochloride (Thermo Scientific) using the manufacturer’s protocol. Thereafter, the free 
thiol-groups on the SAv were reacted with the maleimide group of the DSPE-PEG-
maleimide (Mw = 2000 g/mol) that is present on the PLGA surface. After washing with 
PBS, the biotinylated αCD3 antibody was bound to PLGA-SAv to obtain αCD3-PLGA. 
 
2.2. Characterization of αCD3-PLGA particles 
The size and concentration of the SAv-PLGA and αCD3-PLGA were determined using 
Transmission Electron Microscopy (TEM; JEOL TEM 1010) (Figure 16a and 16b) and 
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Differential Interference Contrast (DIC; Figure 16c) using a confocal microscope 
(FluoView FV1000, Olympus). 
To obtain the particle concentration, the particle suspension was imaged using a Bürker 
chamber. The suspension was imaged under semi-dried conditions on the Bürker chamber 
grid to ensure that all particles had settled on the grid surface. The number of particles on 
the square grid was counted using the program Image J[44]. For the αCD3-PLGA particles, 
the concentration was calculated to be 1.24x1017 particles per mL. To estimate the amount 
of αCD3 bound per αCD3-PLGA particle, a biotinylated and AlexaFluor488-labeled αCD3 
antibody was used in the same way as described for the αCD3-sDCs in the main text. This 
experiment yielded an amount of 3795 αCD3 antibodies per PLGA particle. For the T cell 
experiments, where no fluorescently labeled antibody was used, it was assumed that the 
amount of bound αCD3 will be the same for identical experimental conditions. 
 
 
Figure 16. Characterization of αCD3-PLGA particles. a) Particle size obtained from TEM. The 
result represents mean ± s.e.m. (n = 300 particles); b) representative TEM image of αCD3-PLGA; 
c) representative DIC image of αCD3-PLGA. 
 
 
2.3. Estimation of the contact area and the number of possible interactions 
Based on the above measurements also the number of αCD3 antibodies on a PLGA particle 
as well as their surface density can be calculated. The number of αCD3 molecules per 
αCD3-PLGA particle was estimated to be on average 3795, corresponding to 0.3287 αCD3 
antibodies per nm2. This in turn allows us to obtain the number of possible interactions with 
the cell surface. Before this number can be calculated, the contact area of the PLGA particle 
with the cell has to be determined first. 
 
The calculation of the contact area is based on Hertz theory[45]: 
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Figure 17. Geometry of the particle membrane interaction; with R - particle radius, d - 
indentation depth, a - radius of the contact area. 
 
The contact area A is described by                  
  
  
  (Eq 1) 
with 

a2  R . 
To obtain the contact area, first the force F that the particle exerts on the cell surface and 
the corresponding indentation depth d are calculated: 
The indentation depth d and the Force F are related by the following equations: 
  
 
 
   
 
  
 
  (Eq 2) 
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with the combined elastic modulus 
 
  
 
       
 
     
 
           
 
         
 (Eq 4) 
First, we estimate the force as a function of gravity to model the natural “bouncing” of the 
sphere into the cell membrane in an aqueous environment. A radius of R = 0.9 µM has been 
determined for the SAv-PLGA particles (Figure 16). These particles have a density that is 
1.2x larger than the density of water. Using equation (5)[46] the maximum speed va that a 
PLGA particle can reach in an aqueous environment can be calculated: 
   
       
  
 (Eq 5) 
with DDr - difference in density,   – gravitational acceleration, η – viscosity of water 
For the PLGA particles we find: 
               
The corresponding force can then be calculated for low Reynolds number (Re << 1): 
      (Eq 6) 
where f depends on the particle radius R and the viscosity of the environment η via 
       (Eq 7) 
In this way the force exerted by the particle on a cell can be estimated as 
           for      
  
Cells are known to have a Young’s Modulus of ≈ 400 Pa – 2500 Pa[47], which is much 
smaller than that of PLGA particles. Therefore, E* can be simplified as: 
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 (Eq 8) 
 
Using equations (1) – (8), a PLGA particle indents a cell by δ=0.16 nm. The corresponding 
contact area is A=450 nm2. Using the experimentally determined value of 0.3287 
antibodies/nm2, a number of 150 antibodies can potentially interact with the cell surface. 
Based on these results it can be concluded that multivalent interactions can take place when 
using αCD3-PLGA particles. 
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Chapter 6 : Polyisocyanide hydrogels as synthetic 
extracellular matrix for vasculogenesis 
 
Abstract 
Cell fate is a coordinated response caused by biomechanical and biochemical interactions 
with the extracellular matrix (ECM). The ECM as discussed in Chapter 1 comprises of the 
following components:  insoluble hydrated scaffolds e.g. fibrillar polymers such as fibrin 
and collagen (biomechanical signals), proteins/ligands on the surfaces of neighbouring cells 
and soluble macromolecules (biochemical signals). Hydrogels are uniquely suited for 
synthetic extracellular matrix (sECM) as wet 3D networks with tuneable stiffness, viscosity, 
porosity, interconnective pores and cell adhesion through introduction of ligands. PICs are 
a unique type of hydrogels as they consist of extremely stiff fibrillar polyisocyanopeptides 
with oligo(ethylene glycol) side chains, which show finite bundling, strain stiffening under 
mechanical deformation and thermo-responsive super hydrogelation [1]. In the PIC matrix 
structural control at the nanometer level with modular introduction of ligands e.g. GRGDS 
(Gly-Arg-Gly-Asp-Ser) and controlling stiffness in the range from 10-1000 Pa through 
stoichiometry is possible. In vitro vasculogenesis of human bladder smooth muscle cells 
(hbSMCs) with human umbilical endothelial cells (HUVECs) co-cultured in soft PIC (<100 
Pa) covalently decorated with GRGDS or physically mixed with low concentrations of 
fibrin will be presented. 
 
Introduction 
Controlling cellular fate in 3D remains the holy grail of tissue engineering. A large 
range of natural, synthetic and hybrid hydrogel materials have been used to imitate the 
ECM with varying degrees of success [2-12]. Ultimately there still seems to be a crucial 
modular element missing from the design arsenal of the synthetic chemist. Cellular fate is a 
coordinated response influenced by biomechanical and biochemical interactions with the 
ECM [13]. In response to a series of external triggers a cell may differentiate, proliferate, 
migrate, die or perform other specific functions. The engineering properties desired in a 
biomimetic sECM include high water retention capacity, support of cell anchorage and 
growth, porosity or interconnectivity allowing cells to grow/migrate in 3D and the free flow 
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of nutrients and oxygen, the presentation of chemical signals like receptor-binding ligands, 
biodegradability or rather remodelling to create space for new vasculature [14].  
In the tissue engineering of thick complex constructs (e.g. organs) it is vital to obtain 
vasculature to bring nutrients and oxygen to the newly formed tissue and remove waste 
products [15]. To date this has only been possible in thin skin and cartilage, meaning that 
once damaged, thick tissue like organs need to be replaced and cannot be regenerated [16-
18]. Therefore it is vital to continue the search of sECM mimics that once introduced into 
damaged or diseased tissue would result in vasculogenesis of the native tissue and 
ultimately complete repair of the damaged tissue without the need for donor organs and 
invasive surgery. The generation of new tissue occurs by either sprouting from existing 
vessels or it is initiated by vasculogenesis. Vasculogenesis may be defined as the de novo 
formation of endothelial cells from mesoderm cell precursors whereas angiogenesis is the 
process through which new blood vessels are formed from pre-existing vessels. In nature 
sprouting angiogenesis occurs in clear stages: angiogenic growth factors activate receptors 
on endothelial cells in blood vessels; the activated endothelial cells then release proteases 
that degrade the basement membrane to allow endothelial cells to escape from the original 
vessel walls; endothelial cells proliferate into the surrounding matrix and form solid sprouts 
or tubules connecting neighbouring vessels. As tubules extend toward the source of the 
angiogenic stimulus, endothelial cells migrate in tandem, through integrins, reinforcing 
tubules until finally a full-fledged vessel lumen is formed at the angiogenesis site [19]. 
Lutolf and Hubbell summarized the vascularisation process for endothelial cells in 
morphogenetic steps: endothelial progenitor cells become endothelial cells, which in turn 
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form a vacuole, the vacuole starts to branch or sprout, the tubes connect to form a capillary 
network and the network itself recruits smooth muscle cells to stabilize the newly formed 
network (Figure 1) [14].   
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Figure 1. Morphogenic steps required for tubule formation of endothelial cells.  
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Controlling cellular fate of cells encapsulated in a sECM requires bulk mechanical 
properties of similar stiffness to that of the matrix of origin with the same amount of 
tethering points (e.g. RGD). This approach resulted in similar cellular fates e.g. neurite out 
growth in culture [20-21]. Endothelial cells however are known to be an exception to this 
rule as it has been shown by Shroff et al. that hydrogels with the same stiffness but 
different architectures (strain stiffening fibronectin elements) and ligand densities catalyzed 
different cellular fates [22]. Smooth muscle cells have a matrix of origin of stiffness 
ranging in the kPa [23]. Therefore it is expected that in a soft sECM the hbSMC will 
remain dormant and HUVEC will exhibit different fates when the critical stress and RGD 
density of the sECM is varied. 
Hydrogels are uniquely suited as sECM for vascularisation, because of their innate 
similarities to the ECM as a wet 3D framework. A summary of properties that hydrogels for 
successful vascularisation require are: 3D environment; tuneable stiffness of bulk gel; 
tuneable viscosity; porosity and inter connectivity pores; cell adhesion through ligands; 
dynamic change in material properties over time making room for newly formed tissue 
[14,24-26]. Natural and hybrid hydrogel systems usually contain strain stiffening 
behaviour, that to date has not been easily mimicked by purely synthetic materials in 
biologically relevant media [27-30]. Natural (collagen; fibrin; Matrigel) and hybrid 
(hyaluronic acid-polyethylene glycol-gelatin) hydrogels utilizing extracts from native ECM 
can actively support cell proliferation, migration and differentiation; however, these 
materials are mechanically weak, have compositional inconsistency and could be a 
potential contamination source [31].  
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In the hybrid sECM, thiolated hyaluronic acid (HA) cross-linked with denatured 
thiolated collagen encapsulated embryonic endothelial progenitor cells (EPC) were 
successfully mobilized to kidneys when compared to those delivered in buffer and after 
implantation showed renal regeneration and promoted vasculogenesis [32]. A commercially 
available hybrid system based on HA, gelatine and polyethylene glycol has shown EPC 
tubulogenesis but only in the presence of 50 ng/mL vascular endothelial  growth factor 
[33]. Although promising results are obtainable in the hybrid ECM systems they suffer 
from the same limitations as natural systems, being batch to batch variation, a source of 
possible contamination and fixed mechanical properties. 
Synthetic ECM materials that have been explored for vascularisation are polyethylene 
glycol (PEG) and poly(lactic acid-co-glycolic acid) (PLGA). For 3D tissue in vitro 
vasculogenesis, PLGA has been primarily used as a scaffolding material to provide 
mechanical strength and 3D structure. PLGA seeded with mesenchymal stem cells and 
kidney vascular endothelial cells formed a vascularized network upon implantation into a 
rat thigh. Compared to non-prevascularized PLGA scaffold, there was about a twofold 
increase in the bone density [34]. The biggest drawback of the PLGA system as a whole is 
the degradation by-product poly(α-hydroxy acids), which lowers the pH and causes local 
acidosis [35] and inflammatory responses [36]. The co-culture of endothelial cells and 
mouse pericyte precursor cells (pericytes wrap around blood vessels and can differentiate 
into SMCs) onto PEG-RGDS resulted in slight tubulogenesis with a cobblestone-like 
appearance within 18 days [13]. In another study of HUVECs cultured on top of a PEG-
RGDS gel slab, slight tubule formation was observed within 19 days [9,37].  On surface 
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coated with PEG-RGD hydrogels containing matrix metalloproteinase (MMP) cleavable 
sequences no spreading and complete release of the endothelial cell construct off the 
hydrogel surface was observed within 3 days [3]. In 3D studies of HUVECs imbedded in a 
matrix of PEG-RGDSP (containing no additional growth factors) no vascular-like networks 
were observed within 12 h [38], but embedded in PEG-RGDS they did exhibit limited cell-
cell interaction and mobility within 29 h [9,37].  
Recently a new synthetic hydrogel based on polyisocyanopeptides with oligo(ethylene 
glycol) side chains (PIC) was developed. This super hydrogelator exhibits: finite bundling, 
100-150 nm pores, long persistence lengths lp and strain stiffening behaviour [1]. This 
behaviour of PIC hydrogels closely mimics that of natural ECM fibres such as fibrin, in that 
it contains helical fibrous polymer bundle that respond nonlinearly to applied forces. To the 
knowledge of the authors there is no other synthetic material that exhibits this behaviour in 
biologically relevant media. To make cells interact with PIC, a biologically relevant peptide 
is needed e.g. RGD. This is accomplished by clicking bicyclononyne functionalized RGD 
to the side chains of the PIC. The degree of RGD functionalization on the PIC as well as the 
average distance between RGD units can be controlled due to this system’s inherent highly 
organized 41 helical structure and ease of functionalization through stoichiometric 
copolymerization. Strain promoted acetylene azide cycloaddition (SPAAC) was chosen for 
ligand attachment. By synthesizing an azide-functional monomer and copolymerizing it 
with the spacer monomer it is possible to decorate these polymers with any biological 
recognition element desired. A similar strategy was successfully used to decorate the PIC 
with the streptavidin protein at well defined intervals of ca 50 nm [39]. The spatial control 
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of the RGD has been shown to be critical on 2D surfaces with respect to integrin clustering 
(50 - 70 nm) and eliciting cellular responses [40-41]. The specific cell adhesive ligand 
opted for was the GRGDS peptide (Figure 2) as it has been used successfully in a sECM 
hydrogel to obtain vascularised constructs in the past [42-43]. Alternatively, cell adhesion 
can be obtained by mixing PIC with fibrin to obtain a hybrid system that is compatible with 
HUVEC culture [44]. The co-culture of hbSMCs and HUVECs encapsulated in a soft 
sECM consisting of PIC either covalently decorated with GRGDS or mixed with fibrin was 
investigated as possible matrix to elicit vasculogenesis in vitro 3D vasculogenesis and in 
vivo after subcutaneous injections in mice whether cell penetration of the native results in 
vasculogenesis of the sECM.  
 Figure 2. Schematic representation of (a) polyisocyanopeptide decorated with GRGDS (PIC-GRGDS), (b) the binding of a short model PIC-GRGDS segment into integrin cavity based on the structure of the PIC-GRGDS segment optimized in ChemDraw3D and combined with the PDB 
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structure of integran-αIIbβ3 [37] rendered in PyMol, (c) schematic representation of integrin-
GRGDS-PIC complex through the cellular membrane 
Results and Discussion 
To investigate the effect of different densities of cell adhesion sites in the PIC to 
induce vasculogenesis, a range of polymers with different distance between neighbouring 
azides of (2 – 55 nm) and molecular weights were synthesized (Table 1 ). The GRGDS 
peptide was functionalized with a BCN-NHS (SynAffix) in biologically relevant media, the 
conjugation was confirmed by LC-MS. The BCN-GRGDS conjugate was added to a 
solution of the azide-functional PIC in equivalent molar amounts based on the azides 
present and allowed four days to reach full conversion. The success of the labelling was 
confirmed by determining the azide still available by conjugation through a BCN-Tokyo 
green dye test. The conversion was consistently between 80-95 %. The conjugate will 
hereafter be referred to as PIC-GRGDS, and the homopolymer containing no azide 
monomer will be referred to as PIC. To simplify the results only samples highlighted in 
Table 1 will be discussed. For more information on synthetic and hybrid mixtures used, see 
experimental section (Table 5).  
Table 1. The molecular weight, storage modulus of PIC used as sECM 
Compound M1: M2**  
(mol Azide:CH3) 
Yield wt%        (kg/mol) G’ (Pa) 1.6 
mg/mL PBS @ 
37 °C 
P3 0 80 491 79* 
P41 1:144 91 516 80 
P40 1:126 50 674 28 
P28/29 1:98 70 425 26 
P19 1:187 67 866 21 
*concentration of the hydrogel was 3.2 mg/mL; ** as determined by the dye test 
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The linear rheology of the PIC-GRGDS exhibited a slightly lower storage modulus 
than the azide-functional polymer (Figure 3), most likely due to sample memory effect 
from the additional processing step of conjugation at 4 °C over several days. In Chapter 3 
the effect of prolonged periods in solvated state below the sol-gel temperature was shown 
to affect the storage modules of PIC.  The sol-gel temperature was however unaffected after 
the conjugated of GRGDS. Interestingly in PIC-GRGDS polymers where syneresis was 
present, this effect appeared to be delayed by the presence of GRGDS (Figure 23).  
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Figure 3. Storage modulus as a function of temperature for P28/29 and P28/29RGD at 1.6 
mg/mL in PBS. 
Nonlinear behaviour of the PIC was measured with rheology. The samples were 
equilibrated for 25 minutes at 37 °C prior to starting the measurement. Samples were 
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exposed to a pre-stress protocol and superimposing a small oscillatory stress with an 
amplitude of |δσ| < 0.1σ at a frequency of 0.1 − 10 Hz [45] and allowed to equilibrate 
between incremental stress steps for 3 min. The differential modulus (  ) was calculated 
from the oscillatory strain response δγ, as 
   
  
  
 
  
  
   (Eq 1) 
        (Eq 2) 
     
  
 
 
 
 
 
 
 (Eq 3)  
Where    is the critical stress, G’ is the storage modulus in Pa and A and B values 
derived from the linear fitting of the differential modulus plotted against the stress. For 
example for sample P39 (Figure 4), the initial storage modulus was 85.5 Pa, A= 13.2 and B 
= 1.1, a critical stress value of        
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Figure 4. Differential modulus plotted against stress of P39 in MQ (1 mg/mL) at 37 °C. 
By measuring the differential modulus relative stress and using Eq 3 it was possible to 
determine the critical stress values of PIC with a range of molecular weights (Table 2).  
Table 2. The critical stress values of a range of PIC dissolved in MQ at 1.0 mg/mL used to 
construct the calibration curve (Eq 1) 
Compound Mη 
(kg/mol) 
critical stress σc 
P21 948 12.5 
P37 791 10.2 
P38 733 7.9 
P39 569 5.7 
P28/29  425 1.6 
 
From the data summarized in Table 2 it appeared as if the critical stress values scaled 
with molecular weight. A calibration curve based on the measured critical stresses based on 
Eq 3 of a range of PIC consisting of a broad range of molecular weights was constructed 
y = 13.226x1.0718 
R² = 0.9769 
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(Figure 5). A linear relationship between molecular weight and critical stress was observed 
and a trendline                 (Eq 4), with a R2 = 0.99 was derived from the data.  
Where x is the molecular weight and y is the critical stress. 
 
Figure 5. Critical stress vs. molecular weight at a concentration of 1 mg/mL in MQ at 37 °C. 
The R2 of Eq 4 was very good at 0.99 as seen in Figure 5. The calculated and measured 
critical stress was summerized in Table 3. The average critical stresses compared well with 
the average calculated critical stress of 5.6 ±3.0 and average measured critical stress of 
4.6±3.6. The two data sets that of calculated critical stress and the measured critical stress 
were both normally distributed (see, Figure 6) and when the two sets were compared using 
the two sample t-test a P value = 0.6 was obtained indicating that there was no statistical 
difference between the two. Therefore Eq 4 can be used to predict critical stress of PIC 
based on its molecular weight.  
y = 0.0202x - 6.4228 
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Table 3. Critical stress measured vs. calculated values at a concentration of 1 mg/mL in MQ. 
Compound Mη 
(kg/mol) 
calculated 
critical stress 
critical stress  
1 mg/mL 
Difference 
P28/29 425 2.2 1.6 0.6 
P39 569 5.1 5.7 -0.6 
P38 733 8.4 7.9 0.5 
P41 516 4.0 1.1* 2.9 
P7 796 9.7 10 -0.3 
P28/29RGD 425 2.2 0.8 1.4 
P18RGD 688 7.5 4.8 2.7 
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Figure 6. Probability Plot at 95% confidence interval of measured critical stress and the 
calculated critical stress (Eq 4).  
The stiffness of the PIC hydrogel is important but as discussed in Chapter 1, the porosity is 
also very important when designing a sECM as it affects cellular motility. It was suspected 
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that cellular motility would be limited or hampered in the PIC system as it consists of nm 
pore sizes. Therefore, cellular motility was investigated by culturing hbSMCs or HUVECs 
in PIC for three days and observed with time lapse microscope for 50 h. The small pores 
did not appear to hamper hbSMC motility however, where hbSMCs moved freely through 
the PIC, HUVECs on the other hand only migrated when encapsulated in PIC-GRGDS. 
This behaviour would suggest another mode of migration than one purely driven by passive 
diffusion through pores (Movie 1-2). This behaviour of unhampered motility in hydrogels 
with nm scale pores has been observed before by Zaman et al. in cells immersed in 
Matrigel, an ECM extract. In Matrigel, the cells deformed the matrix and created spaces to 
migrate through, therefore mobility in this system was thought to be regulated by 
mechanical stiffness, proteolysis and integrin expression [46]. In the sECM of PIC the exact 
mode of migration still needs to be investigated, but it is clear that in stiffness of <200 Pa 
motility is unaffected by pore size. 
The hybrid fibrin-PIC was easily prepared by mixing different volume ratios of fibrin 
with PIC (1:1, 1:5, 1:10, and 1:50 (v/v)). Fibrin gel was prepared as described [38]. 
Fibrinogen from bovine plasma (Sigma-Aldrich, Schnelldorf, Germany) was reconstituted 
in 0.9% NaCl to final concentration of 10 mg/mL and thrombin (50 U/mL, Sigma-Aldrich) 
was added to polymerize fibrin gel at varied concentrations in the presence of PIC (2.5 
mg/mL). The linear rheology of the 1:5 fibrin-PIC mixture exhibited similar sol-gel 
transition temperatures but lower overall storage moduli (Figure 24). The non-linear 
behaviour of the mixture also matches that of the PIC (Figure 16). 
6-16 
 
First the initiation of vasculogenesis was investigated by evaluating light microscopy 
images of PIC-GRGDS (P28/29RGD; P19RGD), PIC (P3) and PIC-fibrin mixtures and 
compared to control fibrin gel (10 mg/mL) (Figure 7). The control fibrin experiments have 
a fivefold concentration when compared to the hybrid PIC:fibrin mixtures as at the 
concentrations used in hybrid system fibrin did not form gels. Within 24 h sprouting was 
observed in all the hydrogels containing cell adhesion ligands whether it be from fibrin or 
synthetically introduced. No vasculogenesis was observed in pure PIC as no anchor points 
extended from single cells (Figure 7f). The combination of fibrin-PIC resulted in faster 
vasculogenesis than in PIC-GRGDS. 
 
Figure 7. Initiation of vasculogenesis. Bright field images of HUVEC and hbSMC in hydrogels 
were taken after 24 h. a)P28/29RGD (1 in 10 GRGDS); b) P28/29RGD +Fibrin; c) P19RGD (1 in 
23 GRGDS); d)P19RGD+Fibrin; e) P3+Fibrin (5:1); f) P3; g) Fibrin (positive control 10 mg/mL). 
Next, the effect of culturing hbSMCs/HUVECs in PIC over extended periods of time 
(up to two weeks) was investigated (Figure 8). Vasculogenesis was monitored with light 
microscopy every 3 days over this period. In PIC hydrogels mixed with fibrin (P3 + fibrin 
5:1) the newly formed structures/sprouts were complex and endothelial tubes were 
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substantial as early as four days after initiation (Day 4 scale bar is 500 µm). After 14 days, 
sprouts/construct were too condensed to observe via light microscopy. This is remarkable 
as the concentration of fibrin in PIC:fibrin is only 2 mg/mL and this sprouting would not 
occur in fibrin gels at 2 mg/mL as it does not form an efficient hydrogel at these 
concentrations. The cells still showed characteristic sprouting similar to that observed in 5 
fold higher concentration of fibrin gels at 10 mg/mL (Figure 7- 9). In P41RGD and 
P19RGD, co-cultured cells formed clusters and endothelial tubes sprouted in a radial 
fashion. In P1 (without GRGDS or fibrin) cells formed clusters that increased in size and 
stained positively for propagation markers, but no sprouting was observed (Appendix 
Figure 25, 28-29). In P1 supplemented with unbound GRGDS at similar concentrations to 
the P41, no sprouts formed, only cellular clusters (Figure 8).  
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Figure 8. Vasculogenesis in hydrogels over incubation of two weeks. (Scale bars at first and 
second rows are 175 µm for magnification x40. Scale bar at third column and third row is 500 
µm for magnification x10. Fibrin at x20 magnification. 
To explore the effect on vasculogenesis purely induced by changing the molecular 
weight the GRGDS density was kept constant and the PIC concentration constant and the 
stiffness low (below 100 Pa, Table 1). The onset and degree of vasculogenesis was 
controlled in this manner (Figure 9) irrelevant of hydrogel stiffness. In P28/29RGD the 
cells showed faster tubule formation than in P40RGD from day 1-7 and by day 12 the cells 
have formed a dense structure.  
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Figure 9. (a-c) Light microscopy of HUVEC/hbSMC in PIC-GRGDS 1 in 10 nm at a concentration 
of 1.6 mg/mL with decreasing molecular weights at x20 magnification, (d) Vasculogenesis with 
P3:Fibrin 5:1 from day 1 to day 3. a: on day 1, vasculogenesis initiated. Distance of sprouting is 
around 500 µm. b: on day 3, complex vasculature formed. (Scale bar is 500 µm.)  
To investigate the optimal density of cell adhesion ligands required on PIC, PICs were 
decorated with a range of GRGDS densities from as high as 1 in 2 nm to as low as 1 in 55 
nm (Figure 10). The highest density of 1 in 2 nm GRGDS (P38RGD) resulted in undefined 
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cellular response that did not appear to be tubular in any way and the lowest density of 1 in 
55 nm (P36RGD) showed similar results as pure PIC hydrogels containing no GRGDS. 
 Figure 10. Light microscopy of hbSMC/HUVEC co-culture over two weeks in 3D, PIC with decreasing density of GRGDS: P38RGD (1 in 2 nm); P18RGD (1 in 10 nm); P19RGD (1 in 20 nm); P36RGD (1 in 55 nm). 
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Vascularisation in mixed systems of PIC and fibrin were investigated by mixing 
volume ratios of the two: 1:1 v/v was equal to 1 mg/mL PIC to 5 mg/mL fibrin, 1:5 v/v was 
equal to 2 mg/mL PIC to 2 mg/mL fibrin, 1:10 v/v was equal to 2 mg/mL PIC to 1 mg/mL 
fibrin and 1:50 v/v was equal to 2 mg/mL PIC to 0.2 mg/mL fibrin. In samples containing 
fibrin, sprouting was evident in all the mixtures except 1:50 within a 14 day incubation 
period (Figure 11).  In the mixed PIC:fibrin systems the lowest concentration of RGD from 
the fibrin required for vascularisation (1 mg/mL fibrin) was calculated to be 13.2 µM, but 
the best results were obtained in the PIC:fibrin 1:5 containing 2 mg/mL fibrin which is 
equal to 23.4 µM RGD (Figure 12 and 27). 
6-22 
 
 
Figure 11. Light microscopy of hbSMC/HUVEC over time in the 3D hydrogel constructs 
containing decreasing concentration of fibrin relative to PIC (magnification 10x) a) 1:1, b) 1:5, 
c) 1:10, d) 1:50. 
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Figure 12. Light microscopy images (magnification 20x )a) P41:fibrin 1:5 (2 mg/mL) b) Fibrin 
10 mg/mL. 
In conclusion, the optimal density of GRGDS on the PIC backbone was one every 10 
nm on average which in stoichiometric terms is 63.3 µM. On closer examination of PIC-
GRGDS 1 in 10 nm against 1 in 23 nm, vasculogenesis was observed in both samples over 
a week and half. In P41RGD on day 1, cells started to anchor in the hydrogel. On day 4, 
cells clustered and started to sprout. On day 9, large cell clusters formed (diameter of cell 
cluster is around 500 µm), and communication formed between clusters (Figure 8; 9b). The 
behaviour in P19RGD (1 in 23 nm) over the same time period was comparable but with a 
lower degree of complexity of the formed sprouts (Figure 8). If we now compare the PIC-
GRGDS system to the PIC-fibrin system where fibrin was simply mixed with PIC (P3) 
vasculogenesis was observed within three days. On day 1, vasculogenesis initiated and the 
distance of sprouting was around 500 µm. By day 3, complex vasculature formed (Figure 
9d). Therefore it is clear that the synthetic PIC system requires optimization, possibly by 
the inclusion of additional cell adhesion ligands (e.g. KQAGDV) and covalent attachment 
of growth factors that are present in the fibrin mixed system. 
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The growth of vasculature was followed with light microscopy for 14 days. To confirm 
whether the formed sprouts were indeed vasculature, immunohistochemical (IHC) analysis 
was performed to identify vasculature orientation with specific markers. Von Willebrand factor 
(vWF) is a glycoprotein and CD31 is a protein for adhesion on the membrane. The 
expression of vWF and CD31 in endothelial cells is different but both markers are often 
used to identify vasculature [47]. All constructs formed in various sECM (pure fibrin; 
P3:Fibrin 5:1, P28/29RGD and P19RGD) were evaluated  and the  presence of 3D 
sprouting and branching confirmed (Figure 13). Endothelial tubes were stained against 
vWF or CD31. Tubular structures were supported with smooth muscle cells (SMA or 
vimentin positive).  Endothelial tubes sprouted and extended from a cell cluster to 
communicate with other clusters (Figure 13a). Connection of endothelial tubes indicated an 
initiation of vasculature network in hydrogels (Figure 13b). In hybrid sECM with fibrin as 
cell adhesion component dispersed in PIC, vascularisation was observed (Figure 13c). The 
presence of CD31 positive vascular-like structures, surrounded by vimentin positive cells 
and even some luminal structures were identified in P3:fibrin 1:5 similar to those observed 
in the fibrin positive control where observed (Figure 26). 
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Figure 13. Confocal images of vasculatures after two weeks incubated in hydrogels. Vasculature 
was stained with vWF/α-SMA or CD31/vimentin. Endothelial tubes were clearly showed with 
Alexa 488. Supporting smooth muscle cells were either scattering in hydrogel or surrounding 
endothelial tubes. a) P28/29RGD, b) P19RGD, d) P3:fibrin [5:1]. Magnification is x20.  
To summarize, it was observed that some vasculogenesis of HUVEC/hbSMC does 
occur in PIC-GRGDS over a two week period, but the structures that most closely resemble 
those obtained in the fibrin control were observed in the hybrid mixture of fibrin:PIC (1:5).  
Once formed it would be advantageous to remove formed vasculature for possible 
implantation applications. Skardal et al. have reported the non enzymatic harvesting of 
cellular clusters from HA-gelatin coated beads of a range of cells including endothelial cells 
(HUVECs) excellent viability and growth during 3D expansion and the following cell 
recovery by gentle centrifugation. The use of excessive force or enzymatic degradation 
could result in construct damage and undesired cell surface modification [48]. The use of 
beads is an attractive solution but ideally it would be desirable to simply melt the hydrogel 
away without any chemical or enzymatic degradation. Due to its thermo-responsive 
properties, it was possible to harvest cell clusters from pure PIC by cooling the hydrogel 
down and carefully removing them. The pre-formed clusters could consequently be induced 
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to sprout when immersed in PIC-GRGDS and incubated for three days (Figure 14). To my 
knowledge this is a unique characteristic of PIC sECM and not possible in any other ECM 
mimic. This strategy should be transferable to harvesting sprouted structures from the 
hydrogel after two weeks of incubation, but as the goal of this particular study was to obtain 
vasculogenesis in vivo, the ex situ harvesting of sprouts was not investigated further.  
 Figure 14. Harvest of 3D cell culture. First HUVEC and hbSMC were co-cultured in P1 and then transferred to P41RGD. a) Day 3, cells formed spheres/clusters, b&c) Clusters were harvested via pipette tips and transferred to P41RGD, 3 days after transferring to P41RGD, cell clusters started to sprout. (scale bar is 250 µm). 
The vasculogenesis of native tissue in the presence of PIC-GRGDS in vivo by cellular 
infiltration of the host tissue was investigated by the subcutaneous injection of PIC into 
mice. It was hypothesized that native tissue would infiltrate the PIC-GRGDS and just as 
observed in vitro initiate vasculogenesis inside the hydrogel. The material properties of the 
in vivo experiment were reconstructed (0 °C solution, injection and rapid heating to 37 °C 
Figure 15) in a rheological environment. A significant decrease in stiffness after injection 
was observed in PIC and PIC-GRGDS (34 Pa for the P28/29 and 6 Pa for the P28/29RGD) 
see Figure 15. To counteract the decreased stiffness after injection, the sample 
concentration was increased from 1.6 mg/mL in vitro to 2.0 mg/mL in vivo. 
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Figure 15. Storage modulus as a function of time for PIC samples at 1.6 mg/mL (medium) for 
900 s at 37 °C (2 % strain, 1 Hz). 
To determine the critical stress values of the samples used for animal studies, the 
differential modulus was measured with increasing stress for sECM samples at 2 mg/mL in 
cell culture medium (Figure 16). 
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Figure 16. The differential modulus as a function of stress for P28/29 (Azide; GRGDS), fibrin-PIC 
(Azide; GRGDS) in cell culture medium at 2 mg/mL. Fibrin at 2 mg/mL did not form a hydrogel 
and was therefore not included in this graph. 
The strain stiffening characteristics of the PIC were retained regardless of the presence 
of fibrin at 2.0 mg/mL. The fibrin itself did not form a hydrogel at 2.0 mg/mL. From these 
curves it was possible to derive the critical stress of the aECM used using Eq 3 (Table 4). 
Table 4. Critical stiffness and storage modulus of aECM at 2 mg/mL in cell culture medium at 37 
°C 
Sample name Critical stiffness σc Storage Modulas 
(Pa) 
P28/29 9.1 103.4 
P28/29RGD 2.9 45.3 
Fibrin-P28/29 2.1 60.5 
Fibrin-P28/29RGD 5.2 116.7 
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The penetration of native tissue into PIC-GRGDS was visualized by staining of the 
hydrogel construct one and two weeks after subcutaneous injection with haematoxylin and 
eosin (HE) and Masson staining. In Figure 17 partial cellular penetration was observed in 
P3, but more so in P28/29RGD. The penetrated cells are indicated by the arrows, the 
deposition of native ECM was directly correlated to the degree of cellular penetration and 
moderate immune response from surrounding native tissue was observed from the 
P28/29RGD injections.  
 
 
Figure 17. Microscopic images (magnification 20x) of the  haematoxylin and eosin (HE) and 
Masson staining showing: (a) the P3 construct after one week, (b) P28/29RGD construct after 
one week, (c) P3 construct after two weeks , (d) P28/29RGD after two weeks. 
A B 
C D 
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Microscopic evaluation indicated a moderate inflammatory response in all constructs 
one and two weeks after injection. The cellular response was scored semi-quantitatively 
(Figure 18 and Table 9). Representative images of the different constructs, which were used 
for the scoring, are shown in Figure 17 and Figure 31. After two weeks, cell infiltration and 
native ECM production was clearly present, but no vascular structures were observed. 
These are still very promising results as pure fibrin hydrogels do not survive longer than a 
week in vivo as they are highly susceptible to fibrinolysis [10].  
 
Figure 18. Histograms showing the average score (±SEM) assigned to the cell infiltration, ECM 
production and vascular structures seen in the different PIC constructs evaluated one (left) and 
two (right) weeks after injection. Figures represent the scores assigned to the PIC constructs 
injected (n=1). Scoring: - = not present, +/- - = sporadically present, +/- = a little bit present, + = 
present, ++ = clearly present, +++= abundantly present.   
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Conclusion 
It was shown that polyisocyanides as sECM can be used to induce vasculogenesis in 
vitro if a cell adhesion ligand GRGDS is covalently attached to it in an optimum 
concentration of 63.3 µM. At this optimum peptide concentration, the polymer itself should 
have a molecular weight of 425-516 kg/mol to ensure initial sprouting occurs within three 
days. The sECM (synthetic and hybrid materials) used in vivo had stiffness of <100 Pa and 
a critical stress of 2.0-2.9. It was also shown that vasculogenesis in vitro was possible 
without the covalent attachment of GRGDS to the PIC but by simply mixing fibrin with 
PIC at concentration as low as 1.0 mg/mL, the best results were however obtained in 
mixtures containing 2.0 mg/mL of fibrin. This result was surprising in that the fibrin 
concentration is 10 fold lower than those previously reported in mixed sECM of PEG [49]. 
Minimal inflammatory response was observed, mice thrived and cellular invasion was 
observed into the hydrogel during the in vivo experiments, however no vasculogenesis was 
observed and no difference was observed between the PIC-RGD and mixed PIC:fibrin 
system. The poor results obtained in the mixed fibrin-PIC system could be as a result of 
rapid fibrin degradation resulting in loss sample of volume and mechanical stability [49]. 
Perhaps the mode of PIC introduction subcutaneously into the mice for both systems needs 
to be re-evaluated opting for a cooled injection setup [NanoCoolTM, Harvard Apparatus] or 
larger needle diameter to avoid loss of material integrity through the mode of introduction.  
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Materials and Methods 
Synthesis and Analysis of PIC 
 
The synthesis and analysis of the polymers were discussed in Chapter 2. In Table 5 the 
analytical data of the polymers used in this chapter are summarized.  
 
Table 5. Data summary of Mv, AFM and rheology 
Sample name Mv 
(kg/mol) 
 dye test* to 
determine 
azide to CH3 
1.6 mg/mL 
G' @ T = 37 
°C 
1.0 mg/mL 
G' @ T = 37 °C 
P41 516 1:144 34  11 
P40 674 1:126 28  
P28/29 425 1:97 60 16  
P18 688 1:115    
P19 866 1:225 21   
P39 569 1:250 58 86  
P38 733 1:50 162 184  
P36 835 1:575 184  
P31 755 1:62 481  
P32 735 1:98 279  
P33 714 1:556 395  
P18RGD 688     34  
P19RGD 866   11  
P41RGD 516   80  
P40RGD 674 1:4601 347**  
P39RGD 569 1:1804 615**  
P28/29RGD 425 1:1872 26 5 
P1 498    
P3 491   8  
* See page 6-33 for details on procedure; ** the G’ at a concentration of 3.2 mg/mL 
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Synthesis and characterization PIC-GRGDS 
 
Synthesis of 1-(bicyclo[6.1.0]non-4-yn-9-yl)-29-(carboxymethyl)-23-(3-guanidinopropyl)-
32-(hydroxymethyl)-3,14,18,21,24,27,30-heptaoxo-2,7,10-trioxa-4,13,19,22,25,28,31-
heptaazatritriacontan-33-oic acid  (BCN-GRGDS) 
 
Figure 19. The chemical structure of the BCN-GRGDS  
The GRGDS [Bachem] was dissolved in a 50 mM borate buffer pH 8.4 to a final 
concentration of 2 mg/mL. The 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-
3,14-dioxo-2,7,10-trioxa-4,13-diazaoctadecan-18-oate (BCN-NHS) [SynAffix] dissolved in 
DMSO was added in a 1:1 molar ratio to the peptide solution and mixed 300 rpm at 18 °C 
for one hour before being frozen in 100 µL aliquots. MS calc [C39H62N10O15]: 910.4 
obtained: 911.5 
 
Dye test for determining azide concentration 
 
The azide-functional polyisocyanide was dissolved in ACN at 2 mg/mL. To this PIC 
solution, a 2 molar (azide) equivalent of BCN-GRGDS (Figure 19) was added. The mixture 
was allowed to stir for 72 h at 4 °C. The PIC-peptide was purified by precipitation from 
diisopropyl ether. The precipitant was decanted, re-dissolved and precipitated from DCM 
into diisopropyl ether. No further purification was performed. The conversion of azides to 
peptide was determined by determining the residual azide concentration by coupling BCN-
TokyoGreen [SynAffix] dye. 
 
To determine the remaining azide density on the PIC, a colorimetric test was performed by 
conjugating BCN-TokyoGreen (Figure 20) to a known amount of PIC-peptide and 
calculating the concentration from the Law of Beer Lambert. A BCN-TokyoGreen stock 
solution of 2.2 mM in DMSO was prepared. The polymer was dissolved on ice in 
acetonitrile (ACN) with rapid stirring until dissolved (5 mg/mL). An excess (10) of BCN-
TokyoGreen based on the mols of azide expected was added to polymer solution. The 
mixture was stirred for 3 h at room temperature. The dyed polymer was precipitated from 
diisopropyl ether, the diisopropyl ether was decanted from the polymer and the polymer 
redissolved in DCM. This step was repeated once more. The diisopropyl ether was decanted 
from the polymer precipitate which was subsequently dried in vacuo. For UV analysis a 1 
mg/mL solution in a mixture of 0.75 ACN: 0.25 DMSO: 1.0 H2O was prepared. The stock 
solution was measured against a background of the same mixture of solvents in a quartz-
cuvet with a path length of 1 cm on a Cary UV-vis spectrometer. Multiple measurements 
were made over a range of (1.0 -0.01 mg/mL) polymer concentrations by diluting the stock 
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solution with H2O.  The extinction coefficient of the BCN-tokyoGreen in this mixture was 
determined to be 35493 M-1 cm-1 by measuring the free dye at different concentrations and 
calculating the slope of the curve at 506 nm. The ratio of azides still present after BCN-
GRGDS conjugation was determined in this way.  
 
Figure 20. Chemical structure of 9-(4-(((1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-yl)methoxy)-2-
methylphenyl)-6-hydroxy-3H-xanthen-3-one (BCN-TokyoGreen)  
Table 6. Dye test results to determine the efficacy of the BCN-GRGDS conjugation 
Sample name Equivalent of peptide 
used 
Yield of conjugation 
(%) 
P28/29RGD 2 88 
P31RGD 2 98 
P32RGD 2 94 
P33RGD 2 89 
 
From this point forward, care was taken to ensure that the polyisocyanopeptide remained 
sterile. All equipment was sprayed with ethanol before use. The PIC-GRGDS was weighted 
directly into a sterile centrifuge tube. The tubes were further sterilized by exposing them to 
UV radiation for a period of 5 minutes. The PIC-GRGDS was covered with sterile cell 
culture medium to obtain the final dilution of polymer in media of 3.2 mg/mL and allowed 
to swell for 24 h at 4 °C. After 24 h a swollen gel-like substance was obtained at the bottom 
of the centrifuge tube. The swollen PIC-GRGDS conjugate was stirred until dissolved for 
up to 72 h at 4 °C. The solution exhibited a sharp transition in viscosity above the sol-gel 
temperature. For the preparation of the constructs of appropriate stiffness and concentration 
a stock solution of PIC at 3.2 mg/mL in cell culture medium was supplied to the cell culture 
laboratory. 
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Rheology 
For gel studies, the polymer was dissolved in purified water (MQ); PBS; cell culture 
medium by first swelling the polymer in a cooled solution before stirring for 16-72 h at 4 
°C. Samples were placed in the rheometer at 5 °C (i.e. as a liquid) and gelation occurred 
between the parallel plates by raising the temperature (2 °C/min). Drying of the sample was 
prevented by maintaining a moist atmosphere.  
 
Non-linear rheology 
 
The nonlinear rheology of the aECM at 2 mg/mL in cell culture medium was measured. 
The differential modulus (  ) is calculated from the oscillatory strain response δγ, as 
   
  
  
 
  
  
   (Eq 1) 
        (Eq 2) 
     
  
 
 
 
 
 
 
 (Eq 3)  
Where    is the critical stress, G’ is the storage modulus in Pa. A and B values derived 
from the linear fitting of the differential modulus plotted against the stress. For example for 
sample P19, at a concentration of 1 mg/mL in MQ, the initial storage modulus was 85.5 Pa, 
A= 13.2 and B = 1.1, a critical stress value of        
 
Statistical analysis 
 
Table 7. Two-sample t-test for calculated critical stress vs. measured critical stress 
Data set N Mean StDev SE Mean 
Calculated 
critical stress 
7 5.6 3.0 1.1 
Measured 
critical stress 
7 4.6 3.6 1.4 
 
Difference = μ (Calculated critical stress) - μ (Measured critical stress) 
Estimate for difference:  1.0 
95% CI for difference:  (-2.9; 4.9) 
t-test of difference = 0 (vs ≠): t-value = 0.6  P-Value = 0.5  DF = 11 
 
In vitro: 
 
Cell culture  
 
Human umbilical vein endothelial cells (HUVEC) were expanded in microvascular 
endothelial cell growth medium-2 (EBM-2MV, Lonza, Basal, Switzerland) with 
supplements (Lonza, CC-4147) and penicillin/streptomycin solution (p/s). Human bladder 
smooth muscle cells (hbSMC) were expanded in smooth muscle cell medium (SMCM, 
Sciencell, Carlsbad, USA) with growth supplement (SMCGS), fetal bovine serum (FBS), 
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and p/s. The medium was changed three times per week. Cells were maintained at 37 °C, 
5% CO2. 
To prevascularized hydrogels, HUVEC (2.5×104 cells/mL) and hbSMC (1×104 cells/mL) 
were mixed with different hydrogels and cultured in 3D in insert rings for 24-well plate (0.4 
μm polyester membranes, Costar, NY, USA). Mixed hydrogels were incubated at 37 °C for 
1 hour in a humidified incubator containing 5% CO2 to ensure the solidity of hydrogels. In 
the end of incubation, EGM-2MV: SMCM (1:1 (v/v)) was added on the lower chamber of 
the transwell plate (Costar, NY, USA).  
 
Cell mobility 
HUVEC (2.5x104 cells/mL) and hbSMC (1x104 cells/mL) were mixed with different 
hydrogels and cultured in inserts (ibidi, Martinsried, Germany). After three days, cell 
mobility was observed with a time lapse microscope for 50 h (Nikon Diaphot 300 with 
Hamamatsu C8484-05G CCD Camera, Japan; Okolab 4 well CO2 stage incubator and 
Okolab 2D time lapse software, Italy).  
 
Harvesting of 3D construct 
HUVEC (2.5x105 cells/mL) and hbSMC (1x105 cells/mL) were cultured in PIC. After three 
days culturing in PIC, cell clusters were collected from cooled liquid hydrogel without 
damaging them and transferred to RGD 1:10. The volume ratio of PIC and PIC-GRGDS 
was 1:4 (v/v). Three days after transferring, cell clusters started to sprout (Figure 14). 
 
Immunohistochemistry and immunofluorescent staining 
At different time points, samples were collected and either embedded in O.C.T. compound 
TissueTek (Sakura) and snap frozen in liquid nitrogen, or fixed in paraformaldehyde and 
embedded in paraffin. Frozen specimen were cut as 5 µm and fixed with methanol for 10 
minutes at 21 °C. Paraffin embed specimen were cut as 4 µm. For antigen retrieval, slides 
were incubated with boiling sodium citrate buffer (10 mM, pH 6) for 10 minutes and cooled 
down to 21 °C for 1 hour. Non-specific antigens were blocked with 10% normal goat serum 
(NGS) and 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS) for 1 hour 
at 21 °C. In Table 8, the antibodies used are summarized. Primary antibodies were 
incubated in 1% NGS 1% BSA in PBS for 1 hour at 21 °C. Non-specific binding was 
washed away with PBS 5 minutes in 3 times. Secondary antibodies conjugated with Alexa 
fluor probes were incubated in 1% NGS 1% BSA in PBS for 30 minutes at 21 °C. Non-
specific binding was washed away with PBS 5 minutes in 3 times. Slides were mounted 
with Prolong Gold mount medium with DAPI (Invitrogen). Slides were evaluated with 
fluorescence microscopy (LEICA DC 300F, Germany).  
For whole gel staining, hydrogels were washed with PBS 5 minutes in three times. Nuclei 
were stained with Hoechst 33342 (1:2000, 5 µg/mL, Invitrogen). The whole gel staining 
was analyzed with confocal laser scanning microscope (Olympus FV1000, Tokyo, Japan). 
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Table 8. Summary of antibodies 
Antibody Origin Clone React Stock 
Concentration 
Dilution, final 
concentration 
Company 
Von Willebrand 
factor 
Rabbit Polyclonal Human 3.1 mg/ml 1:400 (7.8 
µg/mL) 
Dako 
CD31  Mouse JC70A Human n. a. 1:100 Dako 
α-SMA Mouse 1A4 Human 
and 
mouse 
6 mg/ml 1:8000 (0.8 
µg/mL) 
Sigma 
Vimentin Rabbit n. a. Human, 
mouse, 
and rat 
n. a. 1:400 Abcam 
Ki67 Rabbit SP6 Human n. a. 1:200 Thermo 
Scientific 
Type 1 collagen Rabbit Polyclonal Bovine 1.0 mg/ml 1:100 (1.0 
µg/mL) 
Millipore 
Fibrin/Fibrinogen Mouse MFB-HB Human 
and 
canine 
0.5 mg/ml 1:50 (10.0 
µg/mL) 
Thermo 
Scientific 
Alexa-488 Goat  Mouse  1:200 Invitrogen 
Alexa-568 Goat  Rabbit  1:200 Invitrogen 
Alexa-488 Donkey  Mouse  1:200 Invitrogen 
Alexa-594 Donkey  Rabbit  1:200 Invitrogen 
 
Appendix 
 
Comparing PIC with PIC-GRGDS 
 
The circular dichroism spectra of dilute solutions of PIC in acetonitrile were measured to 
confirm the β-helical conformation of the polymer. After decoration with GRGDS the 
orientation of the helix was retained, but at the same concentration it is somewhat 
diminished in intensity (Figure 21).  
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Figure 21. CD spectra of P41 and P41RGD 1 mg/mL in PBS at 22 °C 
The infrared spectrum of the PIC samples appears very similar except for a weak azide 
signal in the region of 2100 cm-1. This peak only becomes pronounced in the highest 
loading of 1 in 25 azides or rather one azide every 3 nm. It is clear however that after 
conjugation with BCNGRGDS this broad peak disappears completely indicating that the 
azides were completely consumed (Figure 22).   
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Figure 22. a) IR spectrum before and b) after conjugation BCN-GRGDS. Notice the disappearance 
of the azide peak at 2100 cm-1. 
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Linear rheology 
 
To investigate the effect of RGD conjugation on the PIC, linear rheology before and after 
conjugation was performed on a set of PIC with known sample history (see, Figure 23). The 
measurements in the linear response regime were conducted at 2 % strain at a frequency of 
1 Hz. Temperature sweeps were recorded at a heating or cooling rate of 2 °C/min.  
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Figure 23. Storage modulus as a function of temperature comparing PIC before and after GRGDS 
functionalization 1.6 mg/mL in PBS (1 Hz, 2 % strain, 2 deg/min) same sample history. 
To mimic animal experiments, the dissolved samples were placed on ice, sucked up via 
syringe through a needle (G25/30) and ejected on a 5 °C peltier plate. The sample 
temperature was raised to 37 °C rapidly and time sweep performed 15 min at 37 °C under 1 
Hz, 2 % strain. For subcutaneous injection a cooled solution of PIC needed to be passed 
through a syringe. Interestingly the material did recover after 15 min incubation at 5 °C, 
before running a temperature sweep from 5 – 37 °C (Figure 24).  
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Figure 24. Storage modulus as a function of temperature comparing different sample history 
effects at 1.6 mg/mL (1 Hz, 2 % strain, 2 deg/min) 
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Figure 25. Immunohistochemistry of clusters for (a) α-smooth muscle actin, (b) endothelial 
marker CD31, (c)  desmin, (d) Ki67 after 28 days. The nuclei of the cells were stained by 
haematoxylin appear in blue. Markers were stained with diaminobenzidine (DAB) and appear 
in brown. The clusters were both CD 31 and desmin negative (b and c). Weak positive signal of 
α-smooth muscle actin was observed within the cluster (a). The arrow points to the Ki67 
positive cells (brown) present in one cluster (d). Magnification 40x. 
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Figure 26. Immunofluorescent staining for CD31 (endothelial cell marker in green), vimentin 
(mesenchymal cell marker in red) and nuclei (blue) of (a) Fibrin:P3 1:5, (b) Fibrin:P28/29RGD 
1:5, (c) Fibrin control (10 mg/mL) after 21 days. Images were taken with a 40x magnification.  
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Light microscopy:  
 
The vasculogenesis of constructs were followed with light microscopy (LEICA, Germany) 
during cell culturing.  
 
 
Figure 27. Light microscopy images (a) P1:fibrin 1:1 and (b) P1:fibrin 1:5 . Magnification 40x. 
In the fibrin:PIC mixtures, branch formation was observed as early as day 1 and vessel-
like structures were observed at day 14 and day 22. At day 14, sprouts increased and 
connected with each other in mixtures is comparable with pure fibrinogen gels (Figure 10- 
12). 
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c 
    
Figure 28. Light microscopy (a) P36 plus free GRGDS 2mg/mL, (b) P1 plus free GRGDS 2 
mg/mL, (c) P1 without GRGDS Magnification 40x. 
 
Figure 29. Light microscopy of clusters in P1. the diameter of one single individual cell at day 0 
is 18.1 μm and the diameter of one cluster at day 21 is about 93.8 μm. Magnification 40x. 
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In Vivo:  
 
 
Figure 30. Injection procedure. Aliquots of the PIC or PIC-fibrinogen suspension were placed on 
ice for a minimum of 30 minutes (a) Prior to subcutaneous injections the implant area was 
shaved, (b) and disinfected with 70% EtOH. The syringes used for injection were prepared 
under semi-sterile conditions, (c) 100 μL of the PIC or PIC-fibrin was directly injected 
subcutaneously, either on the left or right side of the back of the mouse. Implant areas were 
marked with a waterproof marker, (d) Subsequently, mice were placed in a heating chamber at 
37 °C for a minimum of 10 minutes to ameliorate hydrogel solidification. 
A B 
C D 
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Figure 31. Microscopic images (magnification 20x) of the HE and Masson staining showing the 
rim of the P3 construct (a) P28/29RGD construct, (b) Fibrin:P3 construct, (c) and the 
fibrin:P28/29RGD construct, (d) one and two weeks after injection. The * indicates the area of 
the construct. 
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Table 9. Overview of the semi-quantitative scoring of the cellular response to the constructs. The 
scores assigned to the PIC constructs are based on one sample (n=1). 
Samples: A B  C D E F G H I J K 
P3 1  1.5 2 1.5 0 2 0 2 0 1.75 2 
 2  3 2.5 2 1 3 1 3 1 3 3 
P28/29RGD 1  2.5 2.5 1 1 2.5 0 2.5 0 2 2 
 2  4 4 2.5 1.5 3.5 1 3 0 4 4 
Fibrin-P3[1:5] 1 2 1 0.5 0.5 2 0 2 0 1.75 1 
 2 2 2 0.5 0.5 2 0 2 0 1.75 1 
Fibrin-P28/29RGD [1:5] 1 2.5 2.5 0.5 0 2 0 2 0 2 1 
 2 4 4 2 2.5 4 1 2.5 0 4 4 
Titles: 
A) Evaluation point (weeks) 
B) Cell infiltration 
C)Cells in scaffold centre 
D) Granulocytes 
E) Lymphocytes 
F) Macrophages 
G) Giant cells 
H) Fibroblasts 
I) Vasc. Structures 
J) ECM product 
K) Incorporation in surrounding tissue 
 
Scoring: 
0=not present [-] 
1=sporadically present [+/- -] 
2=a little bit present [+/-] 
3=present [+] 
4=clearly present [++] 
5=abundantly present [+++]  
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Chapter 7 : Epilogue 
Abstract 
Conclusions based on the individual chapters of the thesis will be presented separately. 
Based on these conclusions, suggestions for future projects, and ideas on how to overcome 
certain shortcomings will be provided along with some preliminary results. Finally the 
research questions from chapter 1 will be answered. 
 
The aim of this thesis was to explore the possible biomedical applications of 
polyisocyanopeptide oligoethylene glycol. The biomedical applications investigated were 
the material in its gelled state as an artificial ECM and in its diluted state as a therapeutic 
carrier. It is fair to conclude that PIC is extremely suitable for these applications.  
Over the course of this research it was sometimes difficult to understand why different 
batches of polymers resulted in vastly different hydrogels (Storage moduli and sol-gel 
temperatures). The importance of monomer purity cannot be stressed enough as observed in 
Chapter 3 with constant catalyst ratios of 1:10,000 and experimental procedure a broad 
range of molecular weights were obtained. Even small differences in purity of the 
triethylene glycol monomers affected the polymerisation kinetics, as the average molecular 
weight achievable utilizing the monomer with an optical rotation of -0.4° was 466 kg/mol 
compared to 652 kg/mol with a monomer with an optical rotation of -0.3°. Therefore 
monomer purity is an important key in reproducibly obtaining PIC with the same average 
molecular weight. One aspect of polymer characterization that was not discussed in great 
detail was the dispersity (Đ) of polyisocyanides. In general the Đ values of polymers are 
obtained from size exclusion chromatography (SEC). The SEC of oligoethylene glycol 
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polyisocyanides with THF as solvent is not ideal, a better solvent system would be 
dimethylformamide (DMF) with lithiumchloride, but as this solvent system was not 
available at the Radboud University alternative methods for determining molecular weight 
and Đ had to be used. It was possible to derive the Đ values from the lengths measured on 
AFM height images. The weighted average length (Lw) and the number average lengths 
(Ln) can be divided to obtain the Đ, under the assumption that the Lw is the same as the 
weighted average molecular weight and the Ln is the same as the number average molecular 
weight since it is known that for polyisocyanides length directly correlates to its molecular 
weight [1]. The average Đ obtained using a 1:10,000 catalyst to monomer ratio was 1.5±0.2 
(Table 1). 
Table 1. Polyisocyanide length and corresponding dispersity index values. 
Sample  Spacer monomer Weighted 
average length 
Lw (nm) 
Number average 
length Ln (nm) 
Đ (
  
  
) 
P28 triethylene glycol 296.2 210.0 1.4 
P29 triethylene glycol 362.9 221.7 1.6 
P32 triethylene glycol 1250.8 816.9 1.5 
P54 tetra ethylene glycol 320.9 231.8 1.4 
P46 tetra ethylene glycol 610.5 380.3 1.6 
P47 tetra ethylene glycol 519.2 415.8 1.2 
 
It was clear that the measurement of the molecular weight of polyisocyanides via non 
standard techniques such as AFM and viscometry compared very well to SEC in DMF with 
lithiumchloride, performed at the Stellenbosch University. In the future it should be 
possible to use field flow fractionation combined with a multi angle laser scattering detector 
to determine the Mark Houwik parameters of the oligoethylene glycol functional 
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polyisocyanides. Using a fraction collector attached to the field flow fractionation 
instrumentation it should be possible to separate long (>1 µm) polymers from the shorter 
polymers, to enable experiments requiring low signal to noise ratio such as reptation of 
fluorescently labelled PIC.   
In Chapter 4 it became clear that crosslinking was far more complicated than initially 
expected , the working hypothesis was that intra-bundle crosslinking did not result in 
increased overall stiffness of the hydrogel as it disrupted the overall persistence length of 
the bundle itself. Therefore in the future, inter-bundle crosslinking should be forced by 
crosslinking in the gelled state, with large (> 500 nm) macromolecules that contain multiple 
crosslinking sites, using crosslinking reactions with high efficiency and low concentrations 
of the crosslinker itself e.g. eight-arm star vinyl sulfone polyethylene glycol stars to 
polyisocyanides appended with either thiols or amines.  
The use of tetraethylene glycol appended polyisocyanides as stealthy therapeutic 
devices or synthetic dendritic cells resulted in surprisingly high activity at extremely low 
concentrations. The most inspiring conclusion from Chapter 5 was showing just how 
important shape, stiffness and multivalency are in activating cellular activity at extremely 
low concentrations of the active compound. The multivalent polymer worm effectively 
formed an artificial synapse with the T-cells surface, inducing the prolonged targeted attack 
of model pathogen invaders. In the future it would be possible to decorate the synthetic 
dendritic cell with combinations of not only antibodies but even larger cell instructive 
proteins such as the major histocompatibility complex to mimic natural dendritic cells more 
closely, enabling targeted immunization of e.g. patient specific cancers.  
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The stealthy properties of PIC can be further explored to cross the most sought after 
therapeutic barrier of all, the blood brain barrier.  In Chapter 5, the use of worm-like PIC 
as efficient therapeutic delivery vehicles was discussed as it shows increased circulation 
times and higher activity due to multivalency when compared to spherical carriers. 
Crossing the blood brain barrier remains a difficult endeavour for current therapeutic 
strategies as the blood brain barrier is extremely efficient at “protecting” the brain [2]. 
Serendipitously in a biodistribution study Dr Lambeck observed that PIC labelled with 
indium showed up in brain tissue (Figure 1).  
 
Figure 1. Biodistribution of  111Indium labelled polyisocyanide short = 95 nm and long = 518 nm 
(unpublished work) 
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Preliminary experiments beyond the scope of this thesis were used to investigate if this 
would also be possible in a controlled blood brain barrier experiment as illustrated in Figure 
2.  
 
Figure 2. Schematic of the in vitro blood–brain barrier model 
In this preliminary experiments two PICs with different lengths were prepared and 
coated with a fluorescent dye (Tokyo Green). The cell biology experiments were performed 
by Dr Stojanov [3]. The short (86 nm) PIC crossed the membrane more efficiently when 
compared to the long (208 nm) PIC (Figure 3).  
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Figure 3. Direct comparisons of effects of polymer length and concentration on the percentages 
of fluorescence counts found in the different compartments of the experiment. Short = 86 nm 
and Long 208 nm based on size measurements via Nanosight.  
In the future these experiments should be repeated on a range of polymer lengths, but it 
does seem very promising as the values obtained in these first experiments already match 
those observed for the spherical polymersome counterparts [3]. 
In Chapter 6 Tissue mimetic materials for vasculogenesis were made and the 
following essential parameters defined: the stiffness of the hydrogel should be between 
10-300 Pa, cell adhesion peptides should be present at an average spacing of 1 in 10 nm, 
with a molar concentration of 63.3 µM and as the rate of vasculogenesis is affected by 
the stiffness of the polymer fibre through the molecular weight, the molecular weight 
should be between 425-516 kg/mol. Tissue mimetic materials are expected to mimic 
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extremely complex and crowded environments as is beautifully illustrated in the work by 
Goodsell et al (Figure 4). It should be simple to introduce larger biomolecules such as 
antibodies (Chapter 5), growth factors (GF) and enzymes as those utilized in Chapter 
5&6.  
 
 
Figure 4. Cellular complexity and crowding form an integral part of biological platforms, as seen 
in these illustrations of basement membrane and cellular cross section by Goodsell [12]. The 
basement membrane acts as a support between tissues filled with fibrillar proteins and larger 
biomolecules.  
Vascularisation by the introduction of growth factors: In Chapter 6, 
vasculogenesis was discussed and investigated in tissue-mimetic polyisocyanide. In 
the formation of vasculature, both vasculogenesis and angiogenesis occur. 
Angiogenesis relates to the formation of new capillaries from pre-existing vessels to 
further expand and complete the vasculature [13-15]. It was speculated in the 
conclusion of Chapter 6 that to truly mimic tissue, the combinations of different 
cell adhesion ligands and the presence of additional cellular signals must be 
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incorporated. Vascular endothelial growth factor (VEGF) and basic fibroblast growth 
factor (bFGF) are the most important growth factors for vasculogenesis and angiogenesis 
[16].  In the state of the art in synthetic tissue mimetic materials containing VEGF and 
bFGF have been used as angiogenic growth factors, resulting in an improved environment 
for endothelial cells leading to vessel formation [17-22]. The addition of either VEGF or 
bFGF to tissue mimetic materials resulted in increased blood vessels density [23-24]. 
Asahara et al reported that for the creation of well-developed mature vessels in an 
ischemic hind limb model both VEGF and FGF are required [25]. The way growth 
factors are immobilized onto the tissue mimetic material may either be non-covalently 
linked [26-27], covalently linked [17,28-29] or encased in the hydrogel [30]. Controlled 
slow growth factor release can be desirable because this creates a gradient that stimulates 
endothelial cell migration towards the implants [31]. Preliminary experiments beyond 
the scope of this thesis showed that the SPAAC bioconjugation strategy utilized in 
Chapter 6 could easily be adapted to covalently attach growth factors decorated with 
bicyclononyne (BCN-NHS was non-specifically coupled to the lysine residues present 
on the growth factor, see Figure 5). Linde Zhou performed the initial cell culture 
experiments, the results of which will be discussed below. 
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Figure 5. Structures based on the protein data bank files for VEGF [32] and bFGF [33] with lysine 
residues coloured pink rendered in Pymol. 
After conjugation with bicyclononyne the growth factors did show a slight loss of 
activity, in the future this might be mitigated by using a lower molar ratio of BCN-NHS 
to growth factor (Figure 6). 
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Figure 6. Biological activity after non-specific conjugation with BCN-NHS to lysine residues 
present on the growth factors (molar ratio 10:1). Proliferation with HUVEC cells at day 3. The 
proliferation without added growth factors was set to 100%. Results are mean ± SD for 3 
separate experiments. 
Polyisocyanide (P28/29) containing 1 in a 100 nm GRGDS, but still contain ca 20 % 
free azides were covalently decorated with bicyclononyne functional VEGF, bFGF and 
both VEGF-bFGF (Table 3).  
Table 2. Concentration of PIC to GRGDS and growth factors used to study vasculogenesis.  
Sample PIC 
concentration 
(mg/mL) 
GRGDS 
concentration 
(nmol/mL) 
bFGF 
concentration 
(ng/mL) 
VEGF 
concentration 
(ng/mL) 
PIC_RGD 2.5 79 0 0 
PIC_RGD_FGF 2.5 78 100 0 
PIC_RGD_VEGF 2.5 77 0 200 
PIC_RGD_FGF_VEGF 2.5 76 100 200 
PIC_RGD free VEGF 
and FGF 
2.5 77 10 100 
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The viability and metabolic activity of the HUVECs and SMCs after incorporation in 
different hydrogels were investigated by a proliferation assay. Cell viability was determined 
with CellTiter-Glo luminescent viability assay according to the manufacturer’s instructions. 
To measure cell viability of cells encapsulated in the PIC hydrogel, the hydrogels were 
collected and placed at 0 °C to induce gel-solution transition. The now liquid hydrogels  
and cells were then transferred from the inserts into 1 mL tubes, equal volume CellTiter-
Glo reagent was added into the tubes and allow to react for 10 min. After reaction, the 
solution was transferred into 96-wel plate and analyzed by fluorescence microscopy. After 
4 days, a significant increase in proliferation was present in PIC_RGD with growth factors 
compared to the PIC_RGD hydrogel on its own. At day 21, this difference was more 
prominent. Cells mixed in PIC_RGD_VEGF_FGF or PIC_RGD with free growth factors 
showed almost 3-fold higher proliferation compared to cells within PIC_RGD. Cells mixed 
in PIC_RGD_VEGF and PIC_RGD_FGF showed a 2- and 1.5-folds increase in 
proliferation compared to PIC_RGD hydrogel, respectively (see, Figure 7).  
 
Figure 7. Cell viability at day 4 and day 21. The proliferation of PIC_RGD sample was set to 
100% baseline value. Results are mean±SD for 3 separate experiments. * indicates p<0.05. 
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To create a 3D vasculature in the hydrogel, 500,000 cells (SMCM: HUVECs =1:1) per 
mL were mixed with PIC_RGD_VEGF_FGF and MatrigelTM (n=3 per condition). 200μl 
cell suspended gel solutions were transferred into a 24-well insert with a membrane pore 
size of 0.2 μm (Corning Incorporated, Corning, USA). After 1 hour of incubation at 37 °C, 
700 μl medium was added to the culture well and cultured for 3 weeks. The culture medium 
was changed three times per week.  
Vascular tube-like structures were visualized on all the samples within 12 h, where the 
largest tube length was obtained on the sample containing both growth factors (VEGF-
bFGF). The immunohistochemistry of the structures formed on the surface of PIC-VEGF-
FGF closely resembles those formed on Matrigel surfaces, a naturally sourced tissue 
mimetic material (Figure 8). Remarkably the proliferation of cells cultured on 
polyisocyanide GRGDs containing both growth factors matched those obtained on 
polyisocyanide GRGDS sample that were continuously doped with free growth factor, 
which means that not only was the growth factors still active after covalent immobilization 
to the polyisocyanide scaffold they remained equally potent to free growth factors over a 
period of 21 days (Figure 7).  
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Figure 8. Fluorescence microscopy of tubular structures. Tubular structures on the 
surface of Matrigel and PIC-VEGF-bFGF. Cells were labelled with phalloidin (red) and 
DAPI (blue) to visualize the actin cytoskeleton and nuclei, respectively. Scale bar is 50 µm. 
In the future it would be interesting to investigate the effect of changing the bulk 
stiffness, fibre stiffness and stress stiffening on vasculogenesis in the presence of both 
growth factors covalently immobilized on the same PIC.  
Reflection 
In this thesis, the chemical and mechanical requirements for a synthetic ECM 
consisting of polyisocyanide hydrogel were explored. To control cellular fate of HUVEC-
SMC for vasculogenesis within 3 days, the presence of a covalently immobilized cell 
adhesion ligand GRGDS in a concentration range of 23-63 µM was required. From the 
initial experiments, in addition to cell adhesion ligands, the presence of additional 
covalently immobilized growth factors greatly enhanced the rate and degree of sprouting 
within 12 h and tube formation within 4 days when compared to hydrogels containing only 
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GRGDS. Surprisingly the covalently immobilized growth factors retained and matched the 
bioactivity of continuously refreshed growth factor imbibed matrices over a period of 21 
days. The mechanical properties present in these sECM at 2.0 mg/mL in medium were bulk 
stiffness <100 Pa and strain stiffening fibres with a critical stress of 2.0-2.9. Literature 
indications that synthetic matrix stiffness need to match that of target tissue to elicit the 
desired cellular response does not apply for a strain stiffening matrix. Pore size nm range 
was also shown to be a non factor for a sECM consisting of PIC in obtaining 
vasculogenesis. This is likely caused by the network being sufficiently flexible (soft) to 
facilitate cellular induced matrix remodelling through both cellular cues and native ECM 
deposition.  
Now follows a short overview of the answers to the proposed research topics: Is it 
possible to synthesize water soluble PIC? Yes, it was possible to synthesise water soluble 
PIC. Can the gelation temperature be tuned? Yes, it was possible to change the gelation 
temperature in the range of 18-42 °C either by changing the molecular weight or by making 
copolymers with different ratios of triethylene glycol to tetraethylene glycol monomers. Is 
PIC biologically inert? In cell culture material was biologically inert. Is it possible to add 
copolymers with functional handles and what is the highest tolerable handle loading? Yes it 
was possible to synthesize copolymers with functional handles, with a monomer molar ratio 
of up to 1 handle for every 100 spacer monomers. Can PIC be used as therapeutic carriers 
and how do they compare to the current state of the art? It was possible to use PIC as a 
therapeutic carrier at extremely low concentrations of polymer with high efficacy and it 
compared extremely well with current spherical therapeutic carriers. Is it possible to change 
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the bulk stiffness of PIC hydrogels? It is only possible to increase the bulk stiffness of PIC 
through concentration, all attempts of significantly increasing the stiffness via chemical or 
reversible crosslinking experiments were unsuccessful. Can a PIC hydrogel containing 
GRGDS be used as aECM for vasculogenesis (under cell culture conditions)? Yes cells 
were grown successfully in this PIC hydrogel and vasculogenesis was observed. What 
loading of GRGDS was required to induce a cellular response? A GRGDS loading of 1 in 
100 was the most effective in inducing vasculogenesis during cell culture. What 
concentration of PIC results in a hydrogel that is strong enough to suspend cells in 3D? A 
concentration range of 1.6 mg/mL to 2.0 mg/mL was satisfactory for cell culture purposes. 
Does the hydrogel itself survive cell culture? The hydrogel remains intact over extended 
periods of cell culture, but in some samples syneresis was observed. In the animal model 
PIC is subcutaneously injected; was this the correct technique for administration of the 
PIC? The hydrogels experienced a reduction in stiffness from passing through the thin 
syringe needle and as it was extremely difficult to find the hydrogel at the point of injection 
it would seem that this mode of administration is not advisable. Was the cellular response 
to the PIC hydrogel in vivo similar to that of observed in vitro? No vasculogenesis was 
observed in vivo. 
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Summary 
The aim of this thesis was to explore the possible biomedical applications of 
polyisocyanopeptide oligoethylene glycol (PIC). The biomedical applications investigated 
include the material in its gelled state as a synthetic extracellular matrix (sECM) and in its 
diluted state as a therapeutic carrier. In Chapter 1, the extracellular matrix (ECM) was 
defined to comprise of the following components:  insoluble hydrated scaffolds e.g. fibrillar 
polymers such as fibrin and collagen (biomechanical signals), proteins/ligands on the 
surfaces of neighbouring cells and soluble macromolecules (biochemical signals). The 
design parameters for sECM for vasculogenesis were defined as: 3D network containing 
cell adhesion ligands (RGD), variable bulk stiffness; fibre stiffness (strain stiffening), 
porous and cellular remodelling of the matrix is possible. In Chapter 2, the design, synthesis 
and characterization of isocyanide monomers for the synthesis of polyisocyanodipeptide 
oligoethylene glycol polymers was performed. Alanine-alanine triethylene glycol 
isocyanide monomers with varied enantiomers of alanine-alanine (LD;DL) were 
synthesized. Alanine-alanine (LD) tetraethylene glycol isocyanide monomer was 
synthesized. Isocyanide monomers of alanine-alanine (LD) oligoethylene glycol containing 
a functional handle appendage of either acetylene or azide were synthesized. As a whole, 
all the functional isocyanide monomers were synthesized successfully with overall average 
total yield of 5%. To increase the yields it would be advisable to investigate the use of 
different dehydration methods. In Chapter 3, the monomers synthesized in Chapter 2 were 
used as reactants to synthesize a broad range of (homo-;co-; ter-) polymers. It is possible to 
synthesize co and terpolymers with targeted sol-gel transition (standard deviation 6.4 °C) 
temperatures by varying the ratio of tri- to tetra ethylene glycol monomer. The LCST of tri-
ethylene glycol based homo and co-polymers are shown to be effected by up to 5 °C as a 
direct consequence of the average molecular weight. Polymers with molecular weights of 
<700 kg/mol show LCST of ~12 °C and between 300-630 kg/mol showing LCST of ~18 
°C. The bulk stiffness and critical stress of homo-; co-polymers (at the same concentration) 
above their sol-gel transition temperature are linearly related to their molecular weights. 
The addition of azide and acetylene co monomer do not affect the overall mechanical 
characteristics of the polymers up to densities of 1:50 and 1:100 respectively. It is possible 
to reliably determine the molecular weight of the synthesized water soluble PIC with two 
non standard techniques (viscometry and AFM) that compare well with standard size 
exclusion chromatography (SEC) technique. Crosslinking as a means to increase the bulk 
stiffness was explored in Chapter 4, by using both covalent and physical crosslinking 
strategies. The covalent chemistries investigated were: copper catalyzed and thiolyne click 
chemistry, SPAAC, dithiobridge and Schiff base formation, and the Schmidt reaction. The 
physical crosslinking strategies investigated were: pore blockage with gelatine spheres, 
Host-guest chemistry and ionic interactions. There is no significant increase in stiffness 
observed for any of the applied crosslinking strategies. 
The second biomedical application, PIC as therapeutic carrier, was investigated in Chapter 
5. A new class of antibody-functionalized, semi-flexible and filamentous polymer (diameter 
5-10 nm, length ~200 nm) with a controlled persistence length, a high degree of 
stereoregularity and the potential for multiple simultaneous receptor interactions was 
developed. These highly controlled, semi-stiff polymers were decorated with T cell 
activating anti-CD3 antibodies and were analyzed for application as potential synthetic 
dendritic cells (sDCs). The sDCs do not only activate T cells at significantly lower 
concentrations than free antibodies or rigid sphere-like counterparts (PLGA particles) but 
also induce a more robust T cell response. These novel sDCs are further biocompatible and 
non-toxic. The observed increased efficacy highlights the importance of architectural 
flexibility and multivalency to modulate T cell response and cellular function in general.  
In Chapter 6, PIC hydrogels, decorated with varying densities of the cell adhesion ligand 
GRGDS (Gly-Arg-Gly-Asp-Ser) was investigated as sECM both in vivo and in vitro. PICs 
are a unique type of soft hydrogels (10-1000 Pa) as they consist of extremely stiff fibrillar 
polyisocyanopeptides with oligo(ethylene glycol) side chains, which show finite bundling, 
strain stiffening under mechanical deformation and thermo-responsive super hydrogelation. 
It is shown that PIC (10-300 Pa) as sECM can induce vasculogenesis in vitro if a cell 
adhesion ligand GRGDS is covalently attached to it at a concentration of 63.3 µM. At this 
peptide concentration, the polymer itself should have a molecular weight of 425-516 
kg/mol to ensure initial sprouting occurs within three days. The sECM used in vivo had 
stiffness of <100 Pa and a critical stress of 2.0-2.9. Minimal inflammatory responses are 
observed, mice thrive and cellular invasion is observed, however no vasculogenesis is 
observed. In Chapter 7, the main findings of Chapters 2-6 are discussed and any potential 
future work briefly highlighted. The initial research questions were answered.  
 
Samenvatting 
Het doel van deze thesis was de toepasbaarheid van polyisocyanopetide oligoethyleen 
glycol (PIC) in het biomedische vakgebied te onderzoeken. Onder andere is de PIC, in een 
hydrogel formulering, toegepast als synthetisch extracellulair matrix materiaal (sECM) en 
in een verdunde oplossing is de PIC gebruikt als medicijn drager. In het eerste hoofdstuk 
werdt extracellulair matrix materiaal beschreven (ECM). Hieruit blijkt dat ECM de 
volgende componenten bevat: onoplosbare gehydrateerd vormgevend materiaal gebaseerd 
op vezelachtige polymeren, zoals fibrine en collageen (deze materialen zijn 
verantwoordelijk voor de biomechanische signalering), en eiwitten/liganden op de 
oppervlakte van de naburige cellen en oplosbare macromoleculen (voor de biochemische 
signalering). Een van de toepassingen voor een sECM is de vascularisatie van cellen in 
gebruik bij in vitro cel kweek. De sECM moet de volgende eigenschappen hebben om 
succesvol te zijn in vascularisatie experimenten: een 3D netwerk dat cel adhesie liganden 
bevat (zoals RGD peptide); een variabele bulk stijfheid en vezel stijfheid (strain stiffening); 
sECM moet poreus zijn en een cellulaire her-rankschikking van het matrix materiaal moet 
mogelijk zijn. In hoofdstuk 2 werdt het ontwerp, de synthese en de analyse van isocyanide 
monomeren, die nodig zijn voor de synthese van PICs, beschreven. Alanine-alanine 
triethyleen glycol isocyanide monomeren met verschillende enantiomeren samenstelling 
van alanine-alanine (LD; DL) zijn gemaakt. Als variant hierop is ook alanine-alanine (LD) 
tetraethyleen glycol isocyanide monomeer gesynthetiseerd. Om de verdere modificatie van 
het eindproduct de PIC mogelijk te maken, zijn isocyanide monomeren van alanine-alanine 
(LD) oligoethylene glycol met een functionele reactieve eindgroep ontwikkeld en als 
functionele groep zijn de acetyleen en azide groep gebruikt. Alle hiervoor beschreven 
monomeren zijn succesvol gesynthetiseerd en geanalyseerd. De gemiddelde opbrengst van 
deze syntheses was 5% (mol). Om de opbrengst van deze producten te verbeteren wordt 
aangeraden om verder onderzoek te doen naar de dehydratie stap van de reactie, omdat hier 
het grootste verlies geleden werd. In hoofdstuk 3 worden de verkregen monomeren uit 
hoofdstuk 2 gebruikt voor de synthese van een grote variatie aan PICs. Uit de verschillende 
monomeren zijn homo-, co- en ter-polymeren ontwikkeld. Door te variëren in de ratio 
tussen tetra- en tri-ethyleen glycol monomeren, van co- en ter-polymeren, was het mogelijk 
om de sol-gel transitie temperatuur te sturen (met een standaard deviatie van 6.4 °C). De 
LCST van triethyleen glycol gebaseerde homo- en co- polymeren is ook te beïnvloeden 
door het mol gewicht van de PIC te veranderen. Een variatie in de LCST van 5 °C is op 
deze wijze behaald: polymeren met een mol massa <700 kg/mol hebben een LCST van ~12 
°C waar hetzelfde polymeer met een mol massa van 300-630 kg/mol een LCST van ~18 °C 
heeft. Ook bestaat er een lineair verband tussen het mol gewicht van homo- en co-
polymeren en de bulk stijfheid, als mede de kritische stress van de verkregen hydrogels 
(gemeten bij de zelfde polymeer concentratie) bestaande uit deze polymeren. Het toevoegen 
van azide en acetyleen functioneel monomeer in een ratio van 1:50 of 1:100 heeft geen 
invloed op de mechanische eigenschappen van de polymeren en gels hiervan. Het mol 
gewicht van de gesynthetiseerde polymeren is op 3 manieren bepaald. Als eerste zijn de 
niet conventionele technieken viscometrie en AFM gebruikt voor het bepalen van de mol 
massa. De uitkomst van deze technieken komt goed overeen met de standaard methode van 
size exclusion chromatography (SEC). Omdat SEC niet constant beschikbaar was, is voor 
veel polymeren de molmassa met viscometrie en AFM bepaald.  Voor sommige 
toepassingen is het belangrijk om een hydrogel te hebben met een hele hoge bulk stijfheid. 
Om met de PIC gebaseerde hydrogels aan deze eigenschap te kunnen voldoen moet de bulk 
stijfheid worden verhoogd. In hoofdstuk 4 wordt er onderzoek gedaan naar het verhogen 
van de bulk stijfheid door middel van crosslinken. In dit hoofdstuk worden twee manieren 
van crosslinken vergeleken: de eerste is crosslinken door het creëren van chemische 
bindingen en de tweede methode maakt gebruik van fysische interacties. Voor de eerste 
methode is er gebruik gemaakt van verschillende chemische reacties: koper(I) 
gekatalyseerde Huisgen 1, 3 cycloadditie, thiolyn click chemie, SPAAC, disulfide vorming, 
Schiff base formatie en de Schmidt reactie zijn als crosslink reactie onderzocht. Voor de 
fysische crosslinking zijn 3 methodes onderzocht: porie blokkade met gelatine bolletjes, 
host-guest chemie en ionische interacties. Helaas bleek het onmogelijk om de bulk stijfheid 
van de PIC gels te verhogen door middel van deze geteste crosslink methodes. De 
toepasbaarheid van PICs als medicijn drager is onderzocht in hoofdstuk 5. In dit hoofdstuk 
is een nieuw soort antilichaam ontwikkeld: een semi-flexibel en draderig polymeer 
(diameter 5-10 nm, lengte ~200 nm) met een gecontroleerde persistentie lengte, een hoge 
mate van stereoregulatie en de potentie voor meerdere simultane receptor interacties. De 
ontwikkelde, semi-stijve polymere medicijn dragers zijn gedecoreerd met T-cel activerende 
anti-CD3 antilichamen om gebruikt te worden als synthetische dendritische cellen (sDCs). 
De nieuwe sDCs activeren niet alleen T cellen bij een significant lagere concentratie als 
vrije antilichamen of antilichamen geïmmobiliseerd op onbuigzame polymeren bolletjes 
(PLGA deeltjes), maar introduceren ook een meer robuuste T-cel reactie. Verder bleken de 
nieuwe sDCs niet toxisch en biocompatibel te zijn. De behaalde resultaten laten duidelijk 
het voordeel zien van de flexibiliteit in de architectuur van de PICs en de mogelijkheden die 
de PICs bieden om T-cellen op meerdere plekken te gelijk te activeren, doordat er op de 
lange flexibele hoofdketen op verschillende plekken antilichamen kunnen worden geplaatst. 
In hoofdstuk 6, werdt de toepasbaarheid van PIC hydrogels als sECM onderzocht. Hiervoor 
zijn de PIC moleculen ontwikkeld met verschillende hoeveelheden cel bindende ligand 
GRGDS (Gly-Arg-Gly-Asp-Ser). Deze GRGDS ontwikkelde PICs zijn zowel in vivo als in 
vitro toegepast als sECM. Deze materiaal zijn zo geschikt as sECM omdat dit zachte 
hydrogels (10-1000 Pa) zijn die bestaande uit extreem stijve draderige vezels van 
polyisocyanopeptides met oligo(ethyleen glycol) zijketens, die eindige bundels vormen en 
stijver worden door mechanische deformatie. Het bleekt dat PICs (10-300 Pa) gebruikt als 
sECM vasculogenese kunnen induceren in vitro, mits er cel bindende GRGDS liganden 
covalent gebonden zijn aan de PIC in een concentratie van 63.3 µM. Bij deze peptide 
concentratie gebonden aan een polymeer met een mol massa tussen de 425 en 516 kg/mol 
werden er initiële kiemen gevonden binnen drie dagen. Voor de in vivo studies is een sECM 
gebruikt met een stijfheid <100 Pa en een kritische stress van 2.0-2.9. Tijdens de studie is 
er nauwelijks inflammatie gevonden bij de muizen, in het algemeen ging het erg goed met 
de muizen en leken ze geen last te hebben van het PIC implantaat. Ook kon is er cellulaire 
invasie van het sECM gevonden, wat betekent dat er cellen van uit de muis in de sECM zijn 
gemigreerd. Er werd echter geen vasculogenese gevonden in vivo.  In hoofdstuk 7, zijn de 
hoofdconclusies uit de hoofdstukken 2-6 samengevat en besproken waarbij ook advies 
werdt gegeven voor vervolg onderzoek. De allerlaatste conclusie van deze thesis is dat de 
gestelde onderzoeksvragen zijn beantwoord.  
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